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Abstract
Biochemical and functional characterization of the tapasin/ERp57 conjugate 
David Ryan Peaper 
2007
Recognition of MHC class I/peptide complexes is required for the generation of 
CD8+ T cell responses. Peptide loading onto MHC class I/p2m dimers occurs in the ER 
and involves both specific proteins and cellular chaperones. Tapasin is essential for 
peptide loading onto most MHC class I alleles, and it forms a mixed disulfide with the 
glycoprotein specific oxidoreductase ERp57. I have characterized the biochemical 
requirements for tapasin/ERp57 conjugate formation and addressed potential functions 
for ERp57 in peptide loading. Tapasin specifically recruits ERp57 into a mixed disulfide 
at the expense o f free ERp57 in the ER. Other components of the MHC class I peptide 
loading complex are not required for conjugate formation, and, in contrast to models of 
glycoprotein folding, conjugate formation does not require the generation of 
monoglucosylated glycans.
Once associated, tapasin has evolved to inhibit the reductase activity o f the 
ERp57 a domain leading to the retention of ERp57 in the loading complex over the 
course of normal peptide loading. In contrast, calreticulin undergoes cycles of binding 
and release, and its presence in the loading complex is dependent upon MHC class I. 
ERp57 is a core structural component o f the MHC class I loading complex, and it is 
permanently sequestered there by tapasin.
i
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Finally, I have further characterized cells expressing a tapasin mutant unable to 
form the conjugate. Loading complex assembly is impaired in these cells, and peptide 
loading is inefficiently catalyzed by this mutant. Additionally, ERp57 binding stabilizes 
the structural integrity of tapasin. When endogenous ERp57 expression was suppressed 
using RNAi, all residual ERp57 was bound to tapasin, and both protein disulfide 
isomerase and ERp72, other ER resident oxidoreductases, formed mixed disulfides with 
tapasin. When redox mutant ERp57 proteins were over-expressed in these cells, only 
slight changes were seen in MFIC class I trafficking. My data indicate that ERp57 is a 
key structural component of the MFIC class I loading complex and likely does not exhibit 
any redox activity in this context. The key features o f ERp57 responsible for its function 
remain unknown.
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Chapter 1: Introduction
1.1: General function of MHC class I complexes
It was recognized in the 1950s that a restricted region of the mouse genome was 
responsible for mediating rejection of transplanted grafts. Grafts between mice with a 
common locus were rejected much more slowly, and this genetic region was labeled the 
major histocompatibility complex (MHC). The human MHC is located on chromosome 
6 and encodes a number of different immunologically relevant proteins including the 
human leukocyte antigens (HLA) that mediate graft rejection. The comparable antigens 
in mice are derived from the H-2 locus located on mouse chromosome 17. Subsequent 
work demonstrated that the HLA and H-2 antigens were the basis for recognition by T 
cells and, as such, integral to the development of a cellular immune response (Germain, 
1994; Klein and Sato, 2000).
The HLA complex is traditionally divided into three segments: class I, class II, 
and class III. The class I segment encodes the classical MHC class I proteins HLA-A, B, 
and C as well as the non-classical HLA-E, F, and G and MICA and MICB. Likewise, the 
class II region encodes the MHC class II molecules HLA-DP, DQ, and DR. All of these 
proteins are displayed on the cell surface for recognition by cells of the immune system. 
Other genes encoded in the MHC affect the function of MHC class I and II proteins as 
well as the immune system in general. The MHC also encodes proteins with no known 
function in the immune system(Klein and Sato, 2000).
MHC class I and II molecules display peptides on the cell surface to CD8- and 
CD4-positive T cells, respectively. MHC class I and II proteins are structurally related,
1
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but the natural histories o f these proteins within the cell are quite distinct. After folding 
and assembly in the endoplasmic reticulum (ER), MHC class II molecules traffic through 
the secretory pathway until they reach late endosomes. Here, they become loaded with 
peptides 12 to 16 amino acids long typically derived from the extracellular space in a 
process facilitated by other MHC encoded genes (Watts, 2004). MHC class II molecules 
are essential for the generation o f cellular immunity to extracellular pathogens such as 
bacteria, and their absence also significantly impairs the generation of humoral immunity 
(Grusby and Glimcher, 1995). MHC class II will not be considered further.
MHC class I complexes are composed of MHC encoded heavy chains (HLA-A, B 
or C) and the invariant, non-MHC encoded subunit ( E - m i c r o g l o b u l i n  ((32m). MHC class I 
assembly and peptide loading occur in the ER, and, after trafficking to the cell surface, 
antigen specific CD8+ T cells recognize peptides 8 to 10 amino acids long displayed in 
association with MHC class I/fEm complexes. The peptides presented by MHC class I 
complexes are derived from proteins degraded in the cytosol, and, in theory, CD8+ T 
cells respond to peptides primarily arising from intracellular pathogens such as viruses 
and some bacteria (Figure 1.1a) (Germain, 1994; Klein and Sato, 2000; Pamer and 
Cresswell, 1998).
1.2: The structure of MHC class I
Both MHC class I heavy chain (HC) and (Em are members of the 
immunoglobulin (Ig) superfamily. The exact length and composition of MHC class I HC 
varies among alleles, but all HLA alleles consist of three domains ( a l ,  a2 , and a3) with 
the a3 chain containing an internal disulfide bond between Cys-203 and Cys-259. The
2





Figure 1.1: MHC class I is loaded with peptide in the ER and presents pep­
tides to CD8+ T cells
A) G eneral s c h e m e  of MHC c la s s  I antigen p rocessin g  and presentation. Viral proteins in the  
cytosol are degrad ed  by the p roteasom e, and gen erated  p eptides are translocated  into the ER 
lumen via th e TAP transporter. T he peptide loading com p lex  co m p o sed  of TAP, tapasin , ERp57, 
and CRT facilitates peptide loading onto MHC c la s s  I H C /fom  dim ers. After stably a ssoc ia tin g  with 
peptide, MHC c la s s  I co m p lex e s  exit th e ER and traffic through the Golgi apparatus on their w ay to 
the cell surface. O n ce  there, antigen  sp ecific  C D 8+ T ce lls  recogn ize the p resen ted  peptide leading  
to cell killing and cytokine production.
B) MHC c la s s  I folding and a sse m b ly  ta k e s  p lace in th e ER. CNX m ed ia tes the early folding s ta g e s  
of MHC c la s s  I HC prior to its a ssoc ia tion  with (32m. C om plete h eavy  chain oxidation occu rs during 
this time, and ER p57 facilitates this p ro cess . O n ce  a sso c ia ted  and properly oxid ized, MHC c la s s  I 
H C ^ m  co m p lex e s  rapidly a s so c ia te  with CRT, ERp57, and tapasin, which a cts  a s  bridge to the  
TAP heterodim er, to form the MHC c la s s  I loading com plex. P ep tid es gen erated  in th e cytoso l by 
the p roteosom e are translocated  into the ER by TAP and su b seq u en tly  are bound to MHC c la s s  I 
through the coordinated action of the loading com plex. ERAP trims p ep tid es in th e ER to 8 to 10  
am ino acid s, and tapasin  is essen tia l for the generation  of stab le MHC c la s s  l/peptide co m p lex es  
for m any HLA alle les. G lu co se  trimmed, peptide loaded  co m p lex es  are exported from the ER.
3
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sequence o f (32m does not significantly vary between individuals, and it also contains a 
disulfide bond between Cys-25 and Cys-80. In humans, MHC class I HCs are 
glycosylated at Asn-86, while mouse H-2 alleles are glycosylated at residues Asn-86 and 
Asn-176. |32m is not glycosylated in either humans or mice (Bjorkman et ah, 1987a).
The structure of HLA-A*0201 associated with (32m and peptide was first solved in 
1987, and over 50 different MHC class I/|32m/peptide structures have been solved 
encompassing a variety of human and mouse HLA and H-2 alleles (Bjorkman et ah, 
1987a). These structures share remarkable similarities and explain a variety of 
observations made prior to that time (Parham, 2005). The a3 domain and (32m are 
proximal to the membrane and lie immediately beneath the a2  and a  1 domains, 
respectively. The a l  and a2  domains form the boundaries o f the peptide binding groove, 
and both domains contribute to the (3-pleated sheet comprising the floor of the binding 
groove. The a l  domain forms a continuous a-helix along one side of the peptide, while 
the a2  domain forms an a-helix in three segments opposite the a  1 -helix. The helices 
narrow at the extreme ends o f the peptide binding groove restricting the length of peptide 
that can be bound. A disulfide bond bridges the a2-helix and the (3-pleated floor between 
Cys-101 and Cys-164, respectively (Figure 1.2a and 1.2b) (Bjorkman et al., 1987a; 
Wright et al., 2004).
HLA alleles are the most polymorphic human genes, and the most variable 
regions of MHC class I heavy chains are the floor and helices of the peptide binding 
groove (Bjorkman et al., 1987b). Residues in these locations affect peptide and T cell 
receptor binding (Garboczi et al., 1996). Polymorphisms in the floor of the peptide 
binding groove are the basis for the different binding specificities of different HLA
4
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
d '  VI
a 2 j \ / j oc1 
a3 V\ v > ’
MHC Class I Variability
a1 a2 a3
20 40  60 80  100 120 140 160 180 200  220  240 260  280
HLA-A*0201 R es id u e #
Figure 1.2: MHC class I molecules are comprised of multiple domains and 
are highly polymorphic.
A and B) T he crystal structure of HLA-B*4402 with a  peptide derived from HLA-DPA*0201. The  
MHC c la s s  I HC is sh ow n  in blue with gray a1 and a 2  h elices; P2m is light gray. T he bound peptide  
derived from HLA-DPA*0201 is show n in red. C ys-101 and C y s-164  are sh ow n  in yellow, and  
A sn-86  is sh ow n  in blue. T he fa ce  thought to m ediate tapasin  binding is sh ow n  in (A), and the fa ce  
recogn ized  by the T-cell receptor is sh ow n  in (B).
C) MHC c la s s  I polym orphism s are clustered  in and around the peptide binding groove. Highly 
variable resid u es are sh ow n  in red in a  cartoon of MHC c la s s  I and the crystal structure of HLA- 
A*0201 (upper panel). T he lower panel d isp lays the variability of ea c h  resid ue throughout the  
length of the MHC c la s s  I HC. Figure w a s adapted  from Jan ew ay  et al. Im munobiology, 5*h edition
5
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alleles. The peptide binding groove contains six distinct pockets (A -  F) that 
preferentially bind particular amino acids or side chains. For most alleles, two or three 
residues are highly conserved in all bound peptides (anchor residues), but other peptide 
residues are more variable. In addition to binding the peptide side chains, MHC class I 
molecules strongly interact with both the amino- and carboxy-termini. The combination 
of these interactions determines the overall affinity of a bound peptide (Figure 1.2c) 
(Rammensee, 1995).
1.3: The generation and translocation of MHC class I peptide ligands
MHC class I binding peptides are traditionally derived from protein antigens in 
the cytosol. The precise source of these peptides is somewhat controversial, but it is clear 
that the initial step in the generation of MHC class I binding peptides is proteasomal 
degradation (Strehl et al., 2005; Yewdell and Nicchitta, 2006). Inhibition of proteasome 
activity using specific inhibitors dramatically decreases the pool o f peptides capable of 
binding MHC class I molecules and leads to their retention in the ER and subsequent 
degradation (Hughes et al., 1997; Hughes et al., 1996). The 20S proteasome is composed 
of 28 subunits, and the association of other co-factors that affect its proteolytic activity 
and specificity gives rise to the 26S proteasome (Strehl et al., 2005). Several proteasome 
subunits and a specific activator are upregulated by interferon gamma (IFN-y), and their 
expression alters the pool of generated peptides to be more compatible with MHC class I 
binding (Strehl et al., 2005).
Peptide generation occurs in the cytosol, but peptide loading takes place in the 
ER. The transporter associated with antigen processing (TAP) comprised of TAPI and
6
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TAP2 provides the link between these two distinct cellular compartments (Spies et al., 
1992; Spies and DeMars, 1991). Both TAPI and TAP2 are members of the large ATP- 
binding cassette (ABC) family of transporters, and peptide binding induces ATP 
hydrolysis and translocation (Androlewicz et al., 1993; Neefjes et al., 1993). The TAP 
heterodimer is promiscuous in its peptide binding and transport activities and can act 
upon peptides up to 40 amino acids. However, TAP transports peptides of 8 to 12 amino 
acids most efficiently, and this size is close to ideal for binding MHC class I molecules 
(Androlewicz and Cresswell, 1994; Momburg et al., 1994). Proteasomal cleavage 
typically creates a peptide carboxy terminal compatible with MHC class I binding, and 
peptides are typically extended at their amino terminus (Cascio et al., 2001). The ER 
amino peptidase (ERAP/ERAAP) trims N-extended peptides to a length appropriate for 
MHC class I binding (Chang et al., 2005; York et al., 2002).
1.4: Overview of MHC class I assembly
The expression of MHC class I heavy chain/(^m/peptide complexes at the cell 
surface is the end result o f a process that begins in the ER. Within the ER, MHC class I 
complexes undergo several folding events involving general cellular chaperones as well 
as MHC class I specific proteins. The generation of stable MHC class I/peptide 
complexes depends, in most cases, upon the TAP heterodimer as well as the MHC class I 
specific chaperone tapasin. TAP transports peptides from the cytosol into the ER lumen, 
and tapasin in some way promotes the formation of stable MHC class I/peptide 
complexes (Cresswell, 2000). ERAP/ERAAP plays a further role in trimming peptides 
after translocation (Saric et al., 2002; Serwold et al., 2002). Additionally, calnexin
7
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(CNX) facilitates the early folding o f MHC class I heavy chains, while calreticulin (CRT) 
and ERp57 are intimately involved in the generation o f stable complexes (Figure 1.1b). 
Many factors involved in the generation of stable MHC class I/peptide complexes are 
upregulated by cell exposure to IFN-y including TAPI, TAP2, tapasin, MHC class I HC, 
(32m, and proteasome components. Additionally, the loading and assembly of MHC class 
I complexes is considered a specialized case of protein folding, and a more thorough 
discussion of the general aspects of protein folding and quality control is needed before 
undertaking a specific discussion of MHC class I.
1.5: Protein folding in the endoplasmic reticulum
The ER has evolved multiple functions, but one of its primary roles is to facilitate 
the folding of proteins destined for the secretory pathway or extracellular secretion.
There are a number of resident proteins within the mammalian ER that act as protein 
folding chaperones including BiP, GRP94, CNX, and CRT. CNX and CRT are 
carbohydrate binding proteins (lectins) involved in glycoprotein folding (see below), and 
BiP and GRP94 are members of the highly conserved heat shock protein 70 (Hsp70) and 
Hsp90 families, respectively. In conjunction with oxidoreductases of the thioredoxin 
(Trx) family such as protein disulfide isomerase (PDI), ERp57, and ERp72, these 
proteins prevent the aggregation of newly synthesized, unfolded polypeptides, facilitate 
the acquisition of correct disulfide bonding patterns, and/or, for terminally misfolded 
proteins, initiate protein degradation (Kleizen and Braakman, 2004; Ma and Hendershot, 
2004). Additionally, BiP plays an essential role in sensing stress within the ER 
(Bertolotti et al., 2000).
8
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A common theme of chaperone function is the recognition of hydrophobic 
residues exposed on the surface of folding polypeptides. The luminal and extracellular 
environments contain charged molecules including carbohydrates and inorganic ions, and 
the presence o f hydrophobic residues on the surface of proteins is energetically 
unfavorable (Schroder and Kaufman, 2005). BiP promiscuously binds peptides enriched 
in hydrophobic residues, and the ultimate determinate of CRT and CNX binding depends 
upon exposed hydrophobic patches (Gething, 1999; Sousa and Parodi, 1995). In contrast, 
the recognition substrate for GRP94 remains unclear. GRP94 appears to bind a more 
limited subset of proteins than BiP, and may prefer partially assembled oligomeric 
complexes (Argon and Simen, 1999).
Folding proteins tend to utilize either the CNX/CRT/ERp57 or BiP/PDI folding 
pathways, and the particular chaperones used is determined by the location of the first 
glycan in the polypeptide chain (Molinari and Helenius, 2000). Some proteins 
successively interact with BiP and CNX (Hammond and Helenius, 1994), but complexes 
comprised of BiP/PDI and CNX/CRT/ERp57 are not present at high levels (Meunier et 
al., 2002). While MHC class I heavy chain may interact with BiP during its early folding 
stages, the folding and assembly of MHC class I/fTm/peptide complexes is commonly 
considered a specialized case of glycoprotein folding mediated by the CNX/CRT/ERp57 
pathway(Rudd et al., 2001).
1.6: Glycoprotein folding
Many proteins within the secretory pathway undergo N-linked glycosylation, and 
one report estimated this population at approximately 45% of the total eukaryotic protein
9
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pool (Apweiler et al., 1999). The core N-linked glycan is synthesized in a series of 
reactions beginning on the cytosolic face of the ER and ending with the generation of the 
Glc3Man9GlcNAc2 structure in the ER lumen. This core glycan is associated with the 
ER membrane through a covalent attachment to dolichol-pyrophosphate (Burda and 
Aebi, 1999). N-linked glycans are added to proteins co-translationally by the 
oligosaccharide transferase (OST) complex. The OST is associated with the translocon 
complex and recognizes the consensus sequence NXS/T in unfolded polypeptides shortly 
after passage through the translocon. OST adds the core glycan to the Asn residue of the 
consensus sequence, and this core glycan is quickly trimmed o f its terminal glucose 
residue by the enzyme glucosidase I (Hubbard and Robbins, 1979; Kowarik et al., 2002). 
Further trimming is performed by glucosidase II to generate a monoglucosylated core N- 
linked glycan. Glucosidase II also plays a role in the chaperone mediated folding of 
nascent glycoproteins in the ER. Monoglucosylated glycans serve as the recognition site 
for the two highly conserved ER resident lectin-like chaperones, CNX and CRT (Hebert 
et al., 1995; Ware et al., 1995).
CNX is a transmembrane protein of 572 amino acids that is highly conserved 
from yeast to humans, and CRT is a 400 residue soluble CNX homologue conserved 
from reptiles to mammals (Fliegel et al., 1989; Tjoelker et al., 1994). Both proteins 
consist of a lectin-like globular domain that mediates glycan binding and an extended 
proline-rich P-domain that mediates recruitment o f ERp57 to nascent glycoproteins (see 
below) (Ellgaard et al., 2002; Frickel et al., 2002; Leach et al., 2002). The crystal 
structure of the CNX globular domain has been solved, and the P-domain of CRT has 
been examined by nuclear magnetic resonance (Figure 1.3a) (Ellgaard et al., 2001a;
10
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Ellgaard et al., 2001b; Schrag et al., 2001). The globular domain of CNX contains the 
glycan binding pocket, and the P-domain curves away from the globular domain, partially 
shielding the glycan binding site (Schrag et al., 2001). Based on sequence similarity,
CRT is assumed to adopt a similar structure, but the P-domains of these proteins differ in 
length (Ellgaard and Frickel, 2003). The significance of this difference is unknown, but a 
soluble version of CNX could not fully compensate for the absence o f CRT for some 
folding substrates, including MHC class I HC (Gao et al., 2002; Molinari et al., 2004).
Like classical chaperones, CNX and CRT prevent the aggregation of folding 
substrates, retain improperly folded proteins in the ER, and, at least in the case of CNX, 
facilitate the targeting o f terminally misfolded proteins for degradation (Hebert et al., 
1996; Jackson et al., 1994; Molinari et al., 2003; Oda et al., 2003). However, CNX and 
CRT do not directly recognize misfolded polypeptides like BiP and Grp94, but they 
recognize a single glucose residue exposed on an N-linked glycan (Hebert et al., 1995; 
Ware et al., 1995). Folding substrates undergo successive rounds o f CNX/CRT binding, 
release, glucose trimming, reglucosylation, and rebinding in what is referred to as the 
glycoprotein quality control cycle as described below (Figure 1.3b) (Helenius and Aebi, 
2004).
After translation, translocation, and the generation of a monoglucosylated glycan 
by the sequential action of glucosidases I and II, CNX and CRT bind nascent 
glycoproteins (Daniels et al., 2003; Wang et al., 2005). Glucosidase II then trims the 
remaining glucose residue from the N-linked glycan. This either occurs after substrate 
release from CNX/CRT or while the substrate is still associated with the lectins (Ellgaard 
and Frickel, 2003). The elimination of the terminal glucose residue precludes further
11
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Figure 1.3: CNX, CRT, and ERp57 facilitate glycoprotein folding.
A) Crystal structure of CNX with a  hypothetical substrate and extrapolated structure of ERp57. The  
globular dom ain of CNX binds th e m onoglu cosylated  glycan of a  partially folded su bstrate while 
ER p57 red u ces, ox id izes, and/or isom erizes  a  disulfide bond. The bb’ dom ain s of E R p57 interact 
with the P-dom ain of CNX. CNX is sh ow n  in yellow, ER p57 is in blue, the folding su bstrate is 
yellow, and th e m onoglu cosylated  glycan  is red.
B) G lycoprotein quality control in th e ER. Proteins undergo co-translational g lycosylation  w hen the  
O ST transfers a p re-syn th esized  triply g lu cosy lated  core glycan  to the NXS/T c o n se n su s  
se q u e n c e . G lu co s id a ses  I and II quickly trim the core glycan  to g en era te  the m onoglu cosy lated  
glycan ca p a b le  of binding CRT and CNX. T h e se  ER lectins recruit ER p57 to the folding protein to 
facilitate proper disulfide bond formation. G lu co sid a se  II trims the terminal g lu c o se  resid ue co inci­
d en t with su bstrate re le a se . If UGGT d etec ts  ex p o se d  hydrophobic p atch es, th e su bstrate is re- 
glu cosylated  for s u c c e s s iv e  rounds of CRT/CNX binding. If the substrate ad op ts its native confor­
mation, it ex its the ER. C ST  inhibits th e action of G lu co s id a ses  I and II preventing the generation  
of the m onoglu cosy lated  glycan  n eed ed  for CRT and CNX binding.
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lectin binding. The ER resident enzyme UDP-Glc:glycoprotein glucosyltransferase 
(UGGT) acts as the glycoprotein folding sensor by detecting exposed hydrophobic 
patches in close proximity to N-linked glycans (Sousa and Parodi, 1995). If such patches 
are recognized by UGGT, it reglucosylates the folding substrate allowing further 
interactions with CNX/CRT (Caramelo et al., 2003). Reglucosylation leads to ER 
retention and re-engagement with CNX and/or CRT (Labriola et al., 1995; Van Leeuwen 
and Kearse, 1997). This cycle repeats itself until the proper structure is achieved, and the 
protein is no longer reglucosylated. Alternatively, terminally misfolded proteins are 
targeted for degradation (Wilson et al., 2000).
A number of different folding substrates have been examined to generate this 
model of glycoprotein folding including MHC class I, influenza hemagglutinin (HA), and 
the surface glycoprotein of vesicular stomatitis virus (Hammond and Helenius, 1994; 
Hebert et al., 1995; Vassilakos et al., 1996). When glucose trimming is inhibited using 
either castanospermine (CST) or N-Butyldeoxynojirimycin (NB-DMJ), the generation of 
the lectin binding substrate is prevented and, as predicted, CRT and CNX binding do not 
occur (Hammond et al., 1994; Hammond and Helenius, 1994; Keller et al., 1998). 
Additionally, genetic deletion of CRT or CNX differentially affects substrate folding; 
some proteins absolutely require CNX, while others can fold efficiently with either CNX 
or CRT (Molinari et al., 2004). The complete disruption of CNX or CRT binding with 
CST or NB-DMJ reduces folding efficiency and leads to a loss of ER quality control. 
Under these conditions, enhanced degradation and protein turnover are seen (Hebert et 
al., 1996; Keller et al., 1998).
13
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The recognition of folding substrates by CNX and CRT has classically been 
thought to be mediated solely through lectin/glycan interactions. Recent studies have 
suggested that CNX and CRT are capable of interacting with non-glycosylated substrates 
and preventing their aggregation (Danilczyk and Williams, 2001; Rizvi et al., 2004). 
Additionally, the putative polypeptide binding site has been localized to the CNX 
globular domain (Leach et al., 2002). Most of these studies have examined interactions 
under conditions of severe cellular and biochemical stress such as elevated temperatures 
approaching 42° C, however. Thus, while under some conditions CNX and CRT may 
interact with non-glycosylated proteins or with glycoproteins independent o f lectin 
binding, these interactions are likely not significant for the majority of ER folding 
substrates.
1.7: Oxidative protein folding
The majority of proteins within the secretory pathway contain disulfide bonds that 
stabilize the final folded, conformation (Sevier and Kaiser, 2002). The environment of 
the ER is more oxidizing than the cytosol, and this partially enables spontaneous disulfide 
bond formation in folding proteins (Hwang et al., 1992). However, not all bonds are 
formed at this time, and those that do form may not be correct (Darby et al., 1995). 
Improper disulfide bond formation can lead to protein degradation or aggregation in the 
ER. Thus, a number of proteins have evolved to generate proper disulfide bonds in 
folding proteins (Ellgaard and Ruddock, 2005; Ferrari and Soling, 1999).
The sulfhydryl (-SH) side group of cysteine is unique among amino acids, and, 
when two cysteines are within close proximity a disulfide bond can form. This reaction
14
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requires the deprotonation of one reactive cysteine and the donation of two electrons to 
an acceptor such as oxygen (Sevier and Kaiser, 2002; Wilkinson and Gilbert, 2004). 
These processes are dictated by the local redox conditions, and the relative balance 
between oxidized and reduced glutathione (a tripeptide of glutamic acid, cysteine, and 
glycine) contributes to the redox state in cells (Hwang et al., 1992). When proteins are 
incubated in buffers containing physiologic concentrations of oxidized and reduced 
glutathione, oxidative folding can occur. However, in vitro oxidation rates are often 
much slower than those observed in vivo. Within the mammalian ER, a large family of 
proteins that facilitate the transfer o f electrons has evolved, and the addition of the 
oxidoreductases to in vitro folding reactions can greatly accelerate the acquisition of 
native structures (Weissman and Kim, 1993).
The formation of a disulfide bond between two cysteines is referred to as 
oxidation, the breaking of a disulfide bond is reduction, and the rearrangement (coupled 
reduction and oxidation) o f a bond within a protein is isomerization (Wilkinson and 
Gilbert, 2004). All three reactions can be mediated by PDI, the primary enzyme in the 
ER lumen responsible for controlling disulfide bonding patterns, but PDI primarily acts 
as an oxidase and isomerase in vivo (Frand and Kaiser, 1999; Laboissiere et al., 1995; 
Pollard et al., 1998). PDI is a member of the larger Trx superfamily with relatively high 
sequence and structural homology to Trx (Edman et al., 1985). Trx is a cytoplasmic 
enzyme that mediates reductive events through a well conserved active site consisting of 
two cysteine residues separated by two amino acids (CXXC motif) (Sevier and Kaiser, 
2002). PDI is composed of four Trx-like domains, and the extreme N- and C-terminal 
domains contain CXXC motifs to generate a molecule with an overall abb ’a ’
15
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arrangement where the a and a ’ domains possess redox activity. PDI also contains a 
KDEL ER-retrieval sequence at its C-terminus (Edman et al., 1985; Tian et al., 2006).
The mechanism of action of PDI has been extensively investigated and is 
diagrammed in Figure 1.4a. During the reduction o f a disulfide bond, the N-terminal 
cysteine of the PDI CXXC motif becomes deprotonated to generate a thiolate anion. This 
highly reactive moiety attacks a disulfide bond, contributing an electron to a sulfhydryl 
group in the substrate protein and forming a mixed disulfide between PDI and the 
substrate. The second cysteine of the now reduced disulfide bond is free to react with 
another neighboring cysteine residue, as would occur during an isomerization reaction, 
or to remain in a reduced state (Wilkinson and Gilbert, 2004). The accumulation of 
PDI/substrate mixed disulfides is undesirable for a number of reasons, and the presence 
of this mixed disulfide is very transient (Darby and Creighton, 1995). This is due to the 
presence of the second, C-terminal cysteine of the CXXC motif which becomes 
deprotonated and attacks the mixed disulfide releasing reduced substrate and oxidized 
PDI. This is referred to as the Trx motif escape pathway, and elimination of the C- 
terminal cysteine o f the CXXC motif eliminates the escape pathway leading to the 
accumulation of PDI/substrate mixed disulfides (Walker and Gilbert, 1997; Walker et al., 
1996).
The b ’ domain of PDI mediates its interaction with folding substrates, but, within 
this domain, a number of residues appear responsible for substrate binding. The precise 
means by which PDI recognizes its substrates is not entirely clear, but it likely involves 
exposed hydrophobic patches in non-native proteins (Klappa et al., 1998; Pirneskoski et 
al., 2004). Two recent structural analyses have provided valuable insight into the
16
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Figure 1.4: PDI is a multifunctional oxidoreductase.
A) M echanism  of PDI action. T he N-terminal cy ste in e  of the two thioredoxin (Trx) CXXC m otifs of 
PDI form s a m ixed disulfide with folding su bstrates. T he C-terminal cy ste in e  of the CXXC motif 
attacks the m ixed disulfide leading to r e le a se  of reduced  substrate and oxidized en zym e. 
Pretreatm ent of ce lls  with the cell p erm eable sulfhydryl reactive reagen ts  N-Ethylm aleim ide (NEM) 
or m ethylm ethaneth iosulfonate (MMTS) or deletion  of the C-terminal cy s te in e  theoretically b locks  
e s c a p e  pathw ay activation. T he pathw ay for substrate reduction is sh ow n , and disulfide oxidation  
is the reverse. Isom erization in volves the sequ en tia l reduction and oxidation of substrate  
disulfides.
B) Crystal structure of y e a s t  PDI. T h e a  and a ’ d om ain s are show n in blue, th e b and b ’ dom ain s  
are green , and C-terminal tale is oran ge, co n sisten t with Figure 1.5. Active site  c y s te in e s  are 
show n in yellow.
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relationship between the substrate binding b ’ domain and the CXXC containing a and a ’ 
domains (Li et al., 2006; Tian et al., 2006). In both the crystal structure of yeast PDI and 
a small angle X-ray scattering study of its human homologue, PDI appears to adopt a 
compact, horse-shoe like structure (Figure 1.4b). The face of the b ’ domain responsible 
for substrate binding is oriented towards the innermost surface of the structure, and this 
arrangement may stabilize enzyme/substrate interactions and facilitate CXXC motif 
access to disulfide bonds.
Disulfide bond formation is continuously occurring in the ER, and pathways have 
evolved to maintain the ER redox balance. A genetic screen in yeast revealed that the 
protein ER oxidoreductin (Erol) is essential for the generation and maintenance of the 
ER oxidative capacity, and an Erol deficient yeast strain is not viable (Frand and Kaiser, 
1998; Pollard et al., 1998). Erol is a soluble, membrane associated glycoprotein in the 
ER lumen, and two human homologues have been identified (hErol and hEro2) (Cabibbo 
et al., 2000; Pagani et al., 2000). The Ero proteins transfer electrons from the cytosol 
directly to PDI through transient, covalent interactions involving two CXXXC active 
sites in Erol and the Trx motifs of PDI (Benham et al., 2000; Frand and Kaiser, 1999). 
The factor that transfers electrons from the cytosol across the ER membrane remains 
unknown. Historically, glutathione was thought to be the primary factor maintaining the 
relatively oxidative environment of the ER, but, in contrast, glutathione contributes a net 
reductive effect in the ER (Molteni et al., 2004). Additionally, glutathione directly 
reduces the active sites of PDI-like molecules (Jessop and Bulleid, 2004). Thus, the Erol 
pathway maintains the oxidative activity of the ER, while reducing equivalents arise from 
glutathione and its associated transporters and biosynthetic enzymes. Disruption of either
18
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pathway is lethal in yeast due to the unbalanced activity o f the remaining pathway, but 
the growth of Erol deficient yeast is restored by the additional disruption of the 
glutathione pathway (Cuozzo and Kaiser, 1999).
There are a number PDI homologues found in the human genome consisting of 
various combinations of redox active and inactive domains (Figure 1.5a and 1.5b).
Some are expressed in a tissue-restricted fashion in highly exocytic tissues (e.g. PDIp in 
the pancreas), but others, such as ERp72 and ERp57, are broadly expressed (Ellgaard and 
Ruddock, 2005). These proteins may differ in their ability to interact with Erol(Pollard 
et al., 1998). ERp57 is a glycoprotein specific oxidoreductase (see below), and the 
functional differences between different PDI family members have only recently begun 
to be addressed. Despite similarities, there may be subtle mechanistic differences 
between ER Trx family members (Kulp et al., 2006). One report suggests that PDI 
directs proteins for retro translocation, while ERp72 retains substrates in the ER (Forster 
et al., 2006).
Finally, the importance of pathways facilitating disulfide bond formation is 
emphasized by the degree of functional, structural, and sequence similarities between 
mammalian, yeast, and bacterial disulfide pathways. The periplasm of Gram negative 
bacteria is analogous to the eukaryotic ER and contains a series of proteins responsible 
for the transfer of electrons from the cytoplasm to the periplamsic space to folding 
proteins. Bacterial DsbB is a transmembrane protein that accepts electrons from the 
soluble Trx family member DsbA (Kadokura et al., 2003). DsbB is functionally 
analogous to Erol, while DsbA has both sequence and structural similarities with PDI 
(Sevier and Kaiser, 2002). Additionally, the periplasm also contains DsbC, a two-domain
19
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A Name Sol/TM C-termTail # Active domains
PDI Sol KDEL 2
ERp57 Sol QEDL 2
ERp72 Sol KEEL 3
PDIp Sol KEEL 2
ERp65 Sol KEEL 2
ERp27 Sol KVEL 0
PDIr Sol KEEL 3
ERp28 Sol KEEL 0
P5 Sol KDEL 2
ERp18 Sol EDEL 1
ERp44 Sol RDEL 1
ERp46 Sol KDEL 3
TMX TM Unknown 1
TMX2 TM KKDK 1
TMX3 TM KKKD 1
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Figure 1.5: The mammalian PDI family is diverse.
A) A sam p le  of m am m alian PDI family m em bers. T he table indicates w hether proteins are soluble  
(Sol) or transm em brane (TM). If known, the protein ER-retrieval s e q u e n c e  is  listed, a s  are the  
num ber of redox active PDI a-like dom ains. Table is adapted  from Elgaard and Ruddock, EMBO  
Reports, v6 p28.
B) Domain organization of E R p57, PDI, and ERp72. Both ER p57 and PDI p o s s e s s  two redox  
active a  d om ain s and two redox inactive b dom ains; E R p72 p o s s e s s e s  an additional a  dom ain. 
The a  dom ain of E R p57 form s a  m ixed disulfide with tapasin , and the b and b ’ dom ain s m ed iate  
CNX and CRT binding. T h e b ’ dom ain of PDI binds hydrophobic resid u es on  substrate proteins. 
T he b asic and acidic tails of E R p57 and PDI, respectively, and the acidic N-term inus of ER p72 are 
of unknown function. All three proteins h ave K DEL-based ER retrieval motifs.
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Trx family member that exhibits isomerase activity. In contrast to eukaryotes, however, 
the reductive potential of DsbC is directly maintained by DsbD rather than glutathione, 
which is not found in the periplasm.
1.8: ERp57: a glycoprotein specific oxidoreductase
Human ERp57 was first cloned as GRP58, and a number of different enzymatic 
functions, including phospholipase, transglutaminase, and protease activity, were 
ascribed to ERp57 (Hirano et al., 1995; Mazzarella et al., 1994; Murthy and Pande, 
1994). What has increasingly become clear, however, is that ERp57 is highly 
functionally related to PDI and primarily functions in disulfide bond reactions of folding 
glycoproteins in the ER (Ellgaard and Frickel, 2003). Like PDI, ERp57 is composed of 
two CXXC containing, redox active Trx domains and two redox inactive Trx domains 
with an overall arrangement of abb ’a ’(Frickel et al., 2004; Russell et al., 2004; 
Silvennoinen et al., 2004). ERp57 exhibits reductase, oxidase, and isomerase activity in 
vitro, but the primary in vivo function o f ERp57 remains unclear (Frickel et al., 2004). 
ERp57 has not yet been shown to interact with hErol, but glutathione directly reduces 
ERp57 regenerating its enzymatic activity (Jessop and Bulleid, 2004; Mezghrani et al.,
2001).
ERp57 is specifically recruited to folding glycoproteins through interactions with 
CNX and CRT (Oliver et al., 1999; Oliver et al., 1997). The P-domains of CNX and 
CRT primarily bind the b ’ domain of ERp57 analogous to substrate recognition and 
binding by the b ’ domain of PDI (Frickel et al., 2002; Pollock et al., 2004; Russell et al., 
2004). Additional contacts between the ERp57 b domain and the P-domain of CNX
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stabilize this interaction. The crystal structure of the bb ’ fragment of ERp57 has been 
solved, and there are several clear differences with PDI in this region. Not surprisingly, 
these differences correlate to regions of CNX binding (Kozlov et al., 2006).
ERp57 forms mixed disulfides with newly translated glycoproteins, and the 
disruption of interactions o f CNX and CRT with folding substrates using CST or NB- 
DMJ also prevents substrate interactions with ERp57 (Molinari and Helenius, 1999). 
Additionally, CST treatment alters the kinetics of oxidative folding for several 
glycoprotein substrates examined (Kang and Cresswell, 2002; Molinari et al., 2004). The 
in vitro activity of ERp57 towards glycosylated substrates is dramatically enhanced by 
the presence of CNX or CRT (Zapun et al., 1998). Thus, ERp57 is thought to function 
specifically with CNX and CRT to promote correct disulfide bond formation in folding 
glycoproteins. Inhibition of lectin/substrate interactions abolishes the recruitment of 
ERp57 to folding substrates.
The role of ERp57 in the oxidative folding of glycoproteins was confirmed using 
ERp57 deficient mouse embryonic fibroblasts (MEFs). In the absence o f ERp57, the 
folding of influenza HA was delayed, and the authors suggest that HA is an obligate 
ERp57 substrate. In contrast, two Semiliki Forest virus proteins that normally interact 
with ERp57 were able to fold using alternative oxidative and chaperone pathways, 
suggesting that they are facultative ERp57 substrates (Solda et al., 2006). Additionally, 
in this paper RNA-interference (RNAi) was used to knock-down ERp57 expression 
>90%, but only slight differences were seen in HA oxidative folding. When the work of 
Solda et al. and Molinari et al. are considered together, it becomes clear that one of the 
primary functions o f CNX and CRT is their recruitment of ERp57. The primary defect
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seen in the maturation o f viral glycoproteins in the absence of CNX or CRT or in the 
presence of CST involved altered oxidative folding and the accumulation of high 
molecular weight disulfide-linked oligomers. In particular, HA translated in cells treated 
with CST or cells deficient in ERp57 matured and aggregated with remarkable 
similarities (Molinari et al., 2004; Solda et al., 2006). Thus, glycoprotein folding and 
oxidative protein folding intersect at ERp57.
1.9: MHC class I: Early folding events
MHC class I heavy chain undergoes co-translational glycosylation at residue Asn- 
86. Immediately upon translocation, MHC class I HC interacts with BiP followed by 
CNX (Nossner and Parham, 1995). CNX likely recruits ERp57 to facilitate disulfide bond 
formation within the a3 , Ig-like domain at this time. However, CNX is dispensable for 
MHC class I HC folding and assembly (Sadasivan et al., 1995). A second disulfide bond 
between Cys-101 and Cys-164 of the a l  and a2  domains, respectively, subsequently 
forms, and (32m association appears required for the stable formation o f this bond. In the 
absence o f |32m, MHC class I HC is found in fully oxidized, partially oxidized, and fully 
reduced forms (Tector et al., 1997). The overwhelming majority of both human and 
mouse mutant MHC class I molecules lacking either Cys-101 or Cys-164 do not associate 
with |32m and most proteins are rapidly degraded. However, some mutant molecules 
reach the cell surface, but their ability to stimulate T cells is severely impaired 
(Warburton et al., 1994). After initial oxidative folding, MHC class I/f^m complexes 
dissociate from CNX, but they remain monoglucosylated and associate with CRT.
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1.10: Peptide loading in the ER
The early folding of MHC class I molecules and association with [Cm occurs 
within minutes after synthesis. However, rather than proceed out of the ER, MHC class 
I/fLm complexes associate with the peptide loading complex (PLC). In addition to MHC 
class I HC/|32m dimers, the PLC is composed o f TAPI, TAP2, tapasin, ERp57, and CRT. 
The transport molecule BAP31 and PDI have also been reported to be associated with the 
PLC (Ladasky et al., 2006; Paquet et al., 2004; Park et al., 2006; Spiliotis et al., 2000). 
Several different groups have independently identified the association and function of 
BAP31, but there is only one report of the involvement of PDI in peptide loading. The 
TAP heterodimer is the core of the PLC, and four sub-complexes consisting of tapasin, 
ERp57, CRT and MHC class I/|32m dimers are associated with each TAP heterodimer 
(Ortmann et al., 1997). In mice, the association of CNX with MHC class I is maintained 
within the PLC, but, while CNX can be detected with TAP in human cells, CNX does not 
appear to directly interact with PLC-associated MHC class I HC (Diedrich et al., 2001; 
Ortmann et al., 1997; Suh et al., 1996). Cell lines and animals deficient in different 
components of the MHC class I loading pathway have greatly clarified the particular role 
for each protein.
First and foremost, |32m is an obligate partner for MHC class I HC. As discussed 
above, [Cm association occurs very early during MHC class I folding, and the absence of 
|32m virtually precludes all subsequent folding, assembly, and loading steps. Cells 
lacking |32m do not express MHC class I complexes on their surface, and mice with the 
|32m gene disrupted have severely impaired CD8 T cell mediated immunity (D'Urso et al., 
1991; Sege et al., 1981; Williams et al., 1989; Zijlstra et al., 1990).
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The stability of MHC class I/|32m complexes assembled in cells deficient in TAP 
expression is severely impaired as measured by decreased to absent cell surface 
expression and their rapid degradation (Salter and Cresswell, 1986; Spies et al., 1992; 
Spies and DeMars, 1991). Consistent with this, mice genetically disrupted to lack TAPI 
have no peripheral CD8+ T cells secondary to absent MHC class I expression on cells of 
the thymus. The peripheral cells of these mice resemble TAP deficient cell lines in their 
MHC class I phenotype (Van Kaer et al., 1992). Interestingly, HLA-A*0201 is able to 
bind signal sequence derived peptides and achieve relatively high surface expression in 
the absence of a functional TAP transporter. This appears to be unique among HLA 
molecules examined (Wei and Cresswell, 1992). Thus, peptide transport by TAP is 
absolutely essential for the generation of stable MHC class I/peptide complexes as well 
as productive CD8+ T cell immunity. In contrast, more subtle defects were seen in mice 
deficient in ERAP/ERAAP or the IFN-y inducible proteasomal subunits LMP2 and 
LMP7 (Fehling et al., 1994; Hammer et al., 2006; Van Kaer et al., 1994; Yan et al.,
2006).
Mice genetically disrupted to lack CRT die shortly after birth, but MHC class I 
antigen processing and presentation have been examined in cells derived from these 
animals (Gao et al., 2002). With the exception of CRT, PLC composition appears normal 
in these cells, but the assembly and transport of MHC class I/peptide complexes were 
impaired. Unstable, poorly loaded MHC class I complexes exited the ER more rapidly in 
CRT deficient MEFs compared to wild-type (WT) cells. Additionally, the generation of 
some CD8 T-cell specific epitopes was impaired in these cells. From the experiments 
conducted it is impossible to conclude if the defects in MHC class I antigen presentation
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seen in CRT deficient cells are due to effects in the PLC or more generally within the ER; 
it is clear that CRT plays a key role in regulating the export o f properly loaded MHC 
class I molecules to the cell surface.
1.11: Tapasin is an MHC class I specific chaperone
The laboratory of Robert DeMars generated a series o f mutant cell lines selected 
to be deficient in MHC class I surface expression. Genetically, these cell lines all 
harbored large deletions within the MHC including genes encoding MHC class I HCs and 
TAPI and TAP2. One of these cell lines, 721.220, exhibited an allele specific phenotype. 
The genes encoding endogenous HLA alleles were completely lost, but transfected 
alleles, including HLA-B*0801, were differentially expressed at the cell surface despite 
normal mRNA levels(Greenwood et al., 1994). This cell line was later found to lack 
expression of a novel glycoprotein named tapasin for TAP associated glycoprotein 
(Sadasivan et al., 1996). Re-expression o f tapasin in 721.220 cells restored the surface 
expression of HLA-B*0801, confirming the importance of tapasin in MHC class I 
loading (Ortmann et al., 1997). Additional alleles have been examined for their 
dependence upon tapasin for optimal peptide loading, and HLA-B*4402 is the most 
“tapasin dependent” allele examined to date (Park et al., 2003).
In the absence of tapasin, MHC class I HC, CRT, and ERp57 do not 
appreciably associate with TAP, and, in the absence of (32m, tapasin associates with TAP, 
but CRT and MHC class I HC do not (Hughes and Cresswell, 1998; Sadasivan et al., 
1996). Thus, tapasin acts as a bridge between MHC class I/|32m complexes and TAP. It 
was originally hypothesized that the primary function of tapasin was to bring MHC class
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I/(j2m dimers within close proximity of TAP to facilitate peptide loading. This is clearly 
not the case, however, as a soluble version of tapasin that does not interact with TAP 
mediates peptide loading to a great extent, but the generation of a conformation 
dependent HLA-Bw4 epitope was somewhat impaired in these cells (Lehner et al., 1998; 
Tan et al., 2002). In contrast, the N-terminus of tapasin is essential for MHC class I 
association and peptide loading. Tapasin mutants truncated at the N-terminus by 50 or 19 
amino acids associate with TAP but poorly recruit MHC class I, and peptide loading in 
cells expressing these mutants is indistinguishable from cells lacking tapasin altogether 
(Bangia et al., 1999; Momburg and Tan, 2002). The N-terminus of tapasin appears to 
constitute a distinct domain from the rest of the molecule (Chen et al., 2002). Tapasin 
expression also stabilizes TAP, leading to increased steady-state levels compared to 
tapasin deficient cells (Bangia et al., 1999; Garbi et al., 2003).
Despite numerous studies, tapasin’s mechanism of action remains unclear, and 
these studies have been complicated by the number of alleles examined and the different 
effects of tapasin on different alleles. In the absence of tapasin, HLA-B*0801 is capable 
of binding high affinity peptides, but the overall pool of bound peptides is reduced 
(Zarling et al., 2003). These data suggest that tapasin stabilizes empty MHC class I/|32m 
complexes in the ER, facilitating subsequent productive peptide loading events. 
Alternatively, several studies suggest that tapasin directly optimizes the peptide repertoire 
bound by MHC class I molecules (Barber et al., 2001; Brocke et al., 2002; Howarth et al., 
2004; Purcell et al., 2001; Tan et al., 2002; Williams et al., 2002). Tapasin also exerts a 
general quality control function in the ER preventing the export of empty or poorly 
loaded MHC class I complexes (Barnden et al., 2000). The function of tapasin within the
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PLC awaits a suitable in vitro system analogous to that developed for MHC class II and 
HLA-DM. Using components purified from cells, a series of studies have demonstrated 
that the transient interaction o f HLA-DM with MHC class II complexes induces the 
dissociation of CLIP, the MHC class II invariant peptide, stabilizes empty MHC class II 
complexes, and affects the final pool of peptides presented at the cell surface by MHC 
class II (Denzin et al., 2005). While it has been hypothesized that tapasin could function 
directly analogous to HLA-DM, this has yet to be clearly shown (Brocke et al., 2002). 
Nevertheless, existing data clearly show that the peptide loading of most HLA alleles as 
measured by cell surface expression, thermostability, turnover, etc. is improved in the 
presence of tapasin.
1.12: Tapasin and ERp57 form a mixed disulfide within the MHC class I loading 
complex
From a glycoprotein folding perspective, MHC class I complexes are substrates to 
be acted upon by the chaperones CRT, ERp57 and tapasin. When ERp57 was identified 
as a PLC component it was expected to interact directly with MHC class I HC analogous 
to other glycoprotein folding substrates (Cresswell et al., 1999a; Cresswell et al., 1999b). 
Thus, the identification of a mixed disulfide between ERp57 and tapasin (the conjugate) 
within the PLC was surprising (Dick et al., 2002). Cys-95 of tapasin forms a disulfide 
bond with Cys-57 in the a domain of ERp57, and HLA-B*4402 complexes assembled in 
the presence of a tapasin mutant lacking Cys-95 (C95A) exhibit decreased 
thermostability and impaired peptide loading. Additionally, the redox state of HLA- 
B*4402 HCs associated with C95A mutant tapasin is altered; the Cys-101/Cys-164 bond
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is reduced after PLC isolation and SDS-PAGE. However, the inability of tapasin to form 
the conjugate did not affect its ability to promote peptide loading of SIINFEKL (a peptide 
derived from ovalbumin presented by H2-Kb) and variant peptides (Howarth et al., 2004).
The importance of ERp57 incorporation into the PLC was emphasized by the 
generation of mice lacking expression of ERp57 in B cells. In these cells, surface H2-Kb 
expression was reduced and displayed enhanced turnover compared to ERp57 competent 
cells. Additionally, the recruitment of H2-Kb into the PLC was altered, and its trafficking 
through the Golgi apparatus was accelerated. ERp5 7-deficient fibroblasts had slightly 
decreased presentation of the SIINFEKL epitope, but no alterations in the redox state of 
PLC-associated H2-Kb were seen in these cells (Garbi et al., 2006).
1.13: Outstanding questions
Despite the generation of mice with ERp5 7-deficient B cells and murine cell lines 
completely deficient in ERp57 expression, the role of ERp57 in MHC class I peptide 
loading remains unclear. There are several discrepancies between data generated using 
human cells expressing HLA-B*4402 and C95A tapasin and murine B cells lacking 
ERp57 and expressing H2-Kb. These differences could arise from species or allelic 
differences or, alternatively, could be a consequence o f the systems used. In particular, 
while the complete absence of ERp57 provides some insight into its function in the PLC, 
studies examining mutants deficient in one of several possible ERp57 functions would be 
more informative.
More generally, however, the presence of ERp57 in the PLC was thought to 
further support the glycoprotein folding model of MHC class I loading. The fact that
29
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ERp57 forms a mixed disulfide with tapasin rather than MHC class I heavy chain 
deviates somewhat from this model, and further differences may exist. Additionally, it 
has proven difficult to detect oxidoreductases containing mixed disulfides under normal 
conditions. Thus, the involvement of ERp57 in MHC class I loading may be exceptional 
in several aspects. In the following dissertation, I will address these two issues to 
generate a more complete understanding of the role of ERp57 in MHC class I loading.
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Chapter 2: Specific recruitment of ERp57 into the MHC class I
loading complex by tapasin.
Optimal peptide loading onto MHC class I molecules depends on the complete 
assembly of the MHC class I loading complex, consisting of TAPI, TAP2, tapasin, 
ERp57, CRT, MHC class I HC, and (32m (Cresswell, 2000). The mixed disulfide 
between ERp57 and tapasin has only recently been described, and the cellular and 
immunologic conditions required for conjugate formation remain somewhat unclear 
(Antoniou and Powis, 2003; Dick et al., 2002). Variations in tapasin conjugation could 
be related to a number of processes relevant to peptide loading, including the peptide 
occupancy of MHC class I/(32m dimers, PLC composition, or others. Finally, if  MHC 
class I peptide loading is a specialized case of glycoprotein folding, the recruitment of 
ERp57 into the PLC should be consistent with its interactions with other folding 
substrates. Thus, I initially examined the conditions required for ERp57 incorporation 
into the MHC class I loading complex and conjugate formation. By using methyl 
methanethiosulfonate (MMTS) instead of N-ethylmaleimide (NEM), I show that tapasin 
alone preferentially recruits ERp57 into the conjugate, and this recruitment is 
independent of glycan binding by ER lectins.
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2.1: Tapasin expression determines free ERp57 levels
We previously showed that in NEM-treated B cell lines, a substantial but 
unquantitated fraction of cellular ERp57 exists in a mixed disulfide with tapasin (Dick et 
al., 2002), but a population of free tapasin was always observed in these experiments. 
Thus, different cellular conditions could dictate the extent of tapasin conjugation and 
potentially affect the efficiency of MHC class I peptide loading. To determine whether 
free versus tapasin-associated ERp57 levels were dictated by cellular folding 
requirements or by the levels of tapasin in the ER, I treated HeLa-M cells with IFN-y to 
increase expression of tapasin and other components of the MHC class I pathway. We 
recently found that MMTS is superior to NEM in preserving the tapasin/ERp57 conjugate 
(P.C., unpublished observation), and cells were treated with MMTS prior to detergent 
extraction. Based on non-reducing SDS-PAGE and quantitative Western blotting, I 
observed that overall ERp57 levels did not change with IFN-y treatment, but the pool of 
free ERp57 was dramatically reduced (Figure 2.1a and 2.1b). Tapasin expression was 
increased 8-fold by IFN-y, and conjugate levels increased by the same amount (Figure 
2.1c). In untreated cells, nearly 85% of the cellular ERp57 pool was free and available to 
assist glycoprotein folding. In contrast, in HeLa-M cells treated with IFN-y, 80% of the 
ERp57 was disulfide-linked with tapasin, as confirmed by immunoprecipitating for 
tapasin and blotting for ERp57 (Figure 2.Id). Additionally, no free tapasin was seen 
under non-reducing conditions, but, due to the experimental design, I could not fully rule 
out the presence of free, unconjugated tapasin in these cells. Interestingly, in both IFN-y 
treated and untreated cells, free ERp57 was found in at least two different redox states 
based on its mobility in SDS-PAGE under non-reducing conditions. Thus, stimulation of
32
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Figure 2.1: IFN-y treatment drives tapasin association and decreases the 
pool of free ERp57
A) IFN-y red u ces the pool of free ERp57. HeLa-M ce lls  w ere treated with IFN-y for two d a y s prior 
to harvesting and MMTS treatm ent. Three fold serial dilutions of cell extracts w ere resolved  by 
SD S-PA G E  under reducing or non-reducing conditions and blotted with rabbit anti-ER p57 raised  
again st a  C-terminal peptide (R .ER p57-C ). After probing for ERp57, m em b ran es w ere stripped, 
cut, and re-probed for tapasin  with R .gp48N  or for ER p72 with R b.ER p72 a s  a  loading control.
B) IFN-y red u ces the pool of free ERp57. B an ds in (A) corresponding to conjugated  and free  
ER p57 under non-reducing conditions w ere quantitated, and the percent of free ER p57 w a s  
calcu lated . D ata sh ow n  are the av era g e  ± SEM of three dilutions from two sep ara te  experim ents.
C) IFN-y in cr ea se s  conjugate le v e ls  to the sa m e  extent a s  tapasin  exp ression . B ands in (A) 
corresponding to tapasin  and conjugated  ER p57 with and without IFN-y treatm ent w ere  
quantitated, and the fold in crease  in exp ression  w a s  calcu lated . D ata sh ow n  are th e a v era g e  ± 
SEM  of three dilutions from two sep ara te  experim ents.
D) IFN-y induction of tapasin  red u ces the pool of free ER p57. L ysates from (A) w ere precleared  
and precipitated with m o u se  anti-tapasin (P a S ta l) , -E R p57 (M aP.ERp57), or -PDI (M.PDI) and  
protein G -sep h a ro se . S a m p les  w ere reso lved  under reducing or non-reducing conditions a s  
indicated and blotted with rabbit anti-peptide R .ERp57-C . The upper m olecular w eight s p e c ie s  
con ta ins both tapasin  and E R p57, and E R p57 ex is ts  in at lea st two oxidation sta te s .
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tapasin expression by IFN-y dramatically reduces the level of non-tapasin associated 
ERp57 available to assist glycoprotein folding.
2.2: Conjugate formation is independent of f^m, MHC class I HC, TAPI, and
TAP2
In the absence of NEM treatment, no ERp57 was found associated with TAP or 
tapasin in the (Em deficient B-LCL Daudi, and only a small fraction o f total tapasin was 
detected in a disulfide-linked conjugate with ERp57 when these cells were treated with 
NEM (Dick et al., 2002; Hughes and Cresswell, 1998). Additionally, no conjugate was 
seen in the (Em-deficient melanoma cell line FO-1 under similar conditions. Expression 
of (32m in these cells by transfection led to increased steady state levels o f the 
tapasin/ERp57 conjugate (Dick et al., 2002). The expression of tapasin in FO-1 cells is 
relatively low and can be increased by IFN-y treatment. To determine whether increased 
tapasin expression in the absence of (32m could promote greater conjugate formation, or if 
defective conjugate formation was due to the absence of (32m, I stimulated FO-1 and FO- 
1 .(32m, a |32m-expressing transfectant, with IFN-y. The cells were then treated with 
MMTS prior to solubilization in digitonin, which preserves the TAP/tapasin interaction, 
or Triton X-100, which does not. By a combination o f immunoprecipitations, reducing 
and non-reducing SDS-PAGE, and Western blotting, I observed that all detectable TAP- 
associated and total intracellular tapasin was conjugated to ERp57, regardless of (32m 
expression (Figure 2.2a). These findings confirm the preliminary data above suggesting 
that, under steady-state conditions, all tapasin is conjugated to ERp57. Unlike Figure 
2.1a however, the design of this experiment allows me to reliably draw this conclusion.
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Figure 2.2: All tapasin is conjugated to ERp57 in the absence of f32m> TAP1, 
TAP2, or MHC class I HC
A) All TAP a sso c ia ted  and cellular tapasin  is conjugated  to ER p57 in the p resen ce  or a b se n c e  of 
P2m. Post-nuclear supern atan ts from IFN-y treated FO-1 or FO -1.p2m ce lls  solubilized  in the  
indicated d etergen ts w ere precipitated with m o u se  anti-TAP1 (148 .3), -E R p57 (M aP.ERp57), 
-tapasin  (P aS ta-1), or -PDI (M.PDI) and protein G -sep h arose . SD S-PA G E  w a s performed under 
reducing or non-reducing conditions and probed for tapasin  with R .gp48C .
B) Full conjugate formation occu rs in the a b se n c e  of TAP1 and TAP2 a s  well a s  FILA-A, B, and C. 
T he indicated derivatives of the B-LCL 721 w ere solubilized in Triton X -100 and post-nuclear  
su pern atan ts w ere precipitated with m o u se  anti-ER p57 (M aP.ERp57) or -tapasin  (P a S ta l)  coupled  
to A 15m  a g a ro se  or m o u se  anti-PDI (M.PDI) and protein G -sep h arose . S a m p les  w ere incubated  
in the p resen ce  or a b se n c e  of DTT a s  indicated. Following separation and transfer, tapasin  w a s  
d etected  by probing with R .gp48C .
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Identical results were obtained with Daudi and its (32m-expressing derivative Daudi.|32m 
(data not shown).
We previously observed conjugate formation in the TAPI and TAP2 negative cell 
line 721.174, but, as with (32m deficient cells, the extent o f conjugate formation varied 
somewhat leading to speculation that the conjugation state of tapasin could be related to 
the relative peptide occupancy or loading state of associated MHC class I/|32m dimers 
(Dick et al., 2002; Wright et al., 2004). Therefore, I next examined the extent of 
conjugate formation under steady-state conditions in cells expressing minimal amounts of 
MHC class I HC (721.221), cells lacking TAPI and TAP2 expression (721.174), and a 
related cell line that is fully competent for MHC class I antigen loading (721.45.1). Once 
again, in cells pretreated with MMTS, all cellular and TAP-associated tapasin was 
disulfide bound to ERp57 regardless of the presence of MHC class I HC, TAPI or TAP2 
(Figure 2.2b). Thus, there appears to be no relationship between the ability of the cell to 
generate MHC class I HC/|32m complexes, with or without TAP translocated peptides, 
and full conjugate formation.
2.3: The kinetics of conjugate formation are unaffected by expression
We previously showed that tapasin and ERp57 rapidly associate with TAP shortly 
after synthesis (Diedrich et al., 2001). These experiments were conducted without NEM 
or MMTS treatment, however, so formation of the disulfide-linked conjugate could not 
be assessed. Additionally, if the kinetics of conjugate formation are related to the 
incorporation of MHC class I heavy chain or other loading complex components, the rate 
or order o f loading complex assembly may be altered in cells lacking (32m. Only minimal
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Figure 2.3: p2m expression does not affect the rate of conjugate formation
A and B) IFN-y treated FO-1 or FO-1.(32m ce lls  pulsed  with [3 5 S]-m ethionine and cy ste in e  for five 
m inutes w ere c h a se d  for the indicated periods prior to solubilization in digitonin. Post-nuclear  
su pernatants w ere precipitated with th e anti-TAP1 mAb 148 .3  or m o u se  IgG coupled  to a g a ro se  
b ea d s  (C = Ctrl). A ssoc ia ted  proteins w ere stripped in 1% S D S  and tapasin  and its conjugate with 
ER p57 w ere reprecipitated with R .gp48C  and protein A -sep h arose.
C) Data from p an e ls A and B p resen ted  a s  a  p ercen tage of the m aximum  ER p57-tapasin  conjugate  
signal throughout th e c h a s e  period.
D) N ewly syn th esized  tapasin  rep resen ts m ost of th e radioactivity incorporated into th e conjugate. 
S a m p les  w ere prepared a s  in A and B, but g e ls  w ere run under reducing conditions.
37
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
amounts o f MHC class I HC are associated with TAP in the absence of (32m, and in these 
cells no TAP-associated CRT is seen. Thus, the altered incorporation o f these key PLC 
components could affect the kinetics of conjugate formation without largely perturbing 
the extent of conjugate formation. To examine these questions, I looked at the kinetics of 
conjugate formation in IFN-y-treated FO-1 and FO-l.|32m cells using pulse-chase 
analyses. After a 5 min pulse with [35S]-methionine and cysteine some TAPI-associated 
tapasin-ERp57 conjugate was already detectable, regardless of (32m expression (Lane 1 in 
Figures 2.3a and 2.3b). Conjugate formation then increased with identical kinetics in 
FO-1 and FO-1. (32m cells (Figure 2.3c). When samples were run under reducing 
conditions, the signals from both ERp57 and tapasin were unchanged with time but 
tapasin was more strongly labeled, arguing that the majority of the dimer signal under 
non-reducing conditions arises from newly synthesized tapasin and resident ERp57 
(Figure 2.3d). Identical results were obtained when the primary immunoprecipitations 
were performed with a monoclonal antibody (mAb) specific for ERp57 (Figure 2.4a-d).
2.4: Complete tapasin oxidation can occur after TAP association
Comparing Figure 2.3a with Figure 2.3d, the band corresponding to free tapasin 
became noticeably sharper at later chase points under non-reducing conditions. Under 
reducing conditions, however, tapasin clearly resolved as a single band. These data 
suggested that tapasin may initially associate with TAP in a partially oxidized state. To 
test this hypothesis, I examined the biosynthesis of the ERp57-tapasin conjugate in a 
pulse chase analysis by first immunoprecipitating for TAPI, releasing associated tapasin 
under non-reducing conditions with SDS, and resolving free and conjugated tapasin by
38
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Figure 2.4: (32m expression does not affect the rate of conjugate formation
A and B) IFN-y treated FO-1 or FO-1.|32m ce lls  pulsed  with [3 5 S]-m ethionine and cy ste in e  for five 
m inutes w ere c h a se d  for the indicated periods prior to solubilization in digitonin. P ost-nuclear  
su pernatants w ere precipitated with the anti-ERp57 mAb M aP.ERp57 or m o u se  IgG coupled  to  
a g a ro se  b e a d s  (C = Ctrl). A ssoc ia ted  proteins w ere stripped in 1% S D S  and tapasin  and its 
conjugate with ER p57 w ere reprecipitated with R .gp48C  and protein A -sep h arose.
C) Data from p a n e ls  A and B p resen ted  a s  a  p ercen tage of the m aximum  E R p57-tapasin  conjugate  
signal throughout th e c h a s e  period.
D) Newly syn th esized  tapasin  rep resen ts m ost of th e radioactivity incorporated into the conjugate. 
S a m p les  w ere prepared a s  in A and B, but g e ls  w ere run under reducing conditions.
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SDS-PAGE under both reducing and non-reducing conditions. Tapasin initially 
associates with TAP as a monomer in two oxidation states (Figure 2.5). Tapasin 
contains two luminal disulfide bonds, between Cys-295 and Cys-362 in the membrane- 
proximal immunoglobulin-like domain and between Cys-7 and Cys-71 in the N-terminal 
region. Ig domains fold relatively freely and independently, and a human tapasin Cys- 
295 mutant fails to associate with TAP (Dick et ah, 2002; Isenman et al., 1979; Tumquist 
et al., 2004). It is highly likely, therefore, that upon TAP association tapasin contains an 
oxidized disulfide bond within the Ig domain, but the Cys-7-Cys-71 bond is initially 
reduced (upper band in Lane 2). Within 30 min of TAP association, all tapasin resolves 
as a single band of increased mobility consistent with full oxidation. The rate of 
ERp57/tapasin dimer formation is inversely related to the rate of disappearance of the 
upper band that putatively lacks the Cys-7-Cys-71 disulfide.
ERp57 can form a mixed disulfide with tapasin mutants lacking the Cys-7-Cys-71 
disulfide bond (Dick et al., 2002), and it is therefore conceivable that the tapasin/ERp57 
conjugate could form during the early folding stages of tapasin and persist after TAP 
association. Alternatively, the conjugate could form concurrently with or rapidly 
following complete tapasin oxidation. My experiments do not differentiate between these 
possibilities. Nevertheless, while ERp57 may play a role in tapasin folding after 
assembly with TAP, in contrast to the behavior expected for a protein disulfide 
isomerase, the association persists after tapasin has acquired the characteristics o f a 
native protein, including full oxidation, functional activity and reactivity with 
conformation specific antibodies.
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Figure 2.5: Tapasin completes oxidative folding after TAP association
IFN-y-stimulated FO -1.p2m ce lls  pulsed  with [3 5 S]-m ethionine and cy ste in e  for 5 min w ere c h a se d  
for the indicated tim es prior to solubilization in digitonin. Post-nuclear su pernatants w ere  
precipitated with an anti-TAP1 mAb (148 .3 ) or m o u se  IgG coupled  to a g a ro se  b e a d s  (C=Ctrl), 
stripped, and reprecipitated with R .gp48C  recognizing tapasin  and protein A -sep h arose . S a m p les  
w ere incubated with DTT b efore SD S-PA G E  w here indicated. The upper band in non-DTT treated  
sa m p les  rep resen ts partially oxidized m onom eric tapasin , and the lower band corresp on d s to fully 
oxidized tapasin . T h e lower panel sh o w s quantitation of the partially oxid ized  upper band and the  
conjugate throughout th e c h a s e  period.
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2.5: Conjugate formation is independent of tapasin glycosylation
I showed above that the mixed disulfide between tapasin and ERp57 can form in 
the absence of TAP-associated MHC class I HC/|32in dimers, and these were the 
presumed source of glycans responsible for recruiting ERp57 into the PLC. However, 
tapasin is also a glycoprotein, and it remained possible that interactions between the 
lectin chaperones and glycosylated tapasin could promote ERp57 recruitment and 
conjugate formation (Ortmann et al., 1997; Sadasivan et al., 1996). To exclude this 
possibility, I used site directed mutagenesis to substitute an alanine residue for Asn-233, 
the residue that undergoes N-linked glycosylation in tapasin. This mutated construct was 
introduced into tapasin deficient 721.220 cells expressing HLA-B*4402 that were 
subsequently selected and cloned by limiting dilution. Tapasin expression was somewhat 
reduced in these cells, and expressed tapasin migrated somewhat faster, consistent with 
the loss o f a single glycan (Figure 2.6a, b). Given the well-known role of N-linked 
glycans in stabilizing protein secondary and tertiary structure, it is likely that N233A 
mutant tapasin exhibits some local misfolding that adversely affects its steady-state 
expression. Despite this, however, N233A tapasin associated with TAP and recruited 
MHC class I and CRT into the PLC (Figure 2.6c). Consistent with this normal 
recruitment, HLA-B*4402 expressed in these cells achieved cell surface expression 
levels comparable to cells expressing WT-tapasin (Figure 2.6d). Finally, in cells 
pretreated with MMTS, N233A-tapasin formed high levels of the tapasin/ERp57 
conjugate (Figure 2.6c). Some free tapasin was consistently seen in cells expressing 
mutant tapasin, and this is likely due to some degree of misfolding. Nevertheless, the
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Figure 2.6: Conjugate formation is independent of tapasin glycosylation.
A) G eneration of a  g lycan-deficient tapasin  mutant. 7 2 1 .2 2 0  ce lls  exp ressin g  HLA-BM 402 with or 
without WT or N 233A  tapasin  w ere fixed with 3.7%  form aldehyde and perm eabilized with 0.1%  
Triton X -100 in FACS buffer. Perm eabilized  ce lls  w ere sta in ed  with m o u se  anti-tapasin (P a S ta l)  or 
anti-HLA-A*0201 (B B 7.2) a s  a  n egative control for 3 0  m inutes, w ash ed , and incubated with a  1 :100  
dilution of goa t anti-m ouse-FITC  secondary.
B) N 233A  tapasin  form s the conjugate and recruits MHC c la s s  I HC and CRT into the PLC. 
2 2 0 .B 4 4 0 2  c e lls  ex p ressin g  either WT or N 233A  tapasin  w ere treated with MMTS prior to 
solubilization in 1% digitonin. P ost-n uclear supern atan ts w ere precipitated with th e m o u se  
anti-TAP1 antibody 148 .3  or the m o u se  anti-HLA-DP antibody B7 coupled  to a g a ro se  b ea d s. After 
w ashing, im m unoprecipitated material w a s resolved  by SD S-PA G E under reducing or 
non-reducing conditions a s  indicated. Following transfer and blocking, m em branes w ere incubated  
with a  rabbit anti-serum  raised again st the C -term inus of tapasin(R .gp48C ), rabbit anti-calreticulin, 
or m o u se  anti-MHC c la s s  I HC (H C10). M em branes w ere then incubated with s p e c ie s  appropriate 
secon d ary  antisera cou p led  to HRP, incubated with ECL substrate, and d etec ted  by ex p o su re  to  
film.
C) Normal MHC c la s s  I su rface exp ression  in N 233A  exp ressin g  ce lls . 7 2 1 .2 2 0  c e lls  exp ressin g  
HLA-B*4402 with or without WT or N 233A  tapasin  w ere incubated in 100  pL of 4E  tis su e  culture 
supernatant, w a sh ed  with FACS buffer, and incubated with 100 pL of 1:100  dilution of goa t  
an ti-m ouse FITC. All s te p s  w ere performed on ice.
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glycan of tapasin is clearly not required for MHC class I, CRT, or ERp57 recruitment and 
conjugate formation.
2.6: C o n ju g a te  fo rm a tio n  occu rs  in  th e  absence  o f  C N X  o r  C R T
I showed above that, amongst MHC class I specific proteins, only tapasin is 
needed to recruit ERp57 normally. However, ERp57 is traditionally thought to be 
recruited to folding substrates through interactions with CRT and/or CNX (Oliver et al., 
1999), and one model o f loading complex assembly predicts that CNX is responsible for 
bringing ERp57 into the loading complex (Diedrich et al., 2001). To test this model, I 
examined conjugate formation in CEM.NKR cells deficient in CNX expression and their 
CNX expressing transfectants. These cells were treated with MMTS prior to 
solubilization in Triton X-100 and immunoprecipitation with the anti-tapasin mAh 
PaStal. After reducing/non-reducing SDS-PAGE, membranes were blotted for tapasin 
using the antiserum R.gp48C. CNX was clearly not required for conjugate formation, 
however, as equal amounts of conjugate were seen in CNX deficient and competent cells 
(F ig u re  2.7a).
Human cell lines deficient in CRT expression have not been described. Gao et al. 
reported that in CRT deficient MEFs, ERp57 was associated with the loading complex, 
but they did not assess conjugate formation (Gao et al., 2002). These experiments are 
complicated by the fact that mouse MHC class I molecules possess at least one additional 
N-linked glycan, and a greater role for loading complex-associated CNX has been 
suggested for mouse cells (Suh et al., 1996). We obtained CRT deficient MEFs and their 
WT counterparts, and I treated IFN-y induced
44
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Figure 2.7: Calnexin and calreticulin are individually dispensable for conju­
gate formation.
A) CNX is d isp en sa b le  for conjugate formation. C N X -negative CEM.NKR ce lls  exp ressin g  HLA- 
A*0201 or HLA-A*0201 and CNX w ere treated with MMTS, solubilized in Triton X -100, and post- 
nuclear supern atan ts w ere precipitated with M.PDI, P a S ta l (anti-tapasin mAb), or M aP.ERp57 and  
protein G -sep h a ro se . SD S-PA G E  w a s  performed under reducing or non-reducing conditions, and, 
following transfer, m em b ran es w ere probed for tapasin  with R .gp48C .
B) CRT is d isp en sa b le  for conjugate formation. CRT deficient M EFs and their WT counterparts 
w ere induced with m o u se  IFN -yfor 4 8  hours prior to MMTS treatm ent and solubilization in 1% 
Triton X -100. P ost-nuclear su pernatants w ere resolved  by SD S-PA G E  under reducing or non­
reducing conditions, and, following transfer, m em b ran es w ere blotted with rabbit antisera raised  
again st full-length recom binant hum an ER p57 (R .ER p57) or tapasin  (R.SinA). T he conjugate, 
reduced tapasin , and background b and s are indicated by arrows in th e R .SinA blot.
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MEFs with MMTS prior to solubilization and blotting with anti-tapasin and anti-ERp57 
antisera raised against full-length human versions o f these proteins. Given the high 
degree of conservation of both ERp57 and tapasin between mice and humans, I reasoned 
that these reagents would likely cross-react with their murine orthologues. Indeed, 
despite the absence of ideal antibody reagents, I found that regardless of the expression of 
CRT all tapasin was conjugated to ERp57, and a substantial portion of ERp57 was 
conjugated to tapasin in IFN-y induced MEFs (F ig u re  2.7b). Thus, I have individually 
eliminated the contribution of CRT, CNX, the MHC class I HC glycan, and the tapasin 
glycan for conjugate formation.
2.7: C o n ju g a te  fo rm a tio n  is in d ep e n d e n t o f  m onog lucosy la ted  N -linked  g lycans
ERp57 is thought to assist glycoprotein folding exclusively through glycan- 
dependent interactions with CRT and CNX. These interactions depend on the generation 
of monoglucosylated glycans by the sequential removal of glucose residues by 
glucosidases I and II from the triply glucosylated core N-linked oligosaccharide 
(Glc3Man9GlcNAc2). Incubation of cells with CST, a glucosidase inhibitor, blocks the 
glycan-dependent interactions of glycoproteins with CRT and CNX and prevents the 
recruitment of ERp57 to all folding substrates examined thus far (Hammond et al., 1994; 
Kang and Cresswell, 2002; Molinari and Helenius, 1999).
To ascertain the requirement for the generation of mono-glucosylated N-linked 
glycans, I examined the effects of CST on the formation of the ERp57-tapasin conjugate. 
When cells were starved, labeled and chased in the presence of 2 mM CST, the rate of 
conjugate formation was unaffected (F ig u re  2.8). The CST treatment was effective in
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Figure 2.8: Mono-glucosylated N-linked glycans are not required for conju­
gate formation
IFN-y-induced FO -1.p2m ce lls  w ere incubated with or without 2 mM castan osp erm in e  (CST) 
throughout starvation, pulse-labeling for 5  min. with [^^Sj-m ethionine and cy ste in e , and c h a se .  
Post-nuclear supern atan ts of digitonin ly sa tes  w ere precipitated with an anti-TAP1 mAb (148 .3 ) or 
m o u se  IgG cou p led  to a g a r o se  b ea d s  (C=Ctrl), stripped, and reprecipitated with R .gp48C  
recognizing tapasin  and protein A -sep h arose . Im munoprecipitated tapasin  and its con jugate with 
ERp57 w ere su bjected  to SD S-PA G E  without reduction. The lower panel d ep icts th e percent 
m aximum  conjugate signal throughout the c h a s e  period. Post-nuclear supern atan ts from ce lls  
c h a sed  for 10 m inutes w ere precipitated with rabbit anti-calreticulin (Rb.CRT) and protein 
A -sep h arose  to confirm the su cc ess fu l inhibition of g lu c o se  trimming following treatm ent with CST.
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that it inhibited the bulk of CRT-substrate interactions (right lane). Additionally, the 
mobility of monomeric tapasin isolated from CST-treated cells was slightly lower than 
that from untreated cells. The increased molecular weight likely corresponds to the 
additional, untrimmed glucose residues resulting from CST treatment.
2.8: Discussion
The events surrounding the assembly of the MHC class I loading complex have 
been extensively examined, but most studies were completed prior to the observation that 
tapasin and ERp57 form a mixed disulfide within the loading complex (Bangia et al., 
1999; Diedrich et al., 2001; Gao et al., 2002; Hughes and Cresswell, 1998). Because a 
tapasin mutant unable to form the conjugate with ERp57 is impaired in its ability to 
promote peptide loading, I examined the kinetics and characteristics of conjugate 
formation in greater detail to better understand the biochemical events leading to the 
formation of this important component o f the MHC class 1 loading complex (Dick et al.,
2002).
My data provide new insight into MHC class I peptide loading complex 
formation. Previously, TAP with non-covalently associated tapasin was thought to 
comprise the core functional unit of the loading complex (Momburg and Tan, 2002), but 
my data indicate that ERp57 conjugated to tapasin is also a core component. Conjugate 
formation does not correlate with the incorporation of MHC class heterodimers 
into the loading complex, arguing against a role for MHC class I in recruiting ERp57. It 
was previously suggested that CNX could fulfill this role, but cells deficient in CNX are 
fully competent for conjugate formation (Diedrich et al., 2001). A role for CRT in
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recruiting ERp57 to TAP is unlikely because CRT is not found associated with TAP or 
tapasin in the absence of |32m, a condition I now find compatible with full conjugate 
formation (Diedrich et al., 2001; Sadasivan et al., 1996), and cells deficient in CRT are 
able to form the conjugate to the same extent as WT cells. Additionally, the kinetics of 
conjugate formation and ERp57 recruitment to TAP are not affected when the generation 
o f CRT and CNX binding sites is blocked by CST. The covalent linkage of tapasin and 
ERp57 may facilitate the assembly of the peptide loading complex by stabilizing the 
much weaker non-covalent interactions between tapasin and MHC class I heavy chain, 
CRT and ERp57, and the MHC class I heavy chain glycan and CRT.
Our previous inability to detect the ERp57-tapasin conjugate in |32m-deficient FO- 
1 cells was likely due to a combination of factors, including less efficient conjugate 
preservation with NEM compared to MMTS and reduced tapasin expression without 
IFN-y treatment. It is possible that Cys-60 of ERp57, which is required for activation of 
the escape pathway and release of tapasin, is less accessible to NEM in the absence of 
ffm  while MMTS is able to react equally well in its presence or absence. Tapasin may 
also exist in slightly different conformations within the loading complex that could affect 
the accessibility of Cys-60. More experiments are needed to resolve this issue, but it is 
clear from the experiments in F ig u re  2.2 that at steady state all the cellular tapasin is 
disulfide linked to ERp57, and that this is not affected by the presence or absence of |32m, 
TAPI, TAP2, or MHC class I HC.
The tapasin/ERp57 conjugate was previously detected in cells deficient in (32m 
(Antoniou and Powis, 2003; Dick et al., 2002). This was under steady state conditions, 
however, and the low levels of conjugate observed could be explained by its transient
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formation and rapid reduction in the absence of other stabilizing factors within the MHC 
class I loading complex. In the absence o f |32m, virtually no CRT and very little free 
MHC class I heavy chain is found associated with TAP (Harris et al., 2001; Hughes and 
Cresswell, 1998; Sadasivan et al., 1996). My data argue that the rate of formation and 
steady-state level are not affected by (32m expression nor by the presence o f other factors 
recruited into the loading complex by MHC class I heavy chain/(32m dimers.
In the pulse-chase analysis, some free tapasin was seen at all chase points, in 
contrast to the results obtained by Western blotting. I have no explanation for these 
differences, but I have limited my conclusions from each set of experiments to those 
appropriate for the technique employed. That is to say, Western blotting most accurately 
represents the steady-state conditions, and pulse-chase analyses are the only means to 
assess the kinetics of assembly of the loading complex.
While there are implications o f my findings specific to loading complex 
formation, the data are also significant in the general context of glycoprotein folding.
The nature of the interaction of ERp57 with tapasin and the loading complex is quite 
different from that with other substrates. The interaction between the MHC class I heavy 
chain and CRT is abolished in the presence of CST, and CST inhibits the interaction of 
ERp57 with all substrates examined to date (Elliott et al., 1997; Kang and Cresswell, 
2002; Molinari and Helenius, 1999; Oliver et al., 1997; Sadasivan et al., 1996; Van der 
Wal et al., 1998). The mixed disulfide formed with tapasin is the only identified 
exception. Additionally, conjugate formation occurs equally well in the presence or 
absence o f CNX in human cells or CRT in MEFs. Doubly deficient cells would be 
needed to fully address the requirement of CNX and CRT for conjugate formation, but
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the CST experiments clearly indicate that conjugate formation is independent of the 
presence of a monoglucosylated N-linked glycan on tapasin or within the loading 
complex.
My data indicate that the behavior of ERp57 with respect to conjugate formation 
and the MHC class I loading complex differs dramatically from its normal activity 
associated with glycoprotein folding. Protein-protein interactions between ERp57 and 
tapasin alone are sufficient to promote conjugate formation, and, under normal 
conditions, tapasin does not form mixed disulfides with other ER resident 
oxidoreductases despite the high degree o f conservation and expression equal to or 
greater than ERp57. Thus, tapasin specifically recruits ERp57 into the MHC class I 
loading complex, and this likely at least partially explains our ability to biochemically 
detect the conjugate with sulfhydryl reactive reagents. However, additional mechanisms 
may stabilize the tapasin/ERp57 conjugate in vivo.
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Chapter 3: Biochemical events following peptide loading
The high levels of the tapasin/ERp57 conjugate achieved through the specific 
recruitment of ERp57 by tapasin no doubt facilitate the detection of this mixed disulfide. 
However, oxidoreductase/substrate interactions are typically transient and exist in 
equilibrium between free and mixed-disulfide forms prior to the acquisition of native 
structure. The absence of free tapasin under all conditions examined indicates this 
equilibrium is dramatically shifted towards the conjugate, suggesting that the redox 
activity of tapasin-associated ERp57 may be altered. I first examined the ability of 
tapasin to modulate the redox activity of ERp57 within the PLC, and non-covalent 
interactions between tapasin and ERp57 inhibit the escape pathway normally associated 
with disulfide bond reduction. This was observed under steady-state conditions, but 
peptide loading onto MHC class I molecules is an active event. The key time during this 
process is likely the period that MHC class I/|32m dimers are engaged with the PLC, and 
the events surrounding peptide loading in the ER and PLC remain somewhat of a “black 
box.” To clarify the dynamics of MHC class I complex assembly, I showed that reduction 
of the conjugate does not occur during peptide loading, reinforcing my hypothesis that 
the conjugate plays a structural role in the PLC. I next examined the interaction of CRT 
with the PLC. By specifically inhibiting the incorporation of newly synthesized MHC 
class I/P2m dimers into the PLC using RNAi against fLm, I was able to follow changes in 
PLC composition following the release of peptide loaded MHC class I molecules. As 
expected, levels of MHC class I HC associated with the PLC decreased following 
transfection of fLm-specific siRNA duplexes. In these cells, conjugate levels did not
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change with time, but PLC-associated CRT decreased with similar kinetics as MHC class 
I HC. Incorporating the data from Chapters 2 and 3 ,1 have constructed a new model of 
MHC class I loading complex formation and cycling.
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3.1: Exposure to cytoplasmic contents, dilution, and time do not lead to conjugate
reduction
Trapping mutants of ERp57 can form stable mixed disulfides with a variety of 
undefined substrates (Dick and Cresswell, 2002), but chemical crosslinking reagents are 
required for the detection of substrate interactions with WT ERp57, with the exception of 
viral glycoproteins in virally infected cells (Molinari and Helenius, 1999). In such cells, 
host protein translation is inhibited and viral proteins are highly expressed. Current 
models of oxidative protein folding predict the transient existence of mixed disulfides due 
to the rapid activation of the Trx escape pathway and enzymatic reduction (Sevier and 
Kaiser, 2002). When particular substrates are abundant, mixed disulfides may exceed the 
minimal levels needed for detection. This most likely explains the findings in virally 
infected cells, and is consistent with our ability to detect the tapasin-ERp57 conjugate 
following the 8-fold increase in tapasin expression induced by IFN-y and its subsequent 
recruitment o f ERp57. However, the absence of free tapasin in these cells suggests that 
the normal cycles of mixed disulfide formation and reduction may be slowed or 
eliminated for tapasin-associated ERp57.
ERp57 is non-covalently associated with the complete MHC class I loading 
complex isolated from cells which have not been treated with NEM or MMTS, arguing 
that reduction of the disulfide bond with tapasin occurs at some point during the isolation 
process (Hughes and Cresswell, 1998; Lindquist et al., 1998; Morrice and Powis, 1998). 
Biochemical isolation from the lumen of the ER involves several steps that could lead to 
the reduction o f the tapasin-ERp57 conjugate and dissociation o f free ERp57, including 
exposure to elevated cytosolic levels of glutathione, extended time periods not
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compatible with conjugate preservation, and detergent effects both during solubilization 
and SDS-PAGE. To better characterize the conditions that lead to conjugate reduction, I 
prepared membranes from cells treated or untreated with MMTS. The membrane 
isolation process requires several hours and involves both the dilution of cellular material 
as well as the mixing of cytosolic and luminal contents, but it takes place in the absence 
of detergents until the addition o f SDS sample buffer. Once membranes were separated 
from the soluble cellular components, they were subsequently treated or untreated with 
MMTS. If  conjugate reduction is a consequence of mixing, dilution, or the duration of 
isolation, free tapasin should be seen in isolated membranes treated with MMTS. 
However, all tapasin remained conjugated to ERp57 in MMTS treated membranes, 
suggesting that other factors lead to conjugate reduction (Figure 3.1).
3.2: Tapasin inhibits the ERp57 escape pathway
The preservation of the conjugate during membrane isolation in the absence of 
detergent suggests that non-covalent interactions between ERp57 and tapasin were 
responsible for the preservation of the conjugate, and the disruption o f these interactions 
by detergent during isolation and analysis promoted reduction of the mixed disulfide. 
Immunoisolation of tapasin from cells solubilized in the non-denaturing detergents 
digitonin and Triton X-100 and subsequent incubation of material with the denaturing 
detergent SDS prior to SDS-PAGE leads to conjugate reduction (Dick et al., 2002). To 
differentiate between detergent effects occurring during isolation or during sample 
preparation for SDS-PAGE, I prepared membranes from cells not treated with MMTS 
and resuspended the membranes in buffer alone, 1.0% Triton X-100, or 0.1% SDS. The
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Figure 3.1: The tapasin/ERp57 conjugate is stable after exposure to cyto­
plasmic contents, dilution, and extended biochemical purification.
IFN-y induced FO-1 .(32m c e lls  w ere treated with MMTS a s  indicated prior to fr e eze  thaw  lysis and  
m em brane preparation by ultracentrifugation. M em branes w ere resu sp en d ed  in TBS with or 
without MMTS for five m inutes prior to the addition of Triton X -100. All m em b ran es w ere solubilized  
for 30  m inutes in detergen t prior to centrifugation. After non-reducing SD S-PA G E  and transfer, 
blots w ere cut into three p ie c e s  and probed with m o u se  anti-ER p57 (M aP.ERp57), rabbit anti- 
tapasin  (R.SinA), or m o u se  anti-GAPDH (M.GAPDH) a s  a  loading control.
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samples were then incubated with or without MMTS prior to heating to 95° C for 5 
minutes in 1% SDS, conditions that lead to complete protein denaturation, and 
precipitated with a conformation independent anti-tapasin antiserum. As can be seen in 
Figure 3.2, the complete disruption of native non-covalent interactions by heating in SDS 
promoted conjugate reduction in membranes not treated with MMTS (Lane 1), but the 
conjugate was preserved when MMTS was added before SDS addition (Lane 3). Note 
that these lanes were run under non-reducing conditions. Simple membrane 
solubilization in Triton X-100 (Lane 5) or 0.1% SDS (Lane 7) promoted conjugate 
reduction to some extent, but only when all non-covalent interactions were disrupted by 
heating in 1% SDS did full conjugate reduction occur. Thus, within intact membranes 
under native conditions, non-covalent interactions between tapasin and ERp57 appear to 
inhibit escape pathway activation and preserve the conjugate, and my current model of 
this process is depicted in Figure 3.3.
The tapasin-ERp57 conjugate exists within the peptide loading complex, which 
contains multiple non-covalently interacting proteins (Wright et al., 2004). I performed 
the experiments in Figure 3.2 with 721.221 cells that do not express HLA-A, B, or C 
alleles to limit possibly confounding effects arising from cooperative interactions within 
the MHC class I loading complex, but identical results were obtained with IFN-y treated 
HeLa-M and FO -1 .(Em cells fully competent for MHC class I loading (data not shown).
3.3: Conjugate reduction does not occur during the course of peptide loading
Our ability to biochemically observe the tapasin-ERp57 mixed disulfide is likely a 
result of two independent factors, the high conjugate levels achieved secondary to the
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Figure 3.2: Non-covalent interactions prevent conjugate reduction
N on-covalent interactions within th e MHC c la s s  I loading com p lex  inhibit ER p57 e s c a p e  pathw ay  
activation. HLA-A, B and C -n egative 721 .221  ce lls  w ere labeled with p 5 S]-m eth ion ine and  
cy ste in e  for 3 0  min and c h a se d  for an additional 3 0  min b efore m em brane preparation. 
M em branes w ere resu sp en d ed  in TBS, 1% Triton X -100, or 0.1%  S D S  in T B S with 1mM C aC l2  for 
1 hr on ice  before MMTS addition w here indicated. All sa m p les  w ere then h eated  at 95° C for 5 min 
in 1% S D S , brought to 1 ml with 1% Triton X -100 in T B S with 2  mM MMTS, and im m unoprecipitated  
with rabbit anti-tapasin (R.SinA) or normal rabbit serum  (Ctrl) and protein A -sep h arose. 
SD S-PA G E w a s  performed under non-reducing or reducing conditions a s  indicated, and percent 
conjugated  tapasin  w a s  calcu lated . Data sh ow n  are the m ean  ± SEM  of two independ en t 
experim ents.
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specific recruitment of ERp57 into the loading complex and the preservation of this 
mixed disulfide through the inhibition of the ERp57 escape pathway. I examined 
conjugate stability and composition under steady-state conditions in Figures 3.1 and 3.2, 
but conjugate reduction could be dynamically regulated by tapasin. Given the 
preferential recruitment of ERp57 into the PLC by tapasin, unconjugated tapasin would 
likely rapidly reform a mixed disulfide with ERp57, and a substantial population of 
unconjugated tapasin would not likely be detectable under these conditions. To examine 
the kinetics of conjugate formation and reduction during the course of peptide loading, I 
used cells expressing either FLAG-tagged WT or C60A mutant ERp57 in addition to 
endogenous ERp57 (Dick et al., 2002). I hypothesized that if  tapasin is regulating the 
activity of the ERp57 escape pathway, released ERp57 could be replaced in the loading 
complex by either endogenous ERp57 or the exogenously expressed, FLAG-tagged WT 
or C60A trapping mutant. Because the escape pathway is inactivated by mutagenesis in 
C60A-FLAG mutant ERp57, reduction of conjugates containing this mutant would not 
occur. Thus, if  there is free exchange of ERp57 between loading complex associated and 
free ERp57 pools, C60A-FLAG ERp57 should accumulate in the loading complex with 
time. It should act as a “dominant negative” mutant with respect to conjugate reduction. 
The presence of C60A-FLAG ERp57 within the loading complex can be detected by 
boiling non-MMTS treated samples in SDS. Tapasin-ERp57 conjugates containing WT- 
FLAG or endogenous ERp57 will become reduced upon denaturation, but C60A-FLAG 
containing conjugates will remain in a mixed disulfide (Figure 3.4a).
I first examined the steady-state composition of the conjugate in C1R cells 
expressing FILA-A*0201 and either FLAG-tagged WT or C60A ERp57 (Figure 3.4b).
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Figure 3.3: Non-covalent interactions between tapasin and ERp57 prevent 
escape pathway activation
Under native conditions, non-covalent interactions b etw een  tapasin  and ER p57 elim inate the ability 
of the sulfhydryl of C ys-60  of ER p57 to attack the m ixed disulfide b etw een  tapasin  and E R p57. I 
hyp oth esize that tapasin  red u ces  the a c c e s s  of C y s-6 0  to th e mixed disulfide and/or alters the local 
redox environm ent to prevent C ys-60  deprotonation. W hen denatured, the interactions of tapasin  
with ER p57 are disrupted, and the sulfhydryl of C y s-6 0  is now ab le to attack th e m ixed disulfide  
leading to conjugate reduction. I sp ecu la te  that the m ixed disulfide with tapasin  se r v e s  a  structural 
rather than enzym atic function.
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As expected, all tapasin in either cell line treated with MMTS was detected in the 
conjugate (Lanes 1 and 7). Cells expressing WT-FLAG ERp57 in addition to 
endogenous ERp57 had no detectable conjugate after immunoprecipitation and blotting in 
the absence of MMTS (Lane 3). In contrast, cells expressing C60A-FLAG ERp57 
contained a mixture of unconjugated and conjugated tapasin in the absence of MMTS 
treatment, indicating that the loading complexes of these cells contain a mixture of 
endogenous and exogenously expressed ERp57 (Lane 9).
The loading complexes of cells expressing C60A-FLAG ERp57 contain a mixture of 
tapasin conjugated to endogenous or exogenous ERp57, but the experiment shown in 
Figure 3.4b only represents a “snap shot” of the peptide loading complex composition.
To examine changes in loading complex composition dynamically, I labeled and chased 
WT- or C60A-FLAG ERp57 expressing cells (Figure 3.5). Cells, not treated with 
MMTS unless indicated, were solubilized in digitonin and precipitated for tapasin prior to 
boiling in SDS sample buffer. Eluted material was then resolved by SDS-PAGE under 
reducing or non-reducing conditions. As expected, in the cells expressing WT-FLAG 
ERp57, no conjugate was seen in cells untreated with MMTS after boiling in SDS 
without DTT (Lanes 2, 4, 6, 8, and 10, upper panel), but MMTS treatment at the 1 hour 
chase point led to conjugate preservation (Lane 13). In contrast, cells expressing both 
endogenous ERp57 and C60A-FLAG ERp57 had substantial amounts of detectable 
conjugate in the absence of MMTS treatment (Lanes 2, 4, 6, 8, and 10, lower panel).
More significantly, the total proportion of reduced tapasin did not change over the course 
of the experiment, arguing that C60A-ERp57 does not accumulate in the loading complex 
with time (Lane 2 v. Lane 10, for example). The time-scale of this pulse-chase is
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Figure 3.4: PLCs contain a mixture of endogenous and C60A ERp57 under 
steady-state conditions.
A) C60A  containing con ju gates are resistant to denaturation-induced reduction. Upon boiling in 
S D S , denaturation re lieves th e inhibition of the ER p57 e s c a p e  pathway leading to the reduction of 
con ju gates containing WT ERp57. C onjugates containing the C 60A  e s c a p e  pathw ay mutant are  
resistant to denaturation-induced reduction.
B) PLCs contain a  mixture of e n d o g e n o u s  and C 60A  ER p57 under stea d y -s ta te  conditions. C1R  
ce ils  exp ressin g  HLA-A*0201 and WT or C 60A  ER p57 in addition to en d o g e n o u s  E R p57 w ere  
treated with MMTS a s  indicated prior to solubilization in 1% digitonin. P ost-n uclear su pern atan ts  
w ere precipitated with th e m o u se  anti-TAP1 antibody 148 .3  or the m o u se  anti-HLA DP antibody B7 
(Ctrl) cou p led  to a g a r o se  b ea d s. After w ashing, im m unoprecipitated material w a s  reso lved  by 
SD S-PA G E  under reducing or non-reducing conditions a s  indicated. Following transfer and block­
ing, tapasin  w a s  d etec ted  by probing with R .gp48C .
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compatible with peptide loading as evidenced by the decrease in tapasin-associated MHC 
class I HC. Thus, regulated conjugate reduction does not appear to occur during peptide 
loading. Once incorporated into the MHC class I loading complex, ERp57 is 
permanently sequestered.
3.4: P2111 RNAi decreases PLC-associated MHC class I HC and CRT, but
conjugate levels are not affected
MHC class I is predicted to associate with the peptide loading complex, become 
loaded with high affinity peptides, and depart the loading complex and ER for eventual 
presentation to CD8+ T cells at the cell surface (Cresswell, 2000). In order to study the 
events that take place surrounding peptide loading and the departure of MHC class 
I/|32m/peptide complexes from the loading complex, I needed to devise a way to 
specifically prevent the incorporation of newly synthesized MHC class I/[32m complexes 
from entering the PLC without disrupting the loading and departure of previously 
assembled complexes. These stringent criteria eliminated the use o f commonly used 
chemical inhibitors because they would tend to globally affect protein folding and/or the 
generation o f peptide ligands. However, the inhibition of [Em translation by RNAi 
should specifically inhibit the generation of new MHC class I/|32m dimers without 
affecting other aspects of cellular physiology.
I determined the optimal [Em specific siRNA oligonucleotides mediating the greatest 
extent of (32m knock-down by examining cell surface MHC class I levels after 
transfection (data not shown). Once identified, I transiently transfected 721.220 cells 
expressing HLA-B*0801 and tapasin with either |32m specific or control siRNA
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Figure 3.5: The conjugate does not undergo escape pathway mediated 
reduction during peptide loading.
C1R ce lls  exp ressin g  HLA-A*0201 and FLAG -tagged WT or C60A  ER p57 w ere labeled  with [^^S]- 
m ethionine and cy ste in e  for 4 5  min. and c h a se d  for th e indicated periods of tim e prior to treatm ent 
with or without MMTS a s  indicated. Frozen cell pellets w ere solubilized in 1% digitonin and pre­
cleared  p ost nuclear supern atan ts w ere im m unoprecipitated with the anti-tapasin mAb P a S ta l or 
anti-OX -6 8  (Ctrl) coupled  to a g a ro se  b ea d s. S a m p les  w ere w ash ed  with 0.1%  Triton X -100 and  
resolved  by SD S-PA G E  under reducing or non-reducing conditions a s  indicated. B an ds corre­
sponding to tapasin  w ere quantitated, and the am ount of free tapasin  under non-reducing con d i­
tions w a s  norm alized to the total am ount of tapasin  p resen t after reduction. T h e chart d ep icts the  
m ean +/- SEM  of two in depend en t experim ents.
64
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
oligonucleotides. Cells were harvested at different times after transfection and treated 
with MMTS. Digitonin lysates were immunoprecipitated for TAPI, and, following non­
reducing SDS-PAGE, the relative amounts of PLC-associated tapasin-ERp57 conjugate, 
TAPI, CRT, and MHC class I HC were examined. As can be seen in Figure 3.6, 
transfection of cells did not affect the levels o f TAPI or TAPI-associated conjugate. As 
expected, the amount of loading complex-associated MHC class I HC decreased with 
time following (32m knock-down. Additionally, loading complex associated CRT 
decreased with similar kinetics and to a similar extent as MHC class I HC. Thus, MHC 
class I HC is needed to recruit CRT into the loading complex, but the departure of 
(presumably) peptide loaded MHC class I/(32m complexes and CRT from the PLC are 
closely related (Sadasivan et al., 1995).
3.5: Discussion
Oxidative folding in the ER is an extremely important process, and aberrant 
disulfide formation can negatively affect protein expression, normal cellular physiology, 
and ultimately organism viability. To facilitate oxidative folding, a complex system of 
enzymes that transfer electrons between the cytosol and recipient proteins has evolved in 
bacteria and eukaryotes (Ellgaard and Ruddock, 2005; Kadokura et al., 2003). A 
common motif present in most of these enzymes is the Trx N-CXXC-C motif frequently 
contained in the highly conserved Trx domain (Sevier and Kaiser, 2002). During an 
oxidation reaction, the N-terminal cysteine residue forms a mixed disulfide with the 
substrate protein, and the deprotonated C-terminal cysteine residue attacks this mixed 
disulfide leading to substrate release and intramotif disulfide formation. This disulfide
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Figure 3.6: Calreticulin departs the loading complex following peptide 
loading.
7 2 1 ,2 2 0  ce lls  exp ressin g  HLA-B*0801 and WT tapasin  w ere transfected  with (32m -specific or 
nonspecific siRNA oligon u cleotides using the A m axa nucleofector d ev ice . C ells w ere harvested  
at the indicated tim es, treated with MMTS, and frozen. Digitonin solubilized cell p elle ts w ere  
precipitated with the anti-TAP1 mAb 148 .3  or m lgG coupled  to a g a ro se  b e a d s  and resolved  by 
non-reducing SD S-PA G E . After transfer, m em branes w ere cut into four p ie c e s  and blotted with 
rabbit anti-tapasin (R .gp48C ), anti-TAP1 (RING.4C), anti-CRT, and rat anti-MHC c la s s  I HC 
(3B 10 .7 ). S a m p le s  w ere quantitated using a  Storm  8 6 0  im aging sy stem  and Im agequant 
softw are. PLC com p on en ts w ere norm alized to th e signal for TAP1, and the chart d ep icts the  
m ean +/- SEM  of three independ en t experim ents.
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bond can be reduced directly by glutathione, and Erol is responsible for generating the 
oxidizing potential of the ER (Jessop and Bulleid, 2004; Mezghrani et al., 2001).
The enzymatic mechanism of PDI is the best studied amongst eukaryotic and mammalian 
Trx-family ER resident oxidoreductases. Activation of the Trx motif escape pathway 
within PDI is an extremely rapid process that occurs in both native and denatured 
proteins, and the rate constant for formation of the intradomain disulfide bond within the 
PDI a domain is 1 0 -3 0  s '1 (Darby and Creighton, 1995; Walker and Gilbert, 1997). 
Thus, the Trx domain active site has evolved to rapidly and efficiently release bound 
substrates for subsequent rounds of oxidative folding. The accumulation o f substrate- 
enzyme mixed disulfides or misfolded proteins containing aberrant disulfide bonds could 
overwhelm the folding capacity o f the ER leading to the release o f misfolded and 
dysfunctional proteins, the cessation o f protein translation, or the induction o f apoptosis, 
the end result of a chronic unfolded protein response (Schroder and Kaufman, 2005).
My data indicate that the normal enzymatic activity of the ERp57 a domain does not 
occur when it is associated with tapasin, but the elimination of non-covalent interactions 
by the denaturation of ERp57 and/or tapasin relieves the inhibition and allows reduction 
to proceed normally, as it would for a typical ERp57 substrate. Additionally, we have 
shown that tapasin alone is capable of mediating this inhibition using purified 
recombinant proteins (Peaper et al., 2005). Thus, tapasin has evolved to specifically 
recruit and stabilize ERp57 within the MHC class I loading complex.
Our understanding of the events surrounding MHC class I peptide loading has 
evolved. With the discovery of the tapasin-ERp57 conjugate, models were proposed 
wherein the conjugation state of tapasin could be related to peptide loading. One model
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predicted that preassembled complexes o f CRT, ERp57, MHC class I HC, and (Tm were 
incorporated into the loading complex through associations with tapasin (Antoniou et al., 
2003). A non-mutually exclusive model predicted that conjugate reduction precedes the 
release o f peptide loaded MHC class I molecules (Dick, 2004; Wright et al., 2004). The 
absence of large amounts o f non-conjugated tapasin associated with the loading complex 
argues against these models (Figure 2.2), but steady-state analyses may not accurately 
reflect the active process of peptide loading.
To better understand the dynamics o f peptide loading, I used two complementary 
approaches. First, using reagents existing in the lab, I analyzed the reduction and 
oxidation of the tapasin-ERp57 conjugate during peptide loading. These experiments 
demonstrated that escape pathway mediated conjugate reduction does not occur within 
the loading complex over the course o f 10 hours, a period during which peptide loading 
was clearly occurring. It remains possible that the conjugate is reduced independently of 
escape pathway activity, but this is unlikely. My findings are contrary to the model of 
Wright et al. and support a static, structural role for ERp57 within the loading complex. 
The precise role of ERp57 in peptide loading remains elusive, but I have conducted 
experiments toward resolving this function (See Chapter 4).
Once associated, ERp57 appears to be permanently sequestered within the loading 
complex. Thus, replacement of PLC-associated ERp57 by ERp57 associated with 
CRT/MHC class I HC/fCm complexes does not appear to take place. However, CRT is 
found associated with MHC class I HC/|32m dimers in both the presence and absence of 
tapasin ((Tumquist et al., 2002) and Pamela Wearsch, manuscript in preparation), and it 
remained possible that complexes lacking ERp57 could incorporate into the PLC upon
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the departure of peptide loaded MHC class I/f^m dimers. In order for this to occur, PLC- 
associated CRT would have to dissociate to allow for the incorporation o f newly 
synthesized, empty MHC class I HC/f^m dimers associated with CRT. When this was 
examined by preventing the assembly o f new MHC class l/fTm dimers through inhibiting 
the translation of (Tm using RNAi, CRT departed the loading complex with similar 
kinetics and to a similar extent as MHC class I HC. Thus, despite the ability o f CRT to 
interact with ERp57, the continued presence of CRT in the loading complex depends on 
the incorporation o f newly synthesized MHC class I HC/(]2in dimers. When the data 
from the literature and Chapters 2 and 3 are considered together, I generated the model of 
conjugate and MHC class I loading complex formation and action depicted in Figure 3.7.
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Figure 3.7: The folding and assembly of MHC class I loading complex 
components.
CNX m ed ia tes the early folding s ta g e s  of MHC c la s s  I h eavy  chain prior to its assoc ia tion  with p2m. 
C om plete h eavy  chain oxidation occu rs during this time, and ER p57 facilitates this p ro cess . O n ce  
a sso c ia ted  and properly oxid ized, MHC c la s s  I HC/p2m co m p lex e s  rapidly a s so c ia te  with CRT. In 
parallel, new ly syn th esized  tapasin  a s s o c ia te s  with TAP with a  reduced C ys7-C ys71  disulfide bond; 
this bond b e c o m e s  oxidized at so m e  point during com p lex  assem b ly . C onjugate formation with 
ER p57 p ro ceed s rapidly after TAP assoc ia tion  independently of lectin binding by CRT or CNX. 
CRT/HC/p2m su b -co m p lex es  rapidly a s so c ia te  with the TA P/tapasin/ER p57 su b-com plex. 
Through unknown m ech an ism s in a  tap asin -d ep en d en t manner, th e loading com p lex  facilitates the  
generation  of highly stab le  MHC c la s s  l/peptide co m p lex e s  leading to the r e le a se  of loaded  MHC 
c la s s  I m o lecu les  and CRT. T he core su b com p lex  of TA P/tapasin/ER p57 is then ab le to facilitate 
peptide loading onto additional MHC c la s s  I m olecu les.
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Chapter 4: Altered PLC structure and function in the absence of
ERp57
Although initially identified in the PLC in 1998, the role o f ERp57 in peptide 
loading remains unclear eight years later. Two key studies have addressed the functional 
significance o f ERp57 within the PLC, but they examined different systems that make 
universal conclusions difficult. Dick et al. used a tapasin mutant unable to form the 
mixed disulfide with ERp57 to determine the role of conjugate formation in HLA- 
B*4402 peptide loading (Dick et al., 2002). In contrast, Garbi et al. used ERp57- 
deficient mouse B cells to primarily study H2-Kb loading (Garbi et al., 2006). Both of 
these studies used NEM to preserve the conjugate, but the increased efficiency of 
conjugate preservation with MMTS may allow for more accurate data to be obtained. 
Thus, I sought to expand the initial work of Dick et al. using 721.220 cells expressing 
HLA-B*4402 and WT or C95A tapasin, emphasizing the contrasting conclusions reached 
by Garbi et al. As expected, some aspects of peptide loading differed between these 
systems, but broadly applicable conclusions can be drawn about the role of ERp57 in 
peptide loading. Specifically, the recruitment of MHC class I HC into the PLC appears 
to depend upon conjugate formation in a species-independent manner, but changes in the 
maturation and stability of MHC class I complexes varied between HLA-B*4402 and 
H2-Kb. Additionally, I show that conjugate formation alters the conformational stability 
of tapasin, suggesting a possible mechanism for the altered recruitment o f MHC class I 
and CRT into the PLC in the absence of ERp57.
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4.1: Impaired loading complex formation in cells expressing a tapasin mutant
unable to form the conjugate
Tapasin in which Cys-95 is mutated to Ala (C95A) is unable to form the 
conjugate with ERp57, and the initial characterization o f cells expressing HLA-B*4402 
and this mutant emphasized qualitative differences in PLC composition compared to cells 
expressing WT tapasin. In particular, C95A-tapasin containing PLCs were able to recruit 
both MHC class I HC and CRT to some extent, and mutant tapasin was recognized by the 
conformation specific anti-tapasin mAb PaStal (Dick et al., 2002). In contrast, a tapasin 
mutant in which the N-terminal 50 amino acids were deleted did not recruit CRT or 
ERp57 into the PLC, and MHC class I was recruited much less efficiently. This mutant 
also did not react with either PaStal or PaSta2, an additional conformation specific anti- 
tapasin antibody (data not shown and (Bangia et al., 1999)). Additionally, mouse B cells 
deficient in ERp57 expression had altered PLC recruitment of MHC class I HC and CRT 
(Garbi et al., 2006).
There could be a number o f reasons why differences were observed between 
mouse cells lacking ERp57 expression and human cells expressing a tapasin mutant that 
does not form a mixed disulfide with ERp57. Thus, I wished to reexamine the PLC 
composition in C95A-tapasin expressing cells using a more quantitative approach to 
more fully determine the phenotype of these cells in relation to ERp57-deficient cells. 
Additionally, MMTS has proven more effective at preserving the tapasin/ERp57 
conjugate than NEM, and this could reveal more pronounced differences between WT- 
and C95A-expressing cells.
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MMTS treated 721.220 cells expressing HLA-B*4402 and either WT or C95A 
tapasin were treated with MMTS, and the PLC was immunoprecipitated from digitonin 
lysates using the anti-TAPl mAh 148.3. Serial dilutions representing a 10-fold 
difference were resolved by reducing SDS-PAGE, and the individual loading complex 
components were blotted with appropriate reagents for fluorimetry and quantitation 
(Figure 4.1). As expected, TAPI and tapasin levels were identical in TAPI 
immunoprecipitates from cells expressing WT and C95A tapasin. Additionally, no 
ERp57 was associated with C95A-containing PLCs. Consistent with previous reports, 
both CRT and MHC class I HC were recruited to TAPI by C95A mutant tapasin, but the 
extent of recruitment in these cells was much less than that seen in cells expressing WT 
tapasin. PLCs from C95A-expressing cells contained only 25% of the CRT and MHC 
class I HC compared with WT-expressing cells.
4.2: Delayed maturation and impaired stability of MHC class I complexes
assembled in 220.B4402.C95A-Tapasin cells
After their synthesis and loading in the ER, MHC class I/(Cm complexes travel 
through the Golgi apparatus on their way to the cell surface. Within the Golgi, further 
glycan processing takes place, and, after passage through the medial Golgi, glycans 
become resistant to cleavage by Endoglycosidase-H (EndoH). Monitoring the rate at 
which MHC class I/f^m complexes acquire EndoH resistance is a traditional method for 
assessing the rate of MHC class I peptide loading and maturation.
H2-Kb molecules assembled in ERp57-deficient B cells acquired EndoH 
resistance more rapidly than in cells expressing ERp57. Additionally, these complexes
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Figure 4.1: MHC class I HC and CRT are inefficiently incorporated into 
conjugate-deficient PLCs.
7 2 1 .2 2 0  c e lls  exp ressin g  HLA-B*4402 and either WT or C 95A  tapasin  w ere treated with MMTS 
prior to solubilization in 1% digitonin. P ost-n uclear su pernatants w ere im m unoprecipitated with the  
m o u se  anti-TAP1 antibody 148 .3  or th e m o u se  anti-HLA-DP antibody B7 coupled  to a g a r o se  b ea d s  
a s  a  control (Ctrl). After w ashing, im m unoprecipitated material w as eluted under reducing con d i­
tions and sep arated  by SD S-PA G E . Following transfer and blocking, m em b ran es w ere cut and 
individually probed with rabbit antisera raised aga in st the C-terminal peptide of TAP1 (RING.4C), 
CRT, the C-terminal peptide of ER p57 (R .ER p57-C ), th e N-terminal peptide of tapasin  (R .gp48N ), 
or rat anti-MHC c la s s  I HC (3B 10 .7 ). S a m p les  w ere quantitated using a  Storm  8 6 0  im aging system  
and Im agequant softw are. S ig n a ls  corresponding to PLC com p on en ts precipitated from C95A  ce lls  
w ere norm alized to th o se  from W T-tapasin exp ressin g  ce lls . V alues are the m ean  +/- SEM  for the  
dilutions, and this is representative of three in depend en t experim ents.
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were less stable as measured by their more rapid internalization from the cell surface 
(Garbi et al., 2006). When the thermostability and tm  o f HLA-B*4402/(32m complexes 
assembled in C95A-expressing cells were examined, these complexes were also less 
stable than those from WT-expressing cells (Dick et al., 2002). However, the initial 
characterization of these cells emphasized the long-term stability of MHC class 1/ 
complexes. Therefore, I wished to examine the rate of short-term maturation of HLA- 
B*4402 assembled in C95A-expressing cells.
721.220 cells expressing HLA-B*4402 and either WT or C95A tapasin were
35pulse-labeled with [ S]-methionine and cysteine for 15 minutes and chased for different 
lengths o f time in the presence of excess cold methionine and cysteine. Cells were 
solubilized in digitonin prior to immunoprecipitation with the conformation specific anti- 
MHC class I/ff m antibody W6/32. Digitonin preserves the interactions of the PLC, but 
W6/32 does not precipitate PLC-associated MHC class I complexes. Thus, only free 
MHC class I/fLm dimers were precipitated in this experiment. Precipitated material was 
then incubated with EndoH overnight and resolved by SDS-PAGE (Figure 4.2). 
Surprisingly, the rate at which MHC class I/|32m complexes acquired EndoH resistance 
was only slightly, but significantly, delayed in C95A-expressing cells. However, 
consistent with previous reports, substantially fewer W6/32 complexes survived for the 
four hours of the experiment. Those complexes that acquired EndoH resistance were 
relatively long-lived, however. Taken together, these results suggest that C95A mutant 
tapasin supports peptide loading to a lesser extent that WT tapasin, but a sub-set of 
complexes assembled in these cells is somewhat stable.
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Figure 4.2: Delayed maturation and enhanced dissociation of MHC class 
l/p2>n complexes assembled in the presence of conjugate-deficient tapasin.
7 2 1 .2 2 0  ce lls  exp ressin g  HLA-B*4402 and either WT or C 95A  tapasin  w ere p u lse-labeled  with 
[35S]-m ethionine and cy ste in e  for 15 m inutes and c h a se d  for th e indicated p eriods of tim e. Frozen  
cell p ellets w ere solubilized in 1 % digitonin, and post-nuclear supern atan ts w ere  
im m unoprecipitated with the anti-MHC c la s s  I H C/fom  conform ation sp ecific  antibody W 6/32 or the  
CD1d sp ecific  antibody 5 1 .1 .3  a s  a  control and protein A -sep h arose. S a m p les  w ere w a sh ed  with 
0.1%  Triton X -100 in TBS, eluted  in 2x EndoH buffer with heating to 9 5° C, and incubated with 1 
m il EndoH overnight at 37° C. D igested  material w a s  then resolved  by reducing SD S-PA G E . 
B ands corresponding to EndoH resistant (upper band) and sen sitive  (lower band) MHC c la s s  I HC 
w ere quantitated, and the % EndoH resistant MHC c la s s  I HC w a s calcu lated  (upper right panel). 
S ign a ls w ere further ex p re sse d  a s  % Max EndoH R e s  MHC c la ss  I HC (lower left panel) and % 
Max Total MHC c la s s  I HC (lower right panel) a s  a  m easu re  of the overall stability of W 6/32  reactive  
co m p lex es  throughout the c h a s e  period. T he m ean  +/- SEM  of two independ en t exp erim en ts is 
show n.
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4.3: Impaired recruitment and retention of MHC class I HC by C95A tapasin
Under steady-state conditions in the presence of C95A mutant tapasin, less MHC 
class I HC and CRT were associated with the PLC than in the presence o f WT tapasin. 
This could be explained by the dissociation of these components during biochemical 
isolation. The coordinating interaction of CRT with ERp57 in these complexes could be 
essential for the stability of the PLC in detergent extracts, but, in vivo, MHC class I HC 
and CRT could be recruited normally. To differentiate between these possibilities, I 
performed a pulse-chase analysis to examine the kinetics of MHC class I HC association 
with the PLC. I hypothesized that if  the loss of MHC class I HC from TAPI 
immunoprecipitates is an artifact of detergent solubilization the same proportion of MHC 
class I HC should be lost from the PLC at each time point. In this model, the absolute 
amount of MHC class I HC associated with C95 A tapasin containing PLCs would be 
less, but the relative amount of PLC-associated MHC class I HC should be constant. 
Additionally, the rate of MHC class I egress from the PLC would be the same for both 
C95A and WT tapasin containing PLCs. Alternatively, if  there truly is a defect in the 
recruitment and/or stabilization of MHC class I HC in mutant PLCs, then both the 
absolute and relative amount of PLC-associated MHC class I HC should be different in 
WT- and C95A-expressing cells.
I labeled 721.220 cells expressing HLA-B*4402 and either WT or C95A tapasin 
with [35S]-methionine and cysteine for 15 minutes and chased them in the presence of an 
excess of cold methionine and cysteine for up to four hours. The PLC was 
immunoprecipitated from MMTS-treated cells using a rabbit antiserum raised against 
TAPI, and Triton X-100 was used to dissociate subcomplexes containing tapasin, ERp57,
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CRT, MHC class I HC, and [Em from the TAP heterodimer. After reducing SDS-PAGE, 
the bands corresponding to MHC class I HC were quantitated, and the %Maximum TAP- 
associated MHC class I HC was calculated for each time point (Figure 4.3). As 
expected, the intensity of the MHC class I HC band associated with C95A tapasin was 
much less than that from WT PLCs despite similar tapasin labeling. The rate at which 
labeled MHC class I departed the loading complex also differed substantially between 
these two cell lines. Thus, the differences in steady-state MHC class I association with 
the PLC are at least partially attributable to decreased recruitment and retention by C95A 
tapasin. These experiments cannot exclude the contributions of the interaction of CRT 
with ERp57, but this will be addressed in the future.
4.4: Conjugation alters the conformational stability of tapasin
The absence of ERp57 from the PLC clearly adversely affects the recruitment of 
MHC class I and CRT. There are a number of non-mutually exclusive explanations for 
this observation. Garbi et al. proposed that ERp57 recruits MHC class I HC into the PLC, 
but they did not speculate about the mechanism(s) controlling this recruitment (Garbi et 
al., 2006). It is possible that interactions between the ERp57 b and b ’ domains and the 
CRT P-domain indirectly recruit MHC class I HC into the PLC, and, once incorporated, 
additional interactions between tapasin and MHC class I HC would stabilize the mature 
subcomplex. The recruitment of MHC class I through direct interactions with ERp57 
seems unlikely. Alternatively, conjugate formation could generate an additional binding 
site for MHC class I on tapasin itself. In the absence of ERp57, low affinity interactions 
between tapasin and MHC class I HC could mediate the degree of recruitment and
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Figure 4.3: Decreased association and more rapid MHC class I egress from 
conjugate deficient PLCs.
7 2 1 .2 2 0  c e lls  exp ressin g  HLA-BM 402 and either WT or C 95A  tapasin  w ere p u lse-labeled  with 
[35S]-m ethionine and cy ste in e  for 15 m inutes and c h a se d  for the indicated periods of tim e. MMTS 
treated frozen cell p ellets w ere solubilized in 1% digitonin, and p ost-nuclear supern atan ts w ere  
pprecipitated with rabbit anti-TAP1 (RING4C) or NRS (C=Ctrl) and protein A -sep h arose . 
Precipitated material w a s w a sh ed  with 0.1%  digitonin in T B S prior to elution in 0.1%  Triton X -100  
in TBS for 5 min at 4° C. Eluted material w a s  incubated with reducing sa m p le  buffer and resolved  
by SD S-PA G E . T he b and s corresponding to MHC c la s s  I HC and tapasin  w ere quantitated and  
ex p re sse d  a s  the % Maximum TAP a sso c ia ted  MHC c la s s  I HC (lower right panel), and the MHC 
c la s s  I HC/tapasin ratio w a s a lso  calcu lated  (lower left panel). T h e m ean  +/- SEM  of two  
independent exp erim en ts is show n.
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peptide loading observed in C95A-expressing cells, but the absence o f a conjugate- 
dependent high affinity binding site would prevent peptide loading comparable to WT 
cells.
I hypothesized that conjugate formation could affect the tertiary structure of 
tapasin in some way. C95A tapasin reacts with the conformation specific antibodies 
PaStal and PaSta2 and is able to support some degree of peptide loading (data not shown 
and (Dick et al., 2002). However, WT and C95A tapasin could respond differently to 
detergent and/or heating. To examine this possibility, I radio-labeled 721.220 cells 
expressing HLA-B*4402 and WT or C95A tapasin with [35S]-methionine and cysteine 
for one hour and chased them for one hour in the presence of excess cold methionine and 
cysteine to allow the cells to reach some degree of steady-state conditions with respect to 
conjugate formation. MMTS treated cell lysates were immunoprecipitated with the anti- 
TAP1 antiserum RING4C, and tapasin and associated components were eluted with 0.1% 
Triton X-100. Triton eluates were split and incubated for 30 minutes at different 
temperatures. Aggregated material was removed by centrifugation, and supernatants 
were immunoprecipitated with either PaStal or R.gp48C, a conformation independent 
rabbit antiserum (Figure 4.4). As expected, the amount of tapasin immunoprecipitated 
with R.gp48C was not affected by heating. In contrast, heating to 40° C caused the 
amount of PaSta 1-precipitable WT tapasin to decrease by 30%, and only 10% of the level 
of unheated WT tapasin was precipitated with PaStal after heating to 45° C.
Surprisingly, incubation at both 4° C and 24° C did not affect the PaStal reactivity of 
C95A tapasin, but only 15% of C95A tapasin remained PaStal reactive after only 30 
minutes at 37° C. Virtually no C95A tapasin was precipitated by PaStal after heating to
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Figure 4.4: The conformational stability of C95A tapasin is decreased.
7 2 1 .2 2 0  ce lls  exp ressin g  HLA-BM 402 and WT or C 95A  tapasin  w ere labeled  with [35S ]-m ethionine  
and cy ste in e  for 1 hr and c h a se d  for 1 hr prior to MMTS treatm ent. C ells w ere solubilized in 1% 
digitonin, and precleared  post-nuclear supern atan ts w ere im m unoprecipitated with m o u se  
anti-TAP1 (148 .3 ) coup led  to a g a r o se  b ea d s. After w ashing in 0.1%  digitonin, sa m p le s  w ere eluted  
in 0.1%  Triton X -100 in TBS for 5  min on ice. Eluted material w a s incubated for 3 0  m inutes at the 
indicated tem perature, allow ed to sit on  ice for 1 0  min, and a g g re g a tes  w ere pelleted  by spinning  
at 1 4 ,000  RPM in a m icrocentrifuge at 4° C. Supernatants w ere then precipitated with a  
conform ation independ en t rabbit anti-tapasin antiserum  (R .gp48C ) or N R S and protein 
A -sep h a ro se  or the conform ation sp ecific  m o u se  anti-tapasin mAb P a S ta l or m o u se  anti-OX6 8  a s  
a  control coupled  to a g a ro se  b ea d s. S a m p les  w ere separated  by reducing SD S-PA G E . 
Precipitated material w a s  v isualized  after ex p o su re  to a  phosphor screen  and b and s corresponding  
to tapasin  w ere quantitated using a  Storm  8 2 0  im aging sy stem  and Im agequant softw are. Tapasin  
b ands w ere norm alized to that specifically  im m unoprecipitated from u nh eated  (4° C) sa m p les, and 
th e m ean +/- SEM  of two independ en t exp erim en ts is show n.
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40° C or 45° C. Thus, the conformational stability of C95A tapasin is lower than that of 
WT tapasin.
4.5: Unconjugated, WT tapasin is less thermostable than conjugated, WT tapasin
Cys-95 o f tapasin is clearly needed to form a mixed disulfide with ERp57, and 
mutation of this residue to Ala altered the susceptibility of tapasin to a heating induced 
conformational change. However, the loss of PaStal reactivity following heating of 
C95A tapasin could be unrelated to the conjugation state and instead arise due to direct 
effects of this mutation. To exclude this possibility, I used a cell line expressing WT 
tapasin in which ERp57 expression was knocked-down by 90% using RNA interference 
(RNAi). These cells will be described in greater detail in Chapter 5, but there is an 
increased population o f unconjugated WT tapasin associated with the PLC.
721.220 cells expressing HLA-B*4402 and WT tapasin with suppressed 
expression of ERp57 were labeled and chased as described above. Triton X-100 eluates 
from TAPI immunoprecipitations were incubated on ice or at 37° C for 30 minutes prior 
to centrifugation and re-precipitation with either R.gp48C or PaStal (Figure 4.5). The 
bands corresponding to conjugated and unconjugated tapasin were quantitated and 
normalized to material precipitated by PaStal incubated at 4° C. As seen above, heating 
to 37° C did not affect the ability of R.gp48C to precipitate free or conjugated tapasin 
(Lanes 1 and 2). Additionally, PaStal precipitated nearly 100% of conjugated tapasin 
after incubation at 37° C (Conj band, lanes 3 and 4). In contrast, only 10% of 
unconjugated tapasin remained PaStal reactive after incubating at 37° C (tapasin band,
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Figure 4.5: WT, unconjugated tapasin is less thermostable than WT, conju­
gated tapasin.
7 2 1 .2 2 0  c e lls  exp ressin g  HLA-B*4402 and WT tapasin  with su p p ressed  ER p57 w ere labeled  with 
[35S]-m ethionine and cy ste in e  for 1 hr and c h a se d  for 1 hr prior to MMTS treatm ent. C ells w ere  
solubilized in 1% digitonin, and precleared  post-nuclear supernatants w ere im m unoprecipitated  
with m o u se  anti-TAP1 (148 .3 ) or m o u se  anti-OX6 8  a s  a  control cou p led  to a g a r o se  b ea d s. After 
w ashing in 0.1%  digitonin, sa m p les  w ere eluted in 0.1%  Triton X -100 in TBS for 5 min on ice. 
Eluted material w a s  incubated for 3 0  m inutes at the indicated tem perature, allow ed to sit on ice for 
10 min, and a g g re g a tes  w ere pelleted  by spinning at 1 4 ,0 0 0  RPM in a  m icrocentrifuge at 4° C. 
Supernatants w ere then precipitated with a  conform ation independ en t rabbit anti-tapasin antiserum  
(R .gp48C , g) and protein A -sep h a ro se  or th e conform ation specific m o u se  anti-tapasin m onoclonal 
antibody P a S ta l (P) cou p led  to a g a ro se  b ea d s. S a m p les  w ere resolved  by non-reducing  
SD S-PA G E . Precipitated material w a s  visualized  after ex p o su re  to a phosphor sc re en  and b and s  
corresponding to free and conjugated  tapasin  w ere quantitated using a  Storm  8 2 0  im aging system  
and Im agequant softw are. S ig n a ls  w ere norm alized to that specifically  im m unoprecipitated from  
unheated  (4° C) sa m p les, and the m ean  +/- SEM  of two independent exp erim en ts is show n.
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lanes 3 and 4). Thus, the altered conformational stability of unconjugated tapasin is a 
direct consequence of its failure to form a mixed disulfide with ERp57.
4.6: Tapasin and ERp57 alone are responsible for determining the
thermostability of tapasin
I showed above that a conformation specific epitope was differentially susceptible 
to heating in a tapasin mutant unable to form a mixed disulfide with ERp57 and 
unconjugated WT tapasin in cells in which ERp57 expression was suppressed. However, 
the overall PLC composition in C95A-expressing cells is altered, and, as is clear from 
Figure 4.4, MHC class I HC and presumably CRT dissociate from tapasin upon heating. 
These components are not associated with C95A tapasin after Triton X-100 elution even 
at 4° C. I wished to clearly show that only tapasin and ERp57 were responsible for 
controlling the conformational stability o f tapasin in response to heating, and 
recombinant, insect cell expressed free and conjugated tapasin were kindly provided by 
Pamela Wearsch to examine this possibility.
Insect cells co-expressing soluble, 6xHis-tagged tapasin and human ERp57 were 
treated with MMTS prior to detergent extraction. Conjugated and free tapasin were co­
purified using cobalt resin, but these were then separated by gel filtration. Equal amounts 
o f conjugated and free tapasin in the absence of detergent were incubated at different 
temperatures for 30 minutes, aggregates were pelleted, and supernatants were 
immunoprecipitated with PaStal. After non-reducing SDS-PAGE and staining with 
Coomassie brilliant blue, I quantitated the amount of PaStal precipitated tapasin using 
densitometry. To ensure that the signals obtained were within the linear range of
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Figure 4.6: Other PLC components are not responsible for conjugate ther­
mostability.
ER p57 conjugated  and free tapasin  isolated  from MM TS-treated in sect ce lls  w a s  purified and  
incubated at th e indicated tem peratures for 3 0  m inutes. S a m p les  w ere co o led  on ice  for 10  
m inutes prior to centrifugation at 1 4 ,0 0 0  RPM for 10 m inutes at 4° C. S up ernatants w ere  
precipitated with the conform ation sp ecific  m o u se  anti-tapasin antibody P a S ta l or m o u se  
anti-OX6 8  a s  a  control cou p led  to a g a ro se  b ea d s  and resolved  by non-reducing SD S-PA G E . G els  
w ere sta in ed  with C o o m a ss ie  brilliant blue, d esta in ed , and quantitated by densiom etry. T h e left 
three la n es  of the gel w ere non-im m unoprecipitated sa m p les  to g en era te  a  standard curve. B ands  
corresponding to free and conjugated  tapasin  w ere norm alized to s ig n a ls  precipitated at 4° C. The  
m ean +/- SEM  of two in depend en t exp erim en ts is show n.
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detection, I also ran serial dilutions of non-immunoprecipitated samples (F ig u re  4.6). 
PaStal reactivity was maintained in both conjugated and free tapasin after heating to 35° 
C. At 40° C, the amount of PaStal-precipitated ERp57-conjugated tapasin was the same 
as that seen at 4° C, while only 25% of the free tapasin was pulled down. This difference 
was exacerbated after heating to 45° C. Neither conjugated nor free tapasin retained 
PaStal reactivity after heating to 50° C. This experiment clearly shows that the 
conformational stability of tapasin is dependent only upon ERp57 and does not require 
other PLC components.
4.7: Discussion
Within the PLC, a number of different interactions take place between PLC 
components. The transmembrane and/or cytoplasmic domain of tapasin is essential for 
its interaction with TAP, but the interaction of MHC class I with tapasin is somewhat 
more complicated (Lehner et al., 1998). There are at least two sites of interaction 
between MHC class I HC and tapasin (Wright et al., 2004). The membrane proximal Ig 
domain of tapasin interacts with the MHC class I a3  domain, and mutants in these 
domains interfere with MHC class I recruitment into the PLC (Kulig et al., 1998; Suh et 
al., 1999; Turnquist et al., 2004; Tumquist et al., 2001). Additionally, there is an 
interaction between the N-terminal domain of tapasin and the a2  domain of MHC class I 
HC (Bangia et al., 1999; Lewis and Elliott, 1998; Peace-Brewer et al., 1996). The studies 
characterizing these mutants are difficult to interpret, however, as most were conducted 
prior to the advent of NEM or MMTS treatment. Indeed, in my hands a D337A mutation 
in tapasin that completely prevents H-2 Ld association with the PLC had only minimal
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effects on HLA-B*0801 and HLA-B*4402 PLC incorporation (data not shown). 
However, while the differences between different MHC class I and tapasin mutants are 
likely not as absolute as originally described, the consistency of the data suggests that the 
general two site binding model is correct.
In addition to binding MHC class I HC, tapasin also catalyzes peptide loading. 
This activity appears to require an intact N-terminus, as N-terminal deletion mutants do 
not support peptide loading (Bangia et al., 1999; Momburg and Tan, 2002). A 
proteolysis study of tapasin also indicated that the N-terminus of tapasin is an 
independent domain, but this study did not examine conjugated tapasin (Chen et al., 
2002). It seems likely that an intact N-terminus is required for both ERp57 recruitment 
and the catalysis of peptide loading, but conjugate formation is not required for peptide 
loading. Rather than impaired peptide loading, the defects seen in C95A cells likely arise 
from the decreased recruitment and stabilization of MHC class I in the PLC secondary to 
poor binding between the a l  domain and the N-terminal binding site of tapasin. The 
combination o f Ig/a3 and low-afflnity N-terminus/a2 interactions are sufficient to 
mediate peptide loading to some extent. The mechanism by which mutation o f Cys-95 
affects this binding site is unclear. Presumably ERp57 binding is responsible for this 
phenotype, and this is supported by the similarities in MHC class I recruitment between 
mouse B cells lacking ERp57 and a human B cell line expressing C95A tapasin. It is 
interesting to speculate that conjugate formation induces a conformational change in 
tapasin to generate a high affinity binding site for MHC class I.
In addition to the interactions between tapasin and MHC class I, CRT also binds 
the monoglucosylated glycan of MHC class I HC with an affinity of approximately 1 uM
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(Wearsch et al., 2004). The binding characteristics of the MHC class I/tapasin interaction 
have not been worked out. ERp57 almost certainly acts as a bridge between tapasin and 
CRT, and the P-domain of CRT binds ERp57 with a Kd ~ 9 uM (Frickel et al., 2002).
The combination of these weak interactions could stabilize the PLC. The decreased 
levels of CRT seen in C95A tapasin containing PLCs is consistent with this hypothesis, 
but it is impossible to determine at this time whether this is a direct result of the 
decreased MHC class I recruitment or the absence of ERp57 from the PLC. It seems 
most likely that some combination of factors will ultimately be found responsible for this 
phenotype.
It is difficult to examine structural changes of small amounts of proteins in crude 
cell extracts, but I used a conformation specific antibody available in the lab to probe 
changes in the structure of tapasin following heating. Incubation o f cell-expressed or 
recombinant unconjugated WT tapasin or the C95A mutant at or near physiologic 
temperatures dramatically destabilized the PaStal binding site. For cell-expressed 
tapasin, this was likely exacerbated by the presence of detergents, but recombinant 
tapasin was incubated in TBS alone. The amount of degradation of C95A tapasin was 
not substantially different from WT tapasin over the course of 8 hrs suggesting that the 
overall stability of this mutant is not impaired (Dick et al., 2002). It is possible that there 
are subtle conformational differences between conjugated and unconjugated tapasin in 
vivo that do not affect protein half-life but adversely affect MHC class I recruitment. A 
detailed structural analysis of free and conjugated tapasin with and without MHC class I 
H C /^m  complexes is needed to fully resolve this hypothesis.
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It is interesting to consider my experiments in conjunction with those of Garbi et 
al. to generate a universal model o f the role o f ERp57 in peptide loading. Indeed, H2-Kb 
and HLA-B*4402 are amongst the most different MHC class I molecules studied. First 
and foremost, the recruitment and stabilization of MHC class I HC into the PLC is 
dramatically reduced in an allele- and species-independent manner. In contrast, the 
trafficking and maturation of these two alleles is quite different when assembled in the 
absence of ERp57. H2-Kb passed through the Golgi much more quickly in the absence of 
ERp57, but HLA-B*4402 was slightly delayed in acquiring EndoH resistance. In 
tapasin-deficient mice, empty H2-Kb molecules reach the cell surface but are quickly 
internalized. The surface expression of these molecules is stabilized by the presence of 
exogenous peptide (Grandea et al., 2000). Cell surface expression of H2-Kb expressed in
721.220 cells is the same in the presence or absence of tapasin, and H2-Kb trafficking is 
accelerated in these cells comparable to tapasin deficient mouse B cells (Bamden et al., 
2000). Additionally, H2-Kb is expressed on the cell surface in human cells deficient in 
TAP expression at 37° C (Anderson et al., 1993). In contrast, in the absence of tapasin, 
HLA-B*4402 surface levels are greatly reduced, and very few MHC class I/|32m 
complexes reach the Golgi apparatus (Dick et al., 2002; Peh et al., 1998). It is likely that 
H2-Kb assembled with or without low affinity peptides is able to pass the quality control 
checkpoints in the ER, but these unstable complexes dissociate in post-ER compartments. 
HLA-B*4402 assembled with or without low affinity peptides does not appear capable of 
exiting the ER and likely undergoes ER associated degradation (ERAD).
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Chapter 5: Absence of ERp57 redox activity within the PLC
The complete absence o f ERp57 from the PLC is detrimental to the acquisition of 
high affinity peptides by both HLA-B*4402 and H2-Kb. In chapter 4 ,1 discussed some 
of the potential mechanisms by which ERp57 could be affecting peptide loading, but 
these experiments and those using ERp57-deficient B cells could not differentiate 
between a direct role for ERp57 in peptide loading and the indirect consequences arising 
from the absence o f conjugate formation. In particular, the redox difference seen in 
HLA-B*4402 associated with the PLC in C95A-expressing cells could be due to the 
absence of ERp57 oxidase activity. I used a combination of RNAi and mutagenesis to 
examine these questions. When ERp57 expression was stably suppressed, all residual 
ERp57 was associated with tapasin leading to minimal changes in PLC composition. 
Accordingly, peptide loading o f HLA-B*4402 was not affected. Interestingly, both PDI 
and ERp72 were able form mixed disulfides with tapasin in the absence of ERp57. 
Exogenous WT or mutant FLAG-tagged ERp57 were efficiently incorporated into the 
PLC in the absence of endogenous ERp57, but peptide loading was not affected by 
mutation o f Cys-60 responsible for the a-domain escape pathway or the complete 
inactivation of a ’ domain redox activity. Finally, the redox state of HLA-B*4402 
associated with a C60/406/409A redox inactive mutant was normal, arguing against a 
role for ERp57 mediated disulfide bond oxidation in the PLC.
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5.1: Successful generation of ERp57-suppressed 721.220.B4402.WT-tapasin cells
One factor complicating the MHC class I antigen processing field is the variety of 
cell lines and alleles studied. When direct comparisons between alleles expressed in
721.220 cells with and without tapasin have been made, HLA-B*4402 has consistently 
exhibited the greatest increase in surface expression following tapasin transfection (Park 
et al., 2003; Peh et al., 1998). Additionally, 721.220 cells expressing HLA-B*4402 were 
used to characterize the functional defects of the C95A tapasin mutant (Dick et al., 2002). 
Thus, to be most consistent with the literature as well as to facilitate comparisons 
between the C95A cells, I wished to stably knock-down ERp57 expression in 721.220 
cells expressing HLA-B*4402 and WT tapasin.
Initial experiments were conducted using HeLa-M cells transiently transfected 
with small inhibitory RNA duplexes (siRNA) specific for the coding region and 3’- 
untranslated region (UTR) of ERp57 (data not shown). From these experiments it 
became clear that both siRNA duplexes effectively knocked-down ERp57 expression, but 
probably because of the high expression and stability o f ERp57, two separate 
transfections were required for efficient knock-down. Because o f these technical 
difficulties, combined with the lack of characterization of HeLa-M expressed HLA 
alleles, I decided to generate cells stably suppressing ERp57 expression. Additionally, 
given that 721.220 cells are somewhat refractory to traditional lipid transfection and 
electroporation, an RNAi retrovirus system was employed (Barton and Medzhitov, 2002). 
Finally, I used the 3 ’ UTR to target ERp57 mRNA for degradation to allow the re­
expression of WT and mutant ERp57 constructs.
91
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Complementary oligonucleotides specific for the 3’ UTR of ERp57 or a non­
specific sequence were ligated into the RVH1 retroviral vector. This vector also contains 
a truncated, non-signaling version of human CD4 under the control of the CMV 
immediate early promoter to allow the identification and sorting of transduced cells. CD4 
expression was previously shown to correlate with genomic integration and RNAi- 
mediated suppression (Barton and Medzhitov, 2002). Retrovirus was produced by co­
transfection of 293T cells with RVHl-ERp57 or RVHl-Ctrl with the amphotrophic 
retroviral packaging vector pCL-Ampho. 721.220 cells expressing HLA-B*4402 and 
WT tapasin were then transduced by three rounds of “spinfection” at 2500 RPM for 90 
minutes at 32° C. Cells were then sorted three times for high CD4 expression.
Transduced and sorted cells were solubilized in Triton X-100, and 3.16-fold serial 
dilutions representing a 10-fold difference in loaded lysate were separated by reducing 
SDS-PAGE prior to quantitative Western blotting. These samples were then blotted 
using a rabbit antiserum raised against the C-terminal peptide of ERp57 or rat anti- 
GRP94 as a loading control (F ig u re  5.1a). Cells transduced with RVHl-Ctrl retrovirus 
maintained high levels of ERp57 expression as expected, but ERp57 expression in 
RVHl-ERp57 transduced cells was decreased by approximately 90%. The differences 
seen in ERp57 expression in this experiment are not the result of decreased loading 
because GRP94 levels were identical between these two cell lines. These levels of 
ERp57 suppression have been maintained for greater than six months (data not shown).
Cells typically have an excess of ERp57 over tapasin, and increasing tapasin 
expression by IFN-y treatment decreases the pool of free ERp57 (F ig u re  2.1). Having 
established a cell line with decreased ERp57 expression, I next wished to examine the
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Figure 5.1: Successful knock-down of ERp57 in 220.B44.Tpsn cells.
A) G eneration of E R p 57-su p p ressed  cell lines. 7 2 1 .2 2 0  ce lls  exp ressin g  HLA-B*4402 and WT 
tapasin  transduced  with retroviruses en cod in g  short-hairpin R NAs sp ecific  for E R p57 or a  
non-specific s e q u e n c e  w ere solubilized in 1% Triton X -100. Serial dilutions of ER p57 su p p ressed  
(+ RNAi) or control c e lls  (-RNAi) w ere resolved  by reducing SD S-PA G E . Following transfer and  
blocking, m em branes w ere cut and probed with a  rabbit antiserum  raised aga in st th e C -term inus of 
ERp57 (R .ER p57-C ) and m onoclonal rat anti-G R P94. S a m p les  w ere quantitated using a  Storm  
8 6 0  im aging sy stem  and Im agequant softw are. ER p57 knock-down w a s approxim ately 90% .
B) All rem aining ER p57 is conjugated  to tapasin . 7 2 1 .2 2 0  ce lls  exp ressin g  HLA-B*4402 and  
tapasin  transduced  with RVH 1-ERp57 or RVH1-Ctrl or untransduced (UT) w ere treated with 10 mM 
MMTS and solubilized in 1% Triton X -100. P ost-n uclear supern atan ts w ere resolved  by 
reducing/non-reducing SD S-PA G E . After transfer and blocking, m em b ran es w ere probed with 
rabbit anti-ER p57-C  or m o u se  anti-GAPDH.
C) C onjugate leve ls  are slightly d ec r e a se d  in E R p 57-su p p ressed  ce lls . C ells w ere prepared a s  in 
(B), but blotted with a  rabbit anti-serum  raised aga in st full length, in sect cell e x p re sse d  tapasin  
(R.SinE) or m o u se  anti-GAPDH.
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distribution of the residual ERp57 between conjugated and non-conjugated pools. 
Consistent with the effects o f lFN-y, all of the residual ERp57 expressed in RVH1- 
ERp57 transduced cells forms a mixed disulfide with tapasin in MMTS treated cells 
(F ig u re  5.1b). Accordingly, the amount of conjugated tapasin was only somewhat 
decreased in these cells compared with untransduced 721.220.B4402.WT-Tpsn or RVHl- 
Ctrl transduced cells (F ig u re  5.1c). These data clearly show that ERp57 is preferentially 
recruited into a mixed disulfide by tapasin and emphasize the data presented in Chapters 
2 and 3.
5.2: T a p a s in  c o n ju g a tio n  w ith  P D I a n d  E R p72  in  E R p 5 7 -su p p ressed  ceils
In HeLa, HeLa-M, and 721.220.B4402.WT-Tpsn cells in which ERp57 
expression was transiently or stably suppressed, higher molecular weight bands were 
consistently seen in whole cell extracts blotted for tapasin under non-reducing conditions 
(data not shown and F ig u re  5.1b). These bands were not present after reduction or when 
blotting for ERp57. This observation suggests that, in the absence of ERp57, tapasin may 
form mixed disulfides with other proteins.
Given the high degree of sequence, structural, and functional homology between 
PDI family members, I examined whether PDI and/or ERp72 were components o f these 
higher molecular species. This experiment was complicated by the limitations of the 
available reagents. Specifically, the only commercially available mouse anti-ERp72 
mAb does not immunoprecipitate under native conditions; it only recognizes denatured 
protein. Additionally, the anti-ERp72 antisera used cross-react with other proteins of 
approximately 57 kDa, and it is possible that these proteins are ERp57. Finally, until
94
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Figure 5.2: Other Trx family members form mixed disulfides with tapasin in 
ERp57 suppressed cells.
PDI and ER p72 form m ixed d isulfides with tapasin  in the a b se n c e  of E R p57. 7 2 1 .2 2 0  ce lls  
exp ressin g  HLA-B*4402 and WT tapasin  with or without ER p57 RNAi w ere treated with MMTS 
prior to solubilization in 1% Triton X -100. S D S  w a s  added  to a  final concentration of 1% to 14 of the  
post-nuclear supern atan ts d estin ed  for m o u se  anti-ER p72 im m unoprecipitation. T h e se  sa m p les  
w ere h eated  to 95° C for 5 m inutes and diluted in 1% Triton X -100 to a  final S D S  concentration of 
0.05% . All sa m p les  w ere then pre-cleared  with protein G- or protein A -sep h a ro se  for 
im m unoprecipitations with m o u se  m onoclonal antibodies or rabbit an tisera or cou p led  b ea d s, 
respectively. S a m p les  w ere then precipitated with P a S ta l or anti-HLA-DP cou p led  to a g a ro se  
b ead s, rabbit anti-tapasin (R .gp48C ) or rabbit anti-HLA-DR (R.DRAB) and protein A -sep h arose , or 
m o u se  anti-ER p72 (M .ERp72), m o u se  anti-PDI (M.PDI), or m o u se  anti-HLA-DM (MaP.DM) a s  a  
control (Ctrl) and protein G -sep h a ro se . S a m p les  w ere resolved  by reducing/non-reducing  
SD S-PA G E  a s  indicated, transferred to PVDF m em branes, and blocked. M em branes w ere then  
probed with rabbit anti-PDI (Rb.PDI), m o u se  anti-ER p72 (M .ERp72), or rabbit anti-tapasin (R .SinE  
for M .ERp72 or R .gp48C  for M.PDI). Following initial blotting, m em b ran es w ere stripped in 1% 
S D S , w ash ed , and re-probed with rabbit anti-tapasin (R .gp48C ), m o u se  anti-tapasin (M .Tpsn-C), 
rabbit anti-ER p72 (R b.E R p72), or rabbit anti-PDI (Rb.PDI) to confirm efficient im m unoprecipitation.
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recently we did not have an anti-tapasin mAb that blotted effectively. However, once 
optimal conditions were worked out, I treated 721.220.B4402.WT-Tpsn cells with or 
without stably suppressed ERp57 with MMTS prior to detergent extraction. One-quarter 
of the lysate was boiled in the presence of SDS to generate the appropriate anti-ERp72 
epitope, and this sample was then diluted into Triton X-100 to minimize the effects of 
SDS on antibody binding. The remaining lysate was precipitated with mouse anti- 
tapasin, rabbit anti-tapasin, or mouse anti-PDI followed by reducing/non-reducing SDS- 
PAGE. Following transfer and blocking, membranes were blotted for PDI, ERp72, or 
tapasin (Figure 5.2). In RVHl-Ctrl transduced cells, no PDI or ERp72 was precipitated 
with tapasin and no tapasin was precipitated with PDI or ERp72, despite efficient pull­
down as indicated by the presence of the appropriate protein after re-blotting (lower 
panel). However, mixed disulfides containing both PDI and ERp72 were precipitated 
with anti-tapasin reagents in ERp57-suppressed cells. Additionally, tapasin was 
immunoprecipitated with anti-PDI and anti-ERp72 mAbs. The amount o f precipitated 
protein was similar between RVHl-ERp57 and RVHl-Ctrl transduced cells when the 
membranes were re-blotted for the immunogens (lower panel). Thus, only when the 
expression of ERp57 is suppressed are other PDI family members including PDI and 
ERp72 capable of forming mixed disulfides with tapasin. These data further argue that 
tapasin specifically recruits ERp57 to the PLC, but the ability of tapasin to inhibit the 
Trx-motif escape pathway is likely universal.
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5.3: Slightly altered PLC composition and normal surface MHC class I
expression in RVHl-ERp57 transduced cells.
Despite achieving ERp57 knock-down of approximately 90%, a substantial 
amount of tapasin was conjugated to the residual ERp57. The differences in PLC 
composition between 721.220.B4402 cells expressing WT or C95A tapasin were 
profound, however, and I wished to determine whether the increase in unconjugated 
tapasin in ERp57-suppressed cells was sufficient to alter the overall PLC composition. 
Cells transduced with RVHl-ERp57 o r-C trl were treated with MMTS prior to extraction 
in digitonin, and PLCs were immunoprecipitated using an anti-TAP 1 mAb. Precipitated 
material was eluted under reducing conditions, and serial dilutions were run across a 10- 
fold concentration range. Membranes were then blotted for individual PLC components 
using appropriate reagents for fluorimetry and quantitation (Figure 5.3a). Consistent 
with the results from WT- and C95A-expressing cells, the amounts of TAPI and tapasin 
incorporated into the PLC did not differ between ERp57-suppressed and competent cells. 
The presence of ERp57 in the PLC was decreased by approximately 30% in RVH1- 
ERp57 transduced cells, consistent with the non-quantitative HRP blots shown in Figure 
5.1. Additionally, incorporation of both CRT and MHC class I HC was decreased by 
30% in ERp57-suppressed cells. However, these differences in PLC composition were 
not sufficient to cause a decrease in the surface expression of HLA-B*4402 (Figure 
5.3b).
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Figure 5.3: Suppression of ERp57 expression does not dramatically alter 
PLC composition.
A) Slightly altered PLC com position  in E R p 57-su p p ressed  ce lls . 7 2 1 .2 2 0  c e lls  exp ressin g  
HLA-BM 402 and WT tapasin  with or without ER p57 su p p ression  (-/+ RNAi) w ere treated with 
MMTS prior to digitonin solubilization. P ost-nuclear su pernatants w ere im m unoprecipitated with 
the m o u se  anti-TAP1 antibody 148 .3  (M.TAP1) or th e m o u se  anti-HLA-DP antibody B7 coupled  to 
a g a ro se  b ea d s  a s  a  control (Ctrl). After w ashing, im m unoprecipitated material w a s  eluted  under 
reducing conditions and sep arated  by SD S-PA G E . Following transfer and blocking, m em branes  
w ere cut and individually probed with rabbit antisera raised  aga in st th e C-terminal peptide of TAP1 
(RING.4C), CRT, the C-terminal peptide of E R p57 (Rb.E R p57-C ), the N-terminal peptide of tapasin  
(R .gp48N ), or rat anti-MHC c la s s  I HC (3B 10.7). S a m p le s  w ere quantitated using a  Storm  8 6 0  
imaging sy stem  and Im agequant softw are. S ign a ls corresponding to PLC com p on en ts precipitated  
from RVH 1-ERp57 transduced  c e lls  w ere norm alized to th o se  from RVH1-Ctrl transduced  ce lls . 
V alues are the m ean  +/- SEM for the dilutions, and this is representative of three independ en t 
experim ents.
B) Normal MHC c la s s  I su rface exp ression  in E R p 57-su p p ressed  ce lls . 7 2 1 .2 2 0  c e lls  exp ressin g  
HLA-B*4402 and WT tapasin  with or without ER p57 RNAi w ere incubated with m o u se  anti-HLA-A, 
B, and C directly cou p led  to APC or an A PC -coupled  non-binding isotyp e control for 3 0  m inutes on  
ice.
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5.4: Normal trafficking and maturation of HLA-B*4402 in ERp57-suppressed
cells.
The composition of the loading complex is dramatically altered in cells 
expressing C95A mutant tapasin, but cell surface HLA-B*4402 expression is only 
slightly decreased in these cells compared to those expressing WT tapasin. It is not 
surprising, therefore, that cells with suppressed ERp57 expression but relatively normal 
PLC composition have normal surface HLA-B*4402 expression. The trafficking and 
maturation of HLA-B*4402 is dramatically impaired in C95A-expressing cells, however. 
Therefore, I wished to determine whether the decreased ERp57 expression and altered 
PLC composition in RVHl-ERp57 transduced cells affected HLA-B*4402 maturation.
Cells transduced with RVHl-ERp57 or RHVl-Ctrl were pulse-labeled for 15 
minutes with [35S]-methionine and cysteine and chased for different lengths of time in the 
presence of excess cold methionine and cysteine. Cell pellets were solubilized in 
digitonin to preserve MHC class I associations with tapasin and allow for 
immunoprecipitation of non-TAP-associated MHC class I/p2m complexes with W6/32. 
Precipitated material was eluted and treated with EndoH overnight prior to reducing 
SDS-PAGE (Figure 5.4). The bands corresponding to EndoH resistant and sensitive 
MHC class I HC were quantitated, and the %EndoH resistant MHC class I HC was 
calculated. In contrast to what is seen in C95A-expressing cells (Figure 4.2), 
suppression of ERp57 expression and the resulting changes in the PLC are not sufficient 
to affect HLA-B*4402 trafficking through the Golgi. However, in RVHl-ERp57- 
transduced cells, the overall stability of W6/32 reactive complexes is reduced compared 
to RVHl-Ctrl or untransduced cells, including those that have passed through the Golgi
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Figure 5.4: Normal trafficking of HLA-B*4402 assembled in
ERp57-suppressed cells.
7 2 1 .2 2 0  ce lls  exp ressin g  HLA-BM 402 and WT tapasin  with or without E R p57-specific RNAi w ere  
p ulse-labeled  with [35S]-m ethionine and cy ste in e  for 15 m inutes and c h a se d  for th e indicated  
periods of tim e. Frozen ceil pellets w ere solubilized in 1 % digitonin, and p ost-nuclear su pern atan ts  
w ere im m unoprecipitated with th e anti-MHC c la s s  I HC/p2m conform ation sp ecific  antibody W 6/32  
or the CD1d sp ecific  antibody 5 1 .1 .3  a s  a  control and protein A -sep h arose. S a m p les  w ere w a sh ed  
with 0.1%  Triton X -100 in TB S, eluted  in 2x EndoH buffer with heating to 95° C, and incubated with 
1 m il EndoH overnight at 3 7° C. D igested  material w a s  then resolved  by reducing SD S-PA G E . 
B ands corresponding to EndoH resistant (upper band) and sen sitive  (lower band) MHC c la s s  I HC 
w ere quantitated, and th e % EndoH resistant MHC c la s s  I HC w a s calcu lated  (upper right panel). 
S ign a ls w ere further e x p re sse d  a s  % Max EndoH R e s  MHC c la s s  I HC (lower left panel) and % 
Max Total W 6/32 reactive MHC c la s s  I HC (lower right panel) a s  a  m easu re of the overall stability 
of W 6/32 reactive co m p lex e s  throughout the c h a s e  period. T h e m ean +/- SEM  of two independ en t  
experim ents is sh ow n, and the com paralb le data obtained  from untransduced  
7 2 1 ,220.B 4402.W T -T psn (UT) ce lls  from Figure 4.2 is sh ow n  for reference.
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(Figure 5.4, lower panels). These differences are not as great as those seen between 
cells expressing WT or C95A tapasin, and may reflect MHC class I complexes that were 
loaded with suboptimal peptides but were allowed to exit the ER.
5.5: Successful expression of FLAG-tagged mutant ERp57
Under ideal circumstances, the information regarding the function of ERp57 
within the PLC that could be obtained from RNAi studies is likely not dissimilar from 
that based on the C95A mutant and ERp57 conditional knock-out. To fully define the 
mechanism of ERp57 action in peptide loading, the phenotype o f cells expressing 
different ERp57 mutants should be examined. In particular, Dick et al. suggested that 
ERp57 could control the proper oxidation state o f the MHC class I HC associated with 
the PLC (Dick et al., 2002). Indeed, when the presence of ERp57 in the PLC was first 
identified, three groups individually hypothesized that PLC-associated ERp57 could be 
redox active (Hughes and Cresswell, 1998; Lindquist et al., 1998; Morrice and Powis, 
1998). The ability of tapasin to inactivate the escape pathway o f the ERp57 a domain 
suggests that the a ’ domain would be responsible for any redox activity in the PLC. An 
ERp57 mutant in which only the active site cysteine residues o f the a ’ domain were 
mutated to alanine (C406/409A) was not able to form the conjugate with tapasin. 
However, the inactivation of the a domain escape pathway in conjunction with this 
mutant (C60/406/409A) led to conjugate formation (Dick et al., 2002).
To determine if redox active sites of ERp57 are required for its function in the 
PLC, I transduced 721.220.B4402.WT-Tpsn cells stably suppressing endogenous ERp57 
with retroviral vectors encoding FLAG-tagged WT, C60A, and C60/406/409A ERp57.
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Figure 5.5: Successful re-expression of FLAG-tagged ERp57 mutants in 
ERp57-suppressed cells.
A) G eneration of ERp57-FLAG exp ressin g  ce lls . 7 2 1 .2 2 0  ce lls  exp ressin g  HLA-B*4402 and WT 
tapasin  with ER p57 RNAi w ere transduced  with retroviruses en cod in g  FLAG -tagged WT, C 60A, or 
C 60/406 /409A  ER p57 bicistronically with EG FP by “Spinfection”. C ells w ere then FACS sorted for 
high EG FP exp ression .
B) Expression  of FLA G -tagged ER p57 restores ER p57 exp ression  levels . 7 2 1 .2 2 0  ce lls  e x p r e ss ­
ing HLA-BM 402 and WT tapasin  with or without ER p57 RNAi exp ressin g  FLAG -tagged WT, C60A, 
or C 60/406 /409A  (3x) E R p57 w ere solubilized in 1% Triton X -100, and p ost-nuclear supern atan ts  
w ere resolved  by reducing SD S-PA G E . Following transfer to PVDF m em b ran es and blocking, 
m em branes w ere cut and probed with m o u se  anti-ER p57 (M aP.ERp57), m o u se  anti-FLAG (M2), or 
m o u se  anti-GAPDH.
C) Expression  of FLAG -tagged E R p57 con stru cts ab rogates ER p72 conjugate form ation. C ells  
from (B) w ere treated with 10 mM MMTS in PB S prior to solubilization in 1 % Triton X -100. Post- 
nuclear supern atan ts w ere reso lved  by reducing/non-reducing SD S-PA G E  a s  indicated. Following 
transfer to PVDF m em b ran es and blocking, m em b ran es w ere cut and probed with rabbit anti- 
tapasin  (R .SinE) or m o u se  anti-GAPDH.
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In these cells, enhanced green fluorescent protein (EGFP) is expressed bicistronically 
with ERp57-FLAG allowing the sorting and isolation o f transduced cells. Transduced 
cells were FACS sorted three times to obtain a population of cells expressing high levels 
of ERp57-FLAG (Figure 5.5a and b). After sorting, cells transduced with ERp57- 
FLAG encoding retroviruses were uniformly positive for EGFP, while RHVl-Ctrl and 
RVHl-ERp57 transduced cells were EGFP negative. The levels of ERp57-FLAG 
expression were comparable to levels of endogenous ERp57 expressed in RVHl-Ctrl 
cells, and no FLAG reactive material was present in untransduced cells. Additionally, 
there is a slight size difference (~1 kDa) between FLAG-tagged and endogenous ERp57 
that is clear in Figure 5.5b. Finally, expression o f exogenous, FLAG-tagged ERp57 leads 
to the loss of the higher molecular weight conjugates seen in RVHl-ERp57-alone 
transduced cells (Figure 5.5c).
5.6: Incorporation of ERp57-FLAG into the PLC
The FLAG-tagged ERp57 constructs expressed in the absence o f endogenous 
ERp57 were presumably able to form the conjugate with tapasin, and this is supported by 
the absence of higher molecular weight tapasin mixed disulfides in the transduced cells. 
However, the likelihood that a specific function associated with ERp57 would become 
apparent would be greater if  the FLAG-tagged mutant proteins were the overwhelming 
majority of PLC-associated ERp57. To examine the extent of mutant ERp57 
incorporation into the PLC, I immunoprecipitated the PLC using an anti-TAP 1 rabbit 
antiserum from MMTS treated lysates. These samples were then resolved by SDS-PAGE 
under reducing conditions and probed with MaP.ERp57 and M.Tpsn-C, a
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Figure 5.6: PLC incorporation of re-expressed FLAG-tagged ERp57 mutants
A) FLAG-tagged ER p57 is th e predom inant ER p57 form incorporated into the PLC. 7 2 1 .2 2 0  ce lls  
exp ressin g  HLA-BM 402 and WT tapasin , with or without ERp57 RNAi, exp ressin g  FLAG -tagged  
WT, C 60A, or C 60 /406 /409A  (3x) E R p57 w ere treated with 10 mM MMTS prior to solubilization in 
1% digitonin. P recleared  post-nuclear su pernatants w ere im m unoprecipitated with rabbit 
anti-TAP1 (RING.4C) or rabbit anti-HLA DR (R.DRAB) and protein A -sep h arose . 
Im m unoprecipitates w ere reso lved  by reducing SD S-PA G E  and, following transfer and blocking, 
m em branes w ere probed with m o u se  anti-ER p57 (M aP.ERp57). M em branes w ere then stripped in 
1% S D S , w a sh ed , and re-probed for tapasin  with m o u se  anti-tapasin (M .Tpsn-C) a s  an  
immunoprecipitation control.
B) FLAG-tagged ER p57 containing con ju gates recruit MHC c la s s  I HC into th e PLC.
7 2 1 .2 2 0  c e lls  exp ressin g  HLA-B*4402 and WT tapasin  with su p p ressed  en d o g e n o u s  ER p57 and  
re-exp ressed  WT, C60A, or C 60 /406 /409A  (3x) FLAG -tagged E R p57 w ere p u lse-lab eled  with 
[35S]-m ethionine and cy ste in e  for 4 5  m inutes, treated with 10 mM MMTS, and solubilized  in 1% 
digitonin. P ost-nuclear supern atan ts w ere im m unoprecipitated with rabbit anti-TAP1 (RING.4C) or 
NRS a s  a  control and protein A -sep h arose . S u b co m p lex es  w ere eluted  by incubating in 0.1%  Triton 
X -100 for 5 min on ice. Eluted material w a s  then re-precipitated with m o u se  anti-FLAG (M2) prior 
to resolution by reducing/non-reducing SD S-PA G E  a s  indicated.
C) FLAG-tagged E R p57 supports normal cell su rface MHC c la s s  I exp ression . 7 2 1 .2 2 0  ce lls  
exp ressin g  HLA-B*4402 and WT tapasin  with E R p57 RNAi exp ressin g  FLAG -tagged WT, C 60A, or 
C 60/406 /409A  (3x) E R p57 w ere sta in ed  with A PC -coupled  anti-HLA-A,B,C or an isotyp e control 
(N eg.). All s te p s  w ere perform ed on ice, and only living ce lls  are show n.
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mAb raised against the C-terminal peptide of tapasin (Figure 5.6a). MaP.ERp57 should 
react equally well with endogenous and FLAG-tagged mutant ERp57. Under these 
conditions, PLC-associated ERp57 from RVEll-Ctrl and RVFU-ERp57 transduced cells 
ran as a single band, but a doublet was seen in TAPI immunoprecipitates from cells 
expressing FLAG-tagged WT, C60A, and C60/406/409A ERp57. The lower molecular 
weight band was consistent in size with endogenous ERp57, and the higher molecular 
weight band most likely corresponds to the FLAG-tagged proteins. In all ERp57-FLAG 
transduced cells, the FLAG-tagged ERp57 appears to represent the majority o f PLC- 
associated ERp57. Additionally, the efficiency o f the TAPI immunoprecipitation was 
comparable from all the cell lines as indicated by the tapasin blot.
The FLAG-tagged ERp57 mutants can associate with TAP, but they may not 
support full subcomplex formation. Additionally, the experiment in Figure 5.6a was 
performed using reducing conditions, and I wanted to examine the ability of the ERp57 
mutants for form the conjugate with tapasin. To examine both conjugate formation and 
the association with MHC class I, I radio-labeled ERp57-FLAG transduced cells with 
[35S]-methionine and cysteine for 45 minutes prior to MMTS treatment and digitonin 
solubilization. PLCs were precipitated with rabbit anti-TAP 1, and subcomplexes were 
eluted with 0.1% Triton X-100. Samples were then immunoprecipitated with a mouse 
mAb targeting the FLAG tag and resolved by reducing/non-reducing SDS-PAGE. Using 
this approach, only proteins contained in specific subcomplexes with the FLAG-tagged 
mutants should be precipitated (Figure 5.6b). Based on the molecular weights of the co­
precipitated proteins, all of the FLAG-tagged ERp57 constructs were able to form the 
conjugate with tapasin, and all recruited MHC class I HC. A band corresponding to CRT
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is not seen in this experiment, but CRT labels poorly and/or it could be lost during the 
biochemical isolation. Additionally, the interaction of MHC class I with FLAG-tagged 
ERp57 containing PLCs supports a high level o f HLA-B*4402 cell surface expression. 
The surface level of HLA-B*4402 in WT-FLAG expressing cells was somewhat higher 
than C60A or C60/406/409A expressing cells, however, suggesting that the redox activity 
of the ERp57 a domain may be important for peptide loading (Figure 5.6c). However, 
a biochemical analysis o f MHC class I assembly is somewhat inconsistent with this 
conclusion (see below). A more detailed analysis o f these discrepancies is ongoing.
5.7: The redox function of ERp57 is not required for MHC class I loading
ERp57 possesses several functional domains. It is unlikely that the a domain is 
involved in peptide loading beyond allowing for conjugate formation. The bb ’ domains 
interact with CRT and CNX, and the role of these domains will be investigated in the 
future. In contrast, a redox active a ’ domain could play an important role in controlling 
the loading and/or egress of peptide loaded MHC class I complexes from the PLC. 
Because a C406/409A mutant did not form the conjugate, I expressed a C60/406/409A 
mutant in ERp57-suppressed cells. The escape pathway of the a domain of this mutant is 
inactivated, and it is important to compare peptide loading and MHC class I trafficking in 
cells expressing this mutant to those expressing the C60A mutant.
I pulse-labeled cells expressing HLA-B*4402, WT tapasin, and WT, C60A, 
C60/406/409A FLAG-tagged ERp57 with [35S]-methionine and cysteine for 15 minutes 
and chased these cells for different lengths o f time up to four hours in an excess o f cold 
methionine and cysteine. Cells were lysed in digitonin, and free MHC class I HC/f^m
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Figure 5.7: Normal trafficking and maturation of HLA-B*4402 in the presence 
of redox mutant conjugates.
7 2 1 .2 2 0  c e lls  exp ressin g  HLA-BM 402 and WT tapasin  with su p p ressed  en d o g e n o u s  E R p57 and  
re-exp ressed  WT, C60A, or C 60 /406 /409A  FLAG -tagged ER p57 w ere p u lse-lab eled  with 
[35S]-m ethionine and cy ste in e  for 15 m inutes and c h a se d  for the indicated periods of tim e. Frozen  
cell p ellets w ere solubilized in 1% digitonin, and post-nuclear supern atan ts w ere  
im m unoprecipitated with the anti-MHC c la s s  I HC/p2m conform ation sp ecific  antibody W 6/32 or the  
CD1d sp ecific  antibody 5 1 .1 .3  a s  a  control and protein A -sep h arose. S a m p les  w ere w a sh ed  with
0.1%  Triton X -100 in TB S, eluted  in 2x  EndoH buffer with heating to 95° C, and incubated with 1 
mU EndoH overnight at 3 7° C. D igested  material w a s  then  resolved  by reducing SD S-PA G E . 
Bands corresponding to EndoH resistant (upper band) and sen sitive  (lower band) MHC c la s s  I HC 
w ere quantitated, and the % EndoH resistant MHC c la s s  I HC w a s calcu lated  (upper right panel). 
S ignals w ere further ex p re sse d  a s  % Max EndoH R e s  MHC c la s s  I HC (lower left panel) and % 
Max Total W 6/32 reactive MHC c la s s  I HC (lower right panel) a s  a  m easu re  of the overall stability 
of W 6/32 reactive co m p lex e s  throughout the c h a s e  period. T h e m ean +/- SEM  of two independ en t 
experim ents is show n.
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dimers were precipitated with W6/32. After an overnight digestion with EndoH, samples 
were resolved by reducing SDS-PAGE. Bands corresponding to EndoH resistant and 
sensitive MHC class I HC were quantitated, and the rate of acquisition o f EndoH 
resistance was calculated (Figure 5.7). The trafficking of HLA-B*4402 assembled in the 
presence o f a redox inactive ERp57 mutant was the same as those assembled in cells 
expressing ERp57 with a functional a ’ domain. Additionally, the stability of W6/32 
complexes was similar in all of these cells over the course of this four-hour experiment 
(Figure 5.7, lower panels). To examine the kinetics of MHC class I egress from PLCs 
containing mutant ERp57,1 prepared cells as described above, but, at the indicated chase 
points, cells were treated with MMTS prior to digitonin lysis and immunoprecipitation 
with an anti-TAP 1 antiserum. Precipitated material was eluted from the TAP 
heterodimer using 0.1% Triton X-100 prior to resolution by reducing SDS-PAGE 
(Figure 5.8). MHC class I HC appeared to transit through PLCs containing C60A mutant 
ERp57 more slowly than those containing WT or C60/406/409A ERp57, but these 
differences were not as pronounced as that seen with WT and C95A tapasin expressing 
cells. When Figure 5.6, 5.7, and 5.8 are considered together, it is difficult to draw 
conclusions from these data. If  the ERp57 a domain is essential for MHC class I loading, 
similar defects should be seen in C60A and C60/406/409A cells, but, if  the a ’ domain 
functions in MHC class I loading, WT and C60A ERp57 should be comparable. The fact 
that WT and C60/406/409A are most similar with respect to MHC class I trafficking 
through the PLC is difficult to reconcile with a clear function for the redox domains of 
ERp57 in PLC action. However, the overall recruitment of MHC class I complexes into 
the PLC is not affected in these cells, as indicated by the MHC class I HC/tapasin ratio.
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Figure 5.8: Altered HLA-B*4402 PLC recruitment and egress in the presence 
of redox mutant conjugates.
7 2 1 .2 2 0  ce lls  exp ressin g  HLA-BM 402 and WT tapasin  with su p p ressed  e n d o g e n o u s  ER p57 and  
re-exp ressed  WT, C 60A, or C 60 /406 /409A  FLAG -tagged ER p57 w ere p u lse-lab eled  with [35S]- 
m ethionine and cy ste in e  for 15 m inutes and c h a se d  for the indicated periods of time. MMTS 
treated frozen cell p ellets w ere solubilized in 1% digitonin, and post-nuclear su pern atan ts w ere  
im m unoprecipitated with either rabbit anti-TAP1 (RING.4C) or NRS a s  a  control and protein A- 
sep h a ro se . Precipitated material w a s  w a sh ed  with 0.1%  digitonin in TBS prior to elution in 0.1%  
Triton X -100 in T B S for 5  min at 4° C. Eluted material w a s  incubated with reducing sa m p le  buffer 
and resolved  by SD S-PA G E . T h e b and s corresponding to MHC c la s s  I HC and tapasin  w ere q uan ­
titated and ex p re sse d  a s  the % Maximum TAP a sso c ia ted  MHC c la s s  I HC (upper right panel), the  
% Maximum TAP a sso c ia ted  tapasin  (middle right panel), and the MHC c la s s  I H C/tapasin ratio 
w a s a lso  calcu lated  (lower rightpanel). The m ean  +/- SEM  of two in depend en t exp erim en ts is 
show n.
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Additionally, the stability of the TAP/tapasin interaction appears to be slightly greater for 
conjugates containing C60A ERp57. The relationship between the TAP/tapasin 
interaction and MHC class I association with the PLC could be inversely related. These 
differences will be further examined in the near future.
5.8: Normal redox state of MHC class I associated with ERp57-mutant PLCs
Dick et al. observed that PLC-associated HLA-B*4402 was partially reduced in 
cells expressing C95A tapasin, but Garbi et al. did not see any differences in the redox 
state of PLC-associated H2-Kb (Dick et al., 2002; Garbi et al., 2006). If  ERp57 plays a 
direct role in maintaining the oxidation state of TAP-associated MHC class I HC, these 
effects are likely mediated by the a ’ domain. Thus, the redox state of PLC-associated 
HLA-B*4402 in C60/406/409A ERp57 expressing cells should be altered if this model is 
correct. However, the work of Dick et al. was performed prior to the use o f MMTS for 
conjugate preservation, and the importance of cell pretreatment in maintaining PLC 
composition was not fully realized (Dick et al., 2002).
I first wished to confirm this key observation using MMTS. Cells expressing 
either C95A tapasin or WT tapasin were labeled with [ S]-methionine and cysteine for 
45 minutes prior to MMTS treatment and digitonin extraction. PLCs were isolated using 
an anti-TAPl antiserum, and precipitated material was released by boiling in 1% SDS. 
Samples were then diluted into 1% Triton X-100, and MHC class I HCs were precipitated 
using the anti-MHC class I specific rat mAb 3B10.7 coupled to agarose beads. However, 
under these conditions, no redox differences were seen in HLA-B*4402 in C95A- and
110
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.


















•mttm * "* *
* * £  .. .
• \
220. B44. C95A-T psn 




MHC c lass  I HC
Tapasin
MHC c lass  I HC
Figure 5.9: C95A-associated MHC class I HC reduction occurs
post-solubilization in an lAA-dependent manner.
7 2 1 .2 2 0  ce lls  exp ressin g  HLA-B*4402 and WT or C 95A  tapasin  w ere labeled  with [35S]-m ethionine 
and cy ste in e  for 4 5  min and treated with MMTS a s  indicated (MMTS Pre-Tx). C ells w ere lysed  in 
1% digitonin in T B S with or without 10 mM IAA a s  indicated. P ost-n uclear su pern atan ts w ere  
im m unoprecipitated with th e anti-TAP1 antiserum  RING.4C or NR S a s  a  control and protein 
A -sep h arose, and bound material w a s  eluted in 0.1%  Triton X -100 with MMTS a s  indicated. 
S a m p les w ere then im m unoprecipitated with C on A -sep h arose and reso lved  by 
reducing/non-reducing SD S-PA G E . B an ds corresponding to the conjugate, ERp57/CRT, tapasin , 
and MHC c la s s  I HC are indicated. T he in set b o x e s  are 2x en largem en ts of the indicated regions  
corresponding to L an es 1 - 3 .
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WT-tapasin expressing cells. All PLC-associated MHC class I HC was fully oxidized 
(data not shown).
The procedure used to demonstrate a redox difference in the presence of C95A 
tapasin was somewhat convoluted, but the data were very clear. Cells were solubilized in 
the presence of NEM and IAA, and subcomplexes were dissociated from TAP by eluting 
in 0.1% Triton X-100 with NEM. The NEM treatment was not very effective, however, 
because comparable amounts of free tapasin were seen in WT- and C95A-expressing 
cells under non-reducing conditions (Dick et al., 2002). Therefore, I wished to identify 
at which point during the experiment MHC class I HC reduction occurred. Cells 
expressing either WT or C95A mutant tapasin were labeled for 45 minutes with [35S]- 
methionine and cysteine. Cells were then treated with MMTS or PBS alone prior to 
solubilization in digitonin with or without 20 mM IAA. TAPI immunoprecipitates were 
then eluted with 0.1% Triton X-100 with or without 5 mM MMTS, and all samples were 
reprecipitated with Concanavalin A (ConA) sepharose. Samples were then resolved by 
reducing/non-reducing SDS-PAGE. ConA was used to precipitate all eluted MHC class I 
regardless of its association with tapasin, (Lm, and/or CRT. Under these conditions, only 
MHC class I HC isolated from C95 A-expressing cells solubilized in the presence of IAA 
without prior MMTS treatment exhibited two redox forms (F ig u re  5.9, L an es  1 v. 2 v.
3).
I next used these conditions to examine the redox state of HLA-B*4402 
associated with WT tapasin in the presence or absence of different ERp57 mutants. As
35described above, cells were labeled for 45 minutes with [ S]-methionine and cysteine 
and treated with or without MMTS prior to solubilization in digitonin with IAA. PLCs
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Figure 5.10: Normal MHC class I redox state in the presence of ERp57-redox 
mutants.
7 2 1 .2 2 0  ce lls  exp ressin g  HLA-B*4402 and WT tapasin  with su p p ressed  en d o g e n o u s  E R p57 and  
ex o g en o u sly  e x p re sse d  FLAG -tagged WT, C60A, or C 60 /406 /409A  (3x) E R p57 w ere labeled  with 
[35S]-m ethionine and cy ste in e  for 4 5  min and treated with MMTS a s  indicated (MMTS Pre-Tx). 
C ells w ere lysed  in 1% digitonin in TBS with 10 mM IAA, and post-nuclear su pern atan ts w ere  
im m unoprecipitated with th e anti-TAP1 antiserum  RING.4C or N R S a s  a  control and protein 
A -S ep h arose . Bound material w a s  eluted  in 0.1%  Triton X -100 with MMTS and reprecipitated with 
C on A -sep h arose prior to resolution by reducing/non-reducing SD S-PA G E . B an ds corresponding  
to the conjugate, ERp57/CRT, tapasin , and MHC c la s s  I HC are indicated. T he lower panel is a  2x  
en largem en ts of the indicated region corresponding to L an es 1 -  6.
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were then isolated by immunoprecipitating for TAPI, and subcomplexes were released 
by incubating in 0.1% Triton X-100 with MMTS prior to precipitation with ConA- 
sepharose. Bound material was then resolved by reducing/non-reducing SDS-PAGE 
(Figure 5.10). Consistent with Figure 5.9, no redox differences were seen in HLA- 
B*4402 when cells were pretreated with MMTS prior to detergent lysis. Additionally, 
MHC class I HCs isolated from non-MMTS treated cells lysed in IAA were fully 
oxidized. While the mechanism by which HLA-B*4402 becomes reduced during 
solubilization of C95A-expressing cells is unclear, the a ’ domain of ERp57 does not play 
a role in maintaining the redox state o f PLC-associated MHC class I.
5.9: Discussion
Over the past decade, RNAi has progressed from an interesting technique 
applicable to lower model organisms to a Nobel Prize winning discovery that has 
revolutionized many aspects of biology. Unfortunately, some of the conditions that could 
limit the suitability of RNAi to a particular system such as target stability, high 
expression, and strength of interaction all seem to apply the interaction of ERp57 with 
tapasin. Thus, despite achieving relatively high levels of ERp57 knock-down in a cell 
line that has traditionally been difficult to transfect, I observed no differences in HLA- 
B*4402 peptide loading. However, the cells I generated that stably suppress ERp57 
expression allow for some conclusions about the nature of the conjugate to be made.
I previously showed that the amount of tapasin expressed controls the amount of 
free ERp57 available in cells (Figure 2.1). This experiment was still conducted under 
relatively physiologic conditions, and the amount of free ERp57 could still be sufficient
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to meet the minimum requirements for glycoprotein folding. However, when I 
suppressed ERp57 expression using RNAi, all o f the residual ERp57 was incorporated 
into the conjugate leaving no detectable free ERp57 in these cells (Figure 5.1). Thus, the 
recruitment of ERp57 into the conjugate is strongly preferred. In addition, the amount of 
unconjugated tapasin is further reduced in these cells due to the recruitment of PDI and 
ERp72 into mixed disulfides. These data also argue that when exposed to the ER lumen, 
Cys-95 of tapasin is very reactive, and maintaining this cysteine in reduced form is 
strongly disfavored.
The detection of mixed disulfides containing tapasin and PDI or ERp72 also 
argues that the ability of tapasin to inhibit the ERp57 escape pathway applies to other 
Trx-motif containing proteins. Admittedly, less tapasin is associated with PDI/ERp72 
than ERp57, but this strongly suggests some degree of escape pathway inactivation for 
both PDI and ERp72. In the presence of MMTS, few if any mixed disulfides are seen for 
PDI and ERp72, consistent with the model of escape pathway activation discussed in 
Chapter 3 and proposed by Walker et al. (Walker and Gilbert, 1997). This is not 
surprising given the high degree of conservation surrounding the Trx active site in these 
oxidoreductases. I was unable to detect complexes o f tapasin conjugated-PDI or -ERp72 
with CRT or (32m, but this does not eliminate the possibility that they associate in vivo 
(data not shown). The isolation conditions required for this experiment were somewhat 
harsh, and the interaction between ERp57 and CRT is relatively weak. The residues 
responsible for CRT binding are absent from PDI, and, while these residues are 
somewhat conserved in ERp72, the domain architecture of ERp72 differs from that of 
ERp57 (Kozlov et al., 2006). If the a ° domain of ERp72 forms a mixed-disulfide with
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tapasin, the b ’ domain would not be orientated properly to coordinate CRT binding. To 
fully assess the ability of PDI/ERp72 conjugated tapasin to recruit MHC class I/f^m 
dimers and/or CRT, ERp57 expression should be knocked-down in cells unable to 
coordinate the 4:1 subcomplex:TAP stoichiometry seen in WT cells.
Given the only slight changes in conjugate level and PLC composition seen in 
cells stably suppressing ERp57, the lack of an effect on MHC class I surface expression, 
acquisition of EndoH resistance, and stability of MHC class I/|32m complexes is not 
surprising. When these parameters are compared between WT- and C95A-tapasin 
expressing cells, differences in complex stability are the most striking. The fact that no 
differences were seen between cells expressing 100% conjugated tapasin and 
approximately 70% conjugated tapasin suggests that MHC class I molecules may 
undergo multiple rounds of PLC engagement. The “quality control” model of peptide 
loading predicts that MHC class I complexes interact with the PLC, bind peptide or 
undergo peptide exchange, and dissociate from the PLC. Once free in the ER, weakly 
bound peptides are lost triggering a conformational change in MHC class I that is sensed 
by UGGT leading to reglucosylation and reengagement with the PLC. Thus, the 
phenotype of cells containing a mixture of PLCs fully and partially competent for 
mediating peptide loading could be masked by the successive reengagement of poorly 
loaded MHC class I/f^m dimers with fully functional subcomplexes containing both 
tapasin and ERp57. This model has yet to be proven, but, if correct, reengagement with 
the PLC must occur rapidly, however, as no differences in trafficking were seen between 
RVHl-Ctrl and -ERp57 transduced cells. Alternatively, the 30% unconjugated tapasin
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present in RHVl-ERp57 transduced cells could support peptide loading sufficiently well 
as to be indistinguishable from fully conjugated tapasin.
The phenotypes of ERp57-deficient mouse B cells and human cells expressing 
HLA-B*4402 and C95A tapasin were very similar in most respects. Both suggest a role 
for ERp57 in recruiting and/or stabilizing MHC class I in the PLC, and this appears 
required for the acquisition of tightly bound peptide by a large population of MHC class 
J/jTm dimers. Therefore, if ERp57 has a function in the PLC beyond forming the 
conjugate, the incorporation of different ERp57 mutants into the PLC should recapitulate 
the phenotype seen in these cells. However, when the redox activity of the ERp57 a ’ 
domain was completely eliminated, no differences in PLC association were seen 
compared to cells expressing WT ERp57. In contrast, MHC class I association with the 
PLC was prolonged in cells expressing predominantly C60A ERp57. These data are not 
straightforward, however, as the ratio of MHC class I HC to tapasin did not differ 
between any of these cell lines. There was an approximately 10-fold difference between 
the MHC class I HC to tapasin ratio in cells expressing WT and C95A tapasin. At best, 
the redox activity of the ERp57 a ’ domain only partially explains the role of ERp57 in the 
PLC. Thus, it is likely that the bb ’ domains are likely responsible for the function of 
ERp57 in peptide loading. Studies are ongoing to assess the role of these domains in 
recruiting CRT and MHC class I HC into the PLC.
It is possible that elimination of the redox activity of the ERp57 a domain while 
the activity of the a ’ domain is retained somehow affects the long-term association of 
tapasin with TAP. While ERp57 does not exhibit domain synergy comparable to PDI 
(Kulp et al., 2006), there is clearly some degree of functional interdependence for the a
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and a ’ domains of ERp57 because, when the a domain is left intact, an a ’ domain redox 
mutant cannot form the conjugate (Dick et al., 2002). Additionally, a C406A mutant in 
which the N-terminal cysteine of the a ’ CXXC  motif is replaced with alanine does not 
form the conjugate (data not shown). These observations suggest that the redox activity 
of the a ’ domain is somehow required for conjugate formation and/or preservation, but 
further studies are needed to clarify the potential redox mechanisms affecting this 
phenomena.
One of the most striking phenotypes observed in C95A-tapasin expressing cells 
was the altered redox state of PLC-associated HLA-B*4402. I have now shown that 
result is somewhat an artifact of solubilization conditions. The reactivity o f MMTS is 
much greater than that of NEM or IAA, and proteins isolated from cells treated with 
MMTS most likely represent the true in vivo redox state. HLA-B*4402 associated with 
the PLC in C95A-tapasin expressing cells is fully oxidized following MMTS treatment, 
and only after solubilization in IAA does a redox difference appear. However, the 
absence of a redox difference in MHC class I HC in cells expressing WT tapasin under 
identical conditions suggests that the HLA-B*4402 associated with C95A tapasin is 
somehow more susceptible to reduction. Nevertheless, the presence of a redox inactive 
ERp57 mutant in the PLC does alter the redox state of HLA-B*4402 compared to WT- 
ERp57 containing conjugates. Park et al. recently identified a role for PDI in controlling 
the redox state and peptide loading of HLA-A*0201 exogenously expressed in HeLa 
cells. They did not pretreat cells with MMTS, but they followed a procedure similar to 
Dick et al. (Dick et al., 2002; Park et al., 2006). I have now shown that the redox state of 
MHC class I HCs in the ER is, under some conditions, exquisitely sensitive to the
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biochemical isolation procedure. It is possible that PDI plays an indirect role in 
controlling the redox state of MHC class I HC, but this requires further clarification. 
NEM, IAA, and MMTS are generally considered interchangeable in their reactivity, but 
this is clearly not the case (Lundblad, 1995). Amongst these reagents, MMTS is the most 
specific for cysteine residues with the most rapid reaction kinetics. Additionally, IAA 
treatment does not preserve the conjugate, suggesting that ERp57 Cys-60 is not 
accessible to IAA in vivo. Differential Cys-60 accessibility may explain the differences 
in conjugate preservation seen with MMTS compared to NEM. For these reasons, the 
redox state of MHC class I isolated from cells pretreated with MMTS is likely the most 
representative of the in vivo redox state, and, under these conditions, I could detect no 
redox differences in PLC-associated HLA-B*4402. Taken together, my data argue 
against a role for the redox regulation of peptide loading.
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Chapter 6: Conclusions and Future Directions
6.1: Peptide loading and PLC assembly
Peptide loading onto MHC class I complexes is a dynamic event involving 
multiple steps within the ER. There are three distinct phases of MHC class I assembly 
and peptide loading: events prior to PLC incorporation, events occurring in the PLC, and 
post-PLC events including ER egress and trafficking to the cell surface. The folding of 
MHC class I HC with (Tm prior to their PLC association is a classic case o f glycoprotein 
folding involving glucosylation-dependent interactions of substrate (MHC class I HC) 
with CNX and ERp57-facilitated disulfide bond oxidation. Intermediates in this process 
can be detected using standard biochemical techniques, and the details o f MHC class I 
HC folding and assembly with (32m seem clear at the present time. In contrast, the 
assembly and mechanism of action of the PLC is less well studied.
To the best of our knowledge, a single PLC contains no less than 22 distinct 
polypeptide chains when the 4:1 tapasin:TAP stoichiometry is considered together with 
the composition of the tapasin-based subcomplexes. It is assumed that subcomplexes are 
functionally identical, and the factors regulating subcomplex assembly should not vary 
with the site of tapasin interaction with the TAP heterodimer. Despite involving well- 
characterized glycoprotein specific chaperones, I have now shown that the assembly of 
the core components o f the PLC deviates substantially from models of glycoprotein 
quality control. In particular, ERp57 is specifically recruited to the PLC by glycan- 
independent interactions with tapasin alone. It remains in a mixed disulfide with tapasin 
despite tapasin having achieved all markers of a correctly folded, native protein. In
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contrast, the interaction of CRT with the PLC appears to be entirely dependent upon the 
presence of monoglucosylated MHC class I HC, consistent with its role in glycoprotein 
folding.
The plethora of proteins and interactions within the PLC provides ample possible 
sources o f variation that were hypothesized to be related to peptide loading. Most 
generally, the peptide loading status of MHC class I could affect the association of CRT 
or ERp57 with MHC class I/fLm/tapasin subcomplexes. Additionally, the redox states of 
MHC class I, tapasin, and ERp57 could be modulated to correspond to different peptide 
loading states. Finally, the glucosylation state of the MHC class I N-linked glycan could 
indicate the quality of loaded peptide in the PLC. Standard biochemical techniques were 
used to address most of these possibilities, but, for all conditions examined, no variability 
was seen (this study and Pamela Wearsch, manuscript in preparation). All tapasin is 
conjugated to ERp57, and all subcomplexes contain monoglucosylated MHC class I HC 
and CRT. Additionally, I showed that variations in MHC class I HC redox state arise 
post-solubilization. It remains possible that the redox state of the Cys-7/Cys-71 disulfide 
bond in the N-terminus of tapasin and/or the a ’ domain of ERp57 are affected by peptide 
loading, but my studies suggest that this is not the case.
The function of ERp57 within the PLC remains unclear. The altered PLC 
composition seen in the absence of ERp57 clearly indicates that proper recruitment of 
MHC class I HC/fLm dimers and CRT critically depend upon conjugate formation. This 
represents a classic “chicken and egg” puzzle. The lack of CRT recruitment could be 
secondary to the loss of ERp57-dependent interactions of MHC class I HC with tapasin.
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Alternatively, the interaction of the CRT P-domain with ERp57 may be required for the 
full recruitment and/or stabilization of MHC class I complexes in the PLC.
The tapasin/ERp57 conjugate with the TAP heterodimer is the core of the PLC, 
and my data indicate that functional studies of tapasin that do not incorporate ERp57 
likely do not reflect the state of tapasin in vivo. Within the cell, there is no unconjugated 
tapasin associated with the PLC, and this is the most functionally important tapasin 
population. While the phenotype of cells unable to form the conjugate is less pronounced 
than cells lacking tapasin altogether, tapasin has clearly evolved to specifically recruit 
and retain ERp57 within the PLC. Comparisons between tapasin-deficient and tapasin- 
sufficient cells are further complicated by the tapasin-mediated stabilization of the TAP 
heterodimer. Thus, the somewhat impaired peptide loading seen in cells expressing 
soluble tapasin could be related to decreased TAP-mediated peptide translocation.
Finally, the conjugate appears able to enhance peptide loading in vitro to a much greater 
extent than tapasin alone (Pam Wearsch, manuscript in preparation).
The conjugate is preserved much more efficiently in cells treated with MMTS 
compared to NEM, but, in the absence of either reagent, no conjugate is seen after SDS- 
PAGE. For conjugates in which Cys-60 remains reactive, detergent solubilization leads 
to some degree of escape pathway activation and the release of non-covalently associated 
ERp57. The full extent of conjugate reduction is dependent on several factors including 
the detergent used, but it is likely that the non-covalently associated ERp57 
immunoprecipitated with the PLC in early studies in the absence of NEM or MMTS was 
conjugated to tapasin immediately prior to the addition of SDS-PAGE sample buffer.
The release of ERp57 in the absence o f MMTS or NEM during solubilization and
122
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
biochemical isolation o f the PLC could dramatically alter the quantity of co-precipitated 
PLC components. Specifically, less MHC class I and CRT are found associated with 
non-MMTS treated PLCs after digitonin lysis, preclear, and TAPI immunoprecipitation 
(unpublished observations).
Conjugate preservation is especially essential for the proper assessment of 
interactions in the context of novel mutations in PLC components, and the duration of 
biochemical isolation could affect the observed phenotype of isolated PLCs. The lengths 
of time specified in Chapter 7 and the figure legends of this dissertation are accurate and 
reflect the shortest periods of time supporting a balance between signal sensitivity, 
specificity, and consistency. While not precisely empirically determined, preliminary 
results obtained following longer preclearing and immunoprecipitation steps were often 
inconsistent and exhibited variable amounts of non-specific background signals. Taken 
together, these observations suggest a series of critical steps that must be considered in 
future studies o f MHC class I antigen loading. Inconsistencies between studies could be 
a reflection of the set of techniques used rather than the systems being studied. In 
particular, MMTS treatment should become standard practice in studies examining 
interactions within the PLC.
6.2: Future Studies
There are a number o f questions surrounding MHC class I loading in the ER that 
remain unanswered. It is generally assumed that all MHC class I molecules interact with 
the PLC at some point, and poorly loaded MHC class I complexes are thought to undergo 
multiple rounds of PLC engagement. Inhibition of glucose trimming with CST prolongs
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the interaction of MHC class I with the PLC (van Leeuwen and Kearse, 1996), but 
monoglucosylated MHC class I complexes could undergo multiple rounds o f PLC 
binding in the absence of glucosidase activity. It remains to be determined where and 
when the final glucose trimming of MHC class I occurs. Additionally, UGGT 
presumably recognizes some aspect of peptide-free MHC class I complexes, but the role 
o f reglucosylation and the structural aspects of UGGT recognition of MHC class I HC are 
entirely unknown.
Structural studies of the tapasin/ERp57 conjugate will greatly enhance our 
understanding o f peptide loading. Tapasin alone has been refractory to crystallization, 
but I have shown that conjugation with ERp57 enhances the structural integrity of 
tapasin. Additionally, as stated above, conjugated tapasin is the most physiologically 
form. Current attempts at conjugate crystallization are encouraging (G. Dong and P. 
Wearsch, personal communication). A structure of the conjugate could provide valuable 
insight into the residues of both ERp57 and tapasin responsible for ERp57 recruitment 
and tapasin-mediated escape pathway inhibition. Furthermore, combining the structures 
of MHC class I/(12111 complexes with mutational analyses will allow the identification of 
the sites of interaction between MHC class I and tapasin. Taken together, these data will 
suggest a series o f novel mutations in MHC class I HC, tapasin, and ERp57 to be 
generated and examined.
The changes that occur in MHC class I and the PLC during the course of peptide 
loading are not detectable given current techniques and reagents. It is likely that subtle 
conformation changes in MHC class I complexes correspond to the binding of high or 
low affinity peptides, and these changes dictate the recognition of MHC class I
124
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
complexes by tapasin. Additionally, tapasin binding could affect the conformation of 
MHC class I (Wright et al., 2004), and the converse cannot be excluded. These changes 
would likely take place on a very rapid time-scale, and their detection may require the 
application of advanced structural and biophysical techniques. In particular, NMR may 
be required to visualize changes in MHC class I and/or tapasin structure during their 
interaction in the presence and absence of peptide
There is a growing body of literature examining MHC class I antigen processing 
and presentation using confocal microscopy and related techniques (Neijssen et al., 2005; 
Pentcheva et al., 2002; Reits et al., 2000; Spiliotis et al., 2000). However, these studies 
largely exist independent of the biochemical literature making it difficult to fully 
incorporate these data into a comprehensive model of MHC class I trafficking. In 
particular, the cell lines that are amenable to examination by microscopy are not those 
that have been traditionally examined biochemically. Future studies should seek to 
combine these two spheres of study. Epstein Barr Virus transformed human B cell lines 
including 721 and its derivatives are the basis for much of our understanding of MHC 
class I biochemistry. Most if  not all of the components of the MHC class I antigen 
processing pathway are constitutively upregulated in these cells lines, and greater insight 
into the factors regulating antigen presentation could be gained by examining epithelial 
and stromal cell lines under different conditions of immune stimulation such as by IFN-y. 
Finally, primary human and mouse dendritic cells may be the most interesting and 
immunologically relevant cells for future studies.
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Chapter 7: Materials and methods
7.1: Cell lines and antibodies
All cell lines used in these studies are listed in Appendix II. For experiments 
involving HeLa-M, FO-1, or FO-l.fLm, the cells were treated with 200 U/mL human 
IFN-y (R&D Systems) for two days prior to harvesting as indicated. HeLa-M, FO-1, FO-
1.(Lm, CEM.NKR.A2, CEM.NKR.A2.CNX, and 293T were maintained in Iscove's 
modified Dulbecco's medium (IMDM) (Invitrogen) supplemented with 5% bovine calf 
serum (BCS) (Hyclone), GLUTAMAX (Invitrogen) and penicillin/streptomycin 
(Invitrogen), and C1R.A2.WT, C1R.A2.C60A, and all derivatives of 721 were grown in 
IMDM with 10% BCS, GLUTAMAX, and penicillin/streptomycin. All cells were grown 
in a humidified incubator with 6% CO2 at 37°C.
Monoclonal antibodies and rabbit antisera used are listed in Appendix III. A new 
rabbit antiserum was raised against soluble, insect cell expressed tapasin (R.SinE) using 
conventional methods by a third party (Open Biosystems). Additionally, this is the first 
use of a mouse mAh raised against the C-terminal peptide of tapasin. Mice were 
immunized and hybridomas generated using conventional methods (Mary Pan, 
unpublished results).
7.2: Plasmids
Retroviral vectors encoding short-hairpin RNA (shRNA) constructs targeting 
ERp57 mRNA (RVHl-ERp57) or a non-targeting control (RVHl-Ctrl) were constructed 
using the RVH1 vector (Barton and Medzhitov, 2002). The RVH1 vector was digested
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with Bglll and Xhol and dephosphorylated by incubating with calf intestinal phosphatase 
(CIP) for 1 hr at 37°C. The digested vector was then gel purified. The following 
oligonucleotides were synthesized with 5’ phosphates: ERp57-F 5’-gat ccc cGG ACT 
CTT CCA TCA GAG ATt tea aga gaA TCT CTG ATG GAA GAG TCC ttt ttg gaa c -3 \ 
ERp57-R 5’-teg agt tcc aaa aaG GAC TCT TCC ATC AGA GAT tct ctt gaa ATC TCT 
GAT GGA AGA GTC Cgg g -3 \ Ctrl-F 5’-ga tcc ccG CTT CAA CAG CAG GCA CTC 
ttc aag aga GAG TGC CTG CTG TTG AAG Ctt ttt gga ac-3\ Ctrl-R 5’-teg agt tcc aaa 
aaG CTT CAA CAG CAG GCA CTC tct ctt gaa GAG TGC CTG CTG TTG AAG Cgg 
g-3’. Upper case letters indicate the complimentary regions giving rise to hairpin 
formation. Complimentary oligonucleotides were annealed by heating to 95°C for 4 min 
in annealing buffer (100 mM potassium acetate, 30 mM HEPES, 2 rnM Mg-acetate, pH 
7.4) followed by 10 min at 70°C with gentle cooling to 4°C. Annealed oligos were 
ligated into RVH1 using the rapid DNA ligation kit (Roche) according to the 
manufacturer’s protocol. Following transformation and cloning, the constructs were 
confirmed by sequencing to generate RVHl-Ctrl and RVHl-ERp57.
Retroviral vectors encoding WT, C60A, and C60/406/409A FLAG-tagged ERp57 
were generated by BamHI digestion and gel purification of ERp57-FLAG from 
pCDNA3.1-Puro (Dick et al., 2002). The retroviral vector pBMN-IRES-EGFP (a gift of 
A. Bothwell, Yale University) in which EGFP is expressed bicistronically with the gene 
of interest was digested with BamHI and dephosphorylated with CIP prior to gel 
purification. ERp57-FLAG was ligated into pBMN-IRES-EGFP as described above. 
Clones were screened for the correct insertion orientation by restriction digestion.
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A glycan deficient tapasin mutant (N233A) was generated using the Quickchange 
Site Directed Mutagenesis kit (Stratagene) with primers N233A-S 5’-GCC CAT GGA 
CCG GAG CCG GGA CCT TCT GGC TG-3’ and N233A-AS 5’-CAG CCA GAA GGT 
CCC GGC TCC GGT CCA TGG GC-3’ with WT tapasin in pCR2.1 as a template 
according to the manufacturer’s instructions (Ortmann et al., 1997). The mutation was 
confirmed by sequencing. WT tapasin in pBMN-IRES-Puro was digested with EcoRI 
prior to dephosphorylation and gel purification (Dick et al., 2002). N233A-tapasin in 
pCR2.1 was also digested with EcoRI and gel purified, and the region corresponding to 
the N-terminus of tapasin was extracted and ligated into pBMN-Tpsn-IRES-Puro using 
the rapid DNA ligation kit. Positive clones were screened for insert orientation by 
restriction digest.
7.3: Production of retrovirus and cell transduction
Infectious retrovirus was produced by the co-transfection of 12 p.g retroviral 
vector with 12 jag pCL-Ampho (Imgenex) into 293T cells in 10 cm dishes using 
Lipofectamine 2000 (Invitrogen) following the manufacturer’s protocol. Four hrs after 
transfection, the media was replaced and cells were shifted to a 32°C humidified 
incubator overnight. The following morning, 5 x 106 target cells were resuspended in 
harvested retrovirus containing media with 8 ug/mL polybrene. Cells were spun in 6- 
well plates for 90 min at 2500 RPM at 32°C (“spinfection”). Spinfected cells were then 
placed in a 32°C humidified incubator overnight. This process was repeated three times. 
For RVHl-Ctrl, RVHl-ERp57, and pBMN-ERp57-FLAG-IRES-EGFP transduced cells,
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following the last spinfection, cells were resuspsended in fresh medium and placed at 
37°C for two days prior to FACS to assess transduction efficiency.
For pBMN-N233A-IRES-Puro transduced cells, cells were placed in 1 p,g/mL 
puromycin for selection. Cells growing after one week in selection were then cloned by 
limiting dilution, and cells were screened for tapasin expression by intracellular FACS 
using PaStal. Clones with similar expression to 721.220.B4402 cells expressing WT 
tapasin were further screened by Western blotting.
7.4: Flow Cytometry and Sorting
All steps were performed at 4°C unless otherwise indicated, and all analysis was 
carried out using FlowJo software (Treestar Inc.). Cells were harvested and washed with 
FACS buffer (PBS with 0.05% BCS, 1 mM CaCl2, and 0.1% Sodium Azide). Cells were 
then incubated with 100 frL of tissue culture supernatant, 1:100 dilutions o f purified 
mouse mAbs, or 1:100 or 1:5 dilutions of directly coupled commercially available 
antibodies for 30 min. Cells were then washed with FACS buffer. Cells stained with 
uncoupled mAbs were then incubated with 1:100 dilutions of goat anti-mouse antiserum 
coupled to fluoroscein isothiocyanate (FITC) (Chemicon) or allophycocyanin (APC) 
(Caltag) for 30 min. After washing in FACS buffer, cells were analyzed using either a 
FACScan or FACScalibur (Becton Dickinson).
For isolation and sorting of RVH1-transduced cells, seven to ten days after the 
final spinfection, 10 x 106 cells were incubated with 1 mL of 1:200 dilution of mouse 
anti-CD4 directly coupled to APC (eBioscience), washed with FACS buffer, and sorted 
using a FACSvantage instrument. For sorting of cells transduced with pBMN-ERp57-
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FLAG-IRES-EGFP, 10 x 106 cells were washed with FACS buffer before sorting. Cells 
highly expressing the CD4 or EGFP marker were isolated by three sorts.
For intracellular FACS, cells were washed with FACS buffer prior to fixation 
with 3.7% formaldehyde in serum free IMDM for 15 min at room temperature (RT). 
Fixation was stopped by washing cells in IMDM with 10 mM glycine, and cells were 
washed once in PBS. Fixed cells were then permeabilized in 0.1% Triton X-100 in 
FACS buffer with 10 mM glycine (permeabilization solution) for 15 min at RT followed 
by incubation in 1:100 dilutions of purified PaSta 1 or BB7.2 in permeabilization solution 
for 30 min. Following washing in permeabilization solution, cells were incubated with a 
1:100 dilution of goat anti-mouse antiserum coupled to FITC for 30 min at RT. After a 
final wash in FACS buffer, cells were analyzed using a FACScalibur.
7.5: Metabolic labeling and pulse chase analyses
For all metabolic labeling experiments, cells were harvested, washed with PBS, 
and resuspended in 3 mL of DMEM without methionine and cysteine with 3% dialyzed 
fetal bovine serum (Gibco) and penicillin/streptomycin (Invitrogen) for 1 hr in a 37°C
35standing incubator with rocking. Starved cells were then labeled with 1 mCi of [ S]- 
methionine and cysteine labeling mix (ICN or Perkin Elmer) per 20 x 106 cells for the 
indicated period o f time prior to harvesting or chase. For pulse-chase analyses, IMDM 
with 5% or 10% BCS, GLUTAMAX, penicillin/streptomycin, and 3 mM cold cysteine 
and methionine was added to the labeled cells, and aliquots were removed at the 
indicated times. During the chase period, cells were maintained in a standing 37°C 
incubator with rocking. Harvested, labeled cells were washed once with PBS with or
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without 10 mM MMTS (Pierce) as indicated and frozen. Frozen cell pellets were 
handled as described below or membranes were prepared as described below. For 
experiments examining the glucosylation dependence o f conjugate formation, cells were 
starved, labeled, and chased in the presence o f 2 mM CST (Sigma) as indicated.
7.6: Detergent extraction of cells
Radio-labeled or unlabeled cells were washed in PBS with or without 10 mM 
MMTS as indicated. Either frozen or fresh cell pellets were solubilized in either 1% 
digitonin (EMD Biosciences) or Triton X-100 (American Bioanalytical) in 0.15M NaCl, 
0.01M Tris-Cl, pH 7.4 (TBS) with 1 mM CaCl2 and 500 pM phenyl-methylsulfonyl 
fluoride (PMSF) with or without 10 mM iodoacetamide (IAA) for 30 min on ice. Cell 
debris was removed by centrifugation at 14,000 RPM in a tabletop microcentrifuge at 
4°C for 5 min.
For Western blotting, all cells were solubilized in 1% Triton X-100, and the 
protein content of the post-nuclear supernatants was quantitated by Bradford assay (Bio- 
Rad). For quantitative Western blots, three-fold serial dilutions were made in 1% Triton 
X-100 in TBS corresponding to the indicated amounts of loaded total protein, and for 
non-quantitative Western blots, 15 pg lysate was resolved by SDS-PAGE. For gels in 
which all samples were reduced, lOx SDS-PAGE sample buffer with 10% (3- 
mercaptoethanol (|3-ME) was added prior to heating to 95°C for 5 min. For gels 
containing both reduced and non-reduced samples, 50 mM dithiothreitol (DTT) (5 mM 
final concentration) (American Bioanalytical) was added to all samples as indicated prior
131
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
to heating at 95°C for 5 min. All samples were subsequently treated with IAA (15 mM 
final concentration) for 5 min at room temperature (RT) and resolved by SDS-PAGE.
7.7: Immunoprecipitations and EndoH digestion
For radio-labeled cells, post-nuclear supernatants were precleared with 7 pL NRS 
and 100 pL protein A-sepharose for 1 hr at 4°C with constant rotation. Precleared 
supernatants were then immunoprecipitated with specific rabbit antisera or NRS as a 
control and protein A-sepharose, mouse or rat mAbs or mlgG directly coupled to agarose 
beads, or mouse mAbs and protein G-sepharose or protein A-sepharose if  an appropriate 
isotype for 1 hr at 4°C with constant rotation. Immunoprecipitated material was washed 
three times with 1 mL 0.1% detergent in TBS with 1 mM CaCF. For experiments 
involving only a single immunoprecipitation step without EndoH digestion, samples were 
eluted in 2x SDS-PAGE sample buffer with or without 2% (3-ME for reducing or non­
reducing gels, respectively, with heating to 95 °C for 5 min. For gels containing both 
reduced and non-reduced samples, eluted material was incubated with or without 5 mM 
DTT at 95°C for 5 min, and IAA was added to all samples to a final concentration of 15 
mM for 5 min at RT. Samples were then resolved by SDS-PAGE. For secondary 
immunoprecipitations, samples were eluted under non-denaturing conditions with 0.1% 
Triton X-100 in TBS with 1 mM C aC f at 4°C, or samples were stripped by heating in 
1% SDS in H2 O at 95°C for 5 min prior to 20-fold dilution into 1% Triton X-100 in TBS 
with 1 mM CaCl2. Secondary immunoprecipitations and sample elution with or without 
reduction were performed as described above. For EndoH digestion, immunoprecipitates 
were eluted in 2x EndoH buffer (0.05M sodium phosphate, 0.25% SDS, pH6.5) by
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heating to 95°C for five min. Samples were then incubated in 1 mU of EndoH (Roche) 
overnight at 37°C prior to reducing SDS-PAGE.
For unlabeled cells, 5x l06 cells per gel lane were treated with or without 10 mM 
MMTS in PBS and extracted as described above. Post nuclear supernatants were either 
immediately precipitated with directly coupled mAh or precleared with protein G- 
sepharose or protein A-sepharose for mouse or rabbit immunoprecipitations, respectively, 
rotating for 1 hr at 4°C. Precleared supernatants were specifically immunoprecipitated 
with mouse mAbs or rabbit antisera and protein G-sepharose or protein A-sepharose, 
respectively. Samples were then washed three times with 0.1% detergent in TBS with 1 
mM CaCf. For gels containing all reduced samples, precipitated material was eluted in 
2x reducing SDS-PAGE sample buffer with heating to 95°C for 5 min. For gels 
containing both reduced and non-reduced samples, material eluted in 2x NRSB with 
heating to 95°C for 5 min was incubated with or without 5 mM DTT at 95°C for 5 min. 
All samples were then incubated with 15 mM IAA for 5 min at RT prior to SDS-PAGE. 
Separated proteins were then transferred as described below.
7.8: Quantitative and non-quantitative immunoblotting
Non-radio-labeled samples separated by SDS-PAGE were transferred to 
Immobilon-P polyvinylidene fluoride (PYDF) membranes (Millipore) using a semi-dry 
method. Non-specific binding was then blocked by incubating membranes in 5% skim 
milk powder (Carnation) in PBS with 0.2% Tween-20 (Blotto) for either 30 min at RT or 
overnight at 4°C. Membranes were then cut or left intact and incubated with primary 
antibody in blotto for either 1 hr at RT or overnight at 4°C. Membranes were washed
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once in PBS followed by two washes in PBS with 0.2% Tween-20 (PBS-T) for 5 min at 
RT. Membranes were then incubated with 1:5000 dilutions of species-specific, 
minimally cross-reactive goat antisera coupled to horseradish peroxidase (HRP) or 
alkaline phosphatase (AP) (Jackson Immunoresearch) for non-quantitative or quantitative 
blots, respectively, for 30 min at RT. Membranes were washed as above. Non- 
quantitative blots were visualized by incubation o f membranes with enhanced 
chemiluminescent (ECL) substrate and exposure to film. Quantitative blots were 
incubated with enhanced chemifluorescent (ECF) substrate and visualized using a Storm 
860 imaging system and ImageQuant software (GE Biosciences).
7.9: p 2m  R N A i
The following [32m specific and control siRNA oligonucleotides were obtained 
from Dharmacon: si|32m # l: 5 ’-AAG AGU AUG CCU GCC GUG UGA-3’, si|32m#2:
5’-AAG CAA GGA CUG GUC UUU CUA-3’, siCtrl: 5 ’-AAG CUU CAA CAG CAG 
GCA CUC-3’. 721.220 cells expressing HLA-B*0801 and WT tapasin were transfected 
using the Amaxa nucleofector device with program V01 and solution R (Amaxa) using a 
modified manufacturer’s protocol. 20 x 106 cells were resuspended in 500 uL of solution 
R with 250 pmol siCtrl or 125 pmol each o f si|32m#l and si|32m#2. Five sets of 100 pL 
cell aliquots were transfected with program V01, and 500 pL of pre-warmed media was 
added to cells prior to transfer to T25 flasks with 9 mL of media equilibrated to 6% C 0 2 
at 37°C. Cells were harvested at 0, 3, 6, and 12 hrs after transfection, treated with 10 mM 
MMTS in PBS, and frozen. Frozen cell pellets were solubilized in 1% digitonin and 
processed as described above for quantitative immunoblotting.
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7.10: Membrane preparation
Radio-labeled 721.221 or unlabeled FO-1. (32m cells were harvested, washed in 
PBS with or without MMTS as indicated and frozen. Frozen cell pellets were 
resuspended in ice-cold TBS with 1 mM C aC f and PMSF and centrifuged at 300xg at 
4°C for 10 min. Supernatants were preserved on ice, and the pelleted material was 
resuspended in ice-cold 10 mM Tris-Cl, pFl 7.4 and centrifuged at 300xg for 10 min. The 
pooled supernatants were pelleted at 100,000xg for 1 h at 4°C, and the membranes were 
treated as described in the figure legends. After the final addition of detergent, debris 
was removed by centrifugation at 14,000 RPM in a table-top microcentrifuge at 4°C for 
10 min. Supernatants were then immunoprecipitated or directly resolved by SDS-PAGE 
for Western blotting.
7.11: Tapasin conformational stability
For the analysis of tapasin isolated from radio-labeled cells, TAPI 
immunoprecipitates were incubated in 0.1% Triton X-100 in TBS with 1 mM C aC f for 5 
min on ice, and eluted material was incubated in heated water baths at the indicated 
temperatures for 30 min. Samples were placed on ice for 10 min followed by 
centrifugation at 14,000 RPM in a tabletop microcentrifuge for 10 min at 4°C. 
Supernatants were then precipitated with the conformation independent tapasin anti­
serum gp48C or the conformation dependent mAb PaSta 1 for 1 hr at 4°C with constant 
rotation. Immunoprecipitated material was washed with 0.1% Triton X-100 in TBS with 
1 mM CaCf, eluted with 2x reducing or non-reducing sample buffer as indicated, and
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resolved by SDS-PAGE. After exposure to phosphor screens, scanned images were 
analyzed with ImageQuant software.
Insect cell expressed, soluble recombinant free tapasin and the tapasin/ERp57 
conjugate were obtained from Pamela Wearsch. 1.5 pg each o f free tapasin and the 
conjugate per lane were diluted into 1 mL TBS with 1 mM CaCfi. Samples were heated, 
cooled, centrifuged, immunoprecipitated, and washed as above. Heating and 
immunoprecipitation of recombinant tapasin was performed in the absence of detergent. 
Samples were eluted in 2x NRSB and separated by SDS-PAGE. Gels were then stained 
with Coomassie Brilliant Blue (0.025% Coomassie Brilliant Blue R, 40% methanol, 7% 
glacial acetic acid) overnight. Gels were destained with 40% methanol, 7% acetic acid 
and scanned using a G-box gel imaging system (Syngene) prior to quantitation. All 
samples were in the linear range of detection.
7.12: Software and analysis
Analysis of all radio-labeled data was performed using ImageQuant v5.2 for 
Windows 2000 (Molecular Dynamics/GE Biosciences). All charts were prepared using 
Graphpad Prizm software v4.0 for Macintosh (Graphpad software). The rates of 
acquisition of EndoH resistance and conjugate formation were compared using the 
“Bottom then increase to top” algorithm with post-test comparisons between fitted lines. 
P < 0.05 was considered significant.
136
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
References
Anderson, K. S., Alexander, J., Wei, M., and Cresswell, P. (1993). Intracellular transport 
o f class I MHC molecules in antigen processing mutant cell lines. J Immunol 151, 3407- 
3419.
Androlewicz, M. J., Anderson, K. S., and Cresswell, P. (1993). Evidence that transporters 
associated with antigen processing translocate a major histocompatibility complex class 
I-binding peptide into the endoplasmic reticulum in an ATP-dependent manner. Proc Natl 
Acad Sci U S A 90, 9130-9134.
Androlewicz, M. J., and Cresswell, P. (1994). Human transporters associated with 
antigen processing possess a promiscuous peptide-binding site. Immunity 1, 7-14.
Antoniou, A. N., and Powis, S. J. (2003). Characterization of the ERp57-Tapasin 
complex by rapid cellular acidification and thiol modification. Antioxid Redox Signal 5, 
375-379.
Antoniou, A. N., Powis, S. J., and Elliott, T. (2003). Assembly and export of MHC class I 
peptide ligands. Curr Opin Immunol 15, 75-81.
Apweiler, R., Hermjakob, H., and Sharon, N. (1999). On the frequency of protein 
glycosylation, as deduced from analysis of the SWISS-PROT database. Biochim Biophys 
Acta 1473, 4-8.
Argon, Y., and Simen, B. B. (1999). GRP94, an ER chaperone with protein and peptide 
binding properties. Semin Cell Dev Biol 10, 495-505.
Bangia, N., Lehner, P. J., Hughes, E. A., Surman, M., and Cresswell, P. (1999). The N- 
terminal region of tapasin is required to stabilize the MHC class I loading complex. Eur J 
Immunol 29, 1858-1870.
Barber, L. D., Howarth, M., Bowness, P., and Elliott, T. (2001). The quantity o f naturally 
processed peptides stably bound by HLA-A*0201 is significantly reduced in the absence 
of tapasin. Tissue Antigens 58, 363-368.
Barnden, M. J., Purcell, A. W., Gorman, J. J., and McCluskey, J. (2000). Tapasin- 
mediated retention and optimization of peptide ligands during the assembly of class I 
molecules. J Immunol 165, 322-330.
137
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Barnstable, C. J., Bodmer, W. F., Brown, G., Galfre, G., Milstein, C., Williams, A. F., 
and Ziegler, A. (1978). Production of monoclonal antibodies to group A erythrocytes, 
F1LA and other human cell surface antigens-new tools for genetic analysis. Cell 14, 9-20.
Barton, G. M., and Medzhitov, R. (2002). Retroviral delivery of small interfering RNA 
into primary cells. Proc Natl Acad Sci U S A 99, 14943-14945.
Benham, A. M., Cabibbo, A., Fassio, A., Bulleid, N., Sitia, R., and Braakman, F (2000). 
The CXXCXXC motif determines the folding, structure and stability of human Erol- 
Lalpha. Embo J 19, 4493-4502.
Bertolotti, A., Zhang, Y., Flendershot, L. M., Flarding, H. P., and Ron, D. (2000). 
Dynamic interaction of BiP and ER stress transducers in the unfolded-protein response. 
Nat Cell Biol 2, 326-332.
Bjorkman, P. J., Saper, M. A., Samraoui, B., Bennett, W. S., Strominger, J. L., and 
Wiley, D. C. (1987a). Structure of the human class I histocompatibility antigen, FILA-A2. 
Nature 329, 506-512.
Bjorkman, P. J., Saper, M. A., Samraoui, B., Bennett, W. S., Strominger, J. L., and 
Wiley, D. C. (1987b). The foreign antigen binding site and T cell recognition regions of 
class I histocompatibility antigens. Nature 329, 512-518.
Brocke, P., Garbi, N., Momburg, F., and Hammerling, G. J. (2002). FILA-DM, FILA-DO 
and tapasin: functional similarities and differences. Curr Opin Immunol 14, 22-29.
Burda, P., and Aebi, M. (1999). The dolichol pathway of N-linked glycosylation.
Biochim Biophys Acta 1426, 239-257.
Cabibbo, A., Pagani, M., Fabbri, M., Rocchi, M., Farmery, M. R., Bulleid, N. J., and 
Sitia, R. (2000). EROl-L, a human protein that favors disulfide bond formation in the 
endoplasmic reticulum. J Biol Chem 275, 4827-4833.
Caramelo, J. J., Castro, O. A., Alonso, L. G., De Prat-Gay, G., and Parodi, A. J. (2003). 
UDP-Glc:glycoprotein glucosyltransferase recognizes structured and solvent accessible 
hydrophobic patches in molten globule-like folding intermediates. Proc Natl Acad Sci U 
S A  100, 86-91.
Cascio, P., Flilton, C., Kisselev, A. F., Rock, K. L., and Goldberg, A. L. (2001). 26S 
proteasomes and immunoproteasomes produce mainly N-extended versions of an 
antigenic peptide. Embo J 20, 2357-2366.
138
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Chang, S. C., Momburg, F., Bhutani, N., and Goldberg, A. L. (2005). The ER 
aminopeptidase, ERAP1, trims precursors to lengths of MHC class I peptides by a 
"molecular ruler" mechanism. Proc Natl Acad Sci U S A 102, 17107-17112.
Chen, M., Stafford, W. F., Diedrich, G., Khan, A., and Bouvier, M. (2002). A 
characterization of the lumenal region of human tapasin reveals the presence of two 
structural domains. Biochemistry 41, 14539-14545.
Cresswell, P. (2000). Intracellular surveillance: controlling the assembly of MFIC class I- 
peptide complexes. Traffic 1, 301-305.
Cresswell, P., Arunachalam, B., Bangia, N., Dick, T., Diedrich, G., Hughes, E., and 
Marie, M. (1999a). Thiol oxidation and reduction in MHC-restricted antigen processing 
and presentation. Immunol Res 19, 191-200.
Cresswell, P., Bangia, N., Dick, T., and Diedrich, G. (1999b). The nature o f the MHC 
class I peptide loading complex. Immunol Rev 172, 21-28.
Cuozzo, J. W., and Kaiser, C. A. (1999). Competition between glutathione and protein 
thiols for disulphide-bond formation. Nat Cell Biol 1, 130-135.
D'Urso, C. M., Wang, Z. G., Cao, Y., Tatake, R., Zeff, R. A., and Ferrone, S. (1991). 
Lack of HLA class I antigen expression by cultured melanoma cells FO-1 due to a defect 
in B2m gene expression. J Clin Invest 87, 284-292.
Daniels, R., Kurowski, B., Johnson, A. E., and Hebert, D. N. (2003). N-linked glycans 
direct the cotranslational folding pathway of influenza hemagglutinin. Mol Cell 11,19- 
90.
Danilczyk, U. G., and Williams, D. B. (2001). The lectin chaperone calnexin utilizes 
polypeptide-based associate with many of its substrates in vivo. J Biol Chem 276, 25532- 
25540.
Darby, N. J., and Creighton, T. E. (1995). Characterization o f the active site cysteine 
residues of the thioredoxin-like domains of protein disulfide isomerase. Biochemistry 34, 
16770-16780.
Darby, N. J., Morin, P. E., Talbo, G., and Creighton, T. E. (1995). Refolding of bovine 
pancreatic trypsin inhibitor via non-native disulphide intermediates. J Mol Biol 249, 463- 
477.
DeMars, R., Chang, C. C., Shaw, S., Reitnauer, P. J., and Sondel, P. M. (1984). 
Homozygous deletions that simultaneously eliminate expressions of class I and class II
139
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
antigens of EBV-transformed B-lymphoblastoid cells. I. Reduced proliferative responses 
of autologous and allogeneic T cells to mutant cells that have decreased expression of 
class II antigens. Hum Immunol 11, 77-97.
Denzin, L. K., Fallas, J. L., Prendes, M., and Yi, W. (2005). Right place, right time, right 
peptide: DO keeps DM focused. Immunol Rev 207, 279-292.
Dick, T. B. (2004). Assembly of MHC class I peptide complexes from the perspective of 
disulfide bond formation. Cell Mol Life Sci 61, 547-556.
Dick, T. P., Bangia, N., Peaper, D. R., and Cresswell, P. (2002). Disulfide bond 
isomerization and the assembly of MHC class I-peptide complexes. Immunity 16, 87-98.
Dick, T. P., and Cresswell, P. (2002). Thiol oxidation and reduction in major 
histocompatibility complex class I-restricted antigen processing and presentation.
Methods Enzymol 348, 49-54.
Diedrich, G., Bangia, N., Pan, M., and Cresswell, P. (2001). A role for calnexin in the 
assembly o f the MHC class I loading complex in the endoplasmic reticulum. J Immunol 
166, 1703-1709.
DuBridge, R. B., Tang, P., Hsia, H. C., Leong, P. M., Miller, J. H., and Calos, M. P. 
(1987). Analysis of mutation in human cells by using an Epstein-Barr virus shuttle 
system. Mol Cell Biol 7, 379-387.
Edman, J. C., Ellis, L., Blacher, R. W., Roth, R. A., and Rutter, W. J. (1985). Sequence of 
protein disulphide isomerase and implications of its relationship to thioredoxin. Nature 
317, 267-270.
Ellgaard, L., Bettendorff, P., Braun, D., Herrmann, T., Fiorito, F., Jelesarov, I., Guntert, 
P., Helenius, A., and Wuthrich, K. (2002). NMR structures of 36 and 73-residue 
fragments of the calreticulin P-domain. J Mol Biol 322, 773-784.
Ellgaard, L., and Frickel, E. M. (2003). Calnexin, calreticulin, and ERp57: teammates in 
glycoprotein folding. Cell Biochem Biophys 39, 223-247.
Ellgaard, L., Riek, R., Braun, D., Herrmann, T., Helenius, A., and Wuthrich, K. (2001a). 
Three-dimensional structure topology of the calreticulin P-domain based on NMR 
assignment. FEBS Lett 488, 69-73.
Ellgaard, L., Riek, R., Herrmann, T., Guntert, P., Braun, D., Helenius, A., and Wuthrich, 
K. (2001b). NMR structure of the calreticulin P-domain. Proc Natl Acad Sci U S A 98, 
3133-3138.
140
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Ellgaard, L., and Ruddock, L. W. (2005). The human protein disulphide isomerase 
family, substrate interactions and functional properties. EMBO Rep 6, 28-32.
Elliott, J. G., Oliver, J. D., and High, S. (1997). The thiol-dependent reductase ERp57 
interacts specifically with N-glycosylated integral membrane proteins. J Biol Chem 272, 
13849-13855.
Exley, M., Garcia, J., Balk, S. P., and Porcelli, S. (1997). Requirements for CD ld 
recognition by human invariant Valpha24+ CD4-CD8- T cells. J Exp Med 186, 109-120.
Fehling, H. J., Swat, W., Laplace, C., Kuhn, R., Rajewsky, K., Muller, U., and von 
Boehmer, H. (1994). MHC class I expression in mice lacking the proteasome subunit 
LMP-7. Science 265, 1234-1237.
Ferrari, D. M., and Soling, H. D. (1999). The protein disulphide-isomerase family: 
unravelling a string of folds. Biochem J 339 ( Pt 1), 1-10.
Fliegel, L., Burns, K., MacLennan, D. H., Reithmeier, R. A., and Michalak, M. (1989). 
Molecular cloning o f the high affinity calcium-binding protein (calreticulin) of skeletal 
muscle sarcoplasmic reticulum. J Biol Chem 264, 21522-21528.
Forster, M. L., Sivick, K., Park, Y. N., Arvan, P., Lencer, W. I., and Tsai, B. (2006). 
Protein disulfide isomerase-like proteins play opposing roles during retrotranslocation. J 
Cell Biol 773,853-859.
Frand, A. R., and Kaiser, C. A. (1998). The EROl gene of yeast is required for oxidation 
o f protein dithiols in the endoplasmic reticulum. Mol Cell 1, 161-170.
Frand, A. R., and Kaiser, C. A. (1999). Erolp oxidizes protein disulfide isomerase in a 
pathway for disulfide bond formation in the endoplasmic reticulum. Mol Cell 4, 469-411.
Frickel, E. M., Frei, P., Bouvier, M., Stafford, W. F., Helenius, A., Glockshuber, R., and 
Ellgaard, L. (2004). ERp57 is a multifunctional thiol-disulfide oxidoreductase. J Biol 
Chem 279, 18277-18287.
Frickel, E. M., Riek, R., Jelesarov, I., Helenius, A., Wuthrich, K., and Ellgaard, L.
(2002). TROSY-NMR reveals interaction between ERp57 and the tip of the calreticulin 
P-domain. Proc Natl Acad Sci U S A 99, 1954-1959.
Gao, B., Adhikari, R., Howarth, M., Nakamura, K., Gold, M. C., Hill, A. B., Knee, R., 
Michalak, M., and Elliott, T. (2002). Assembly and antigen-presenting function o f MHC 
class I molecules in cells lacking the ER chaperone calreticulin. Immunity 16, 99-109.
141
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Garbi, N., Tanaka, S., Momburg, F., and Hammerling, G. J. (2006). Impaired assembly of 
the major histocompatibility complex class I peptide-loading complex in mice deficient 
in the oxidoreductase ERp57. Nat Immunol 7, 93-102.
Garbi, N., Tiwari, N., Momburg, F., and Hammerling, G. J. (2003). A major role for 
tapasin as a stabliizer o f the TAP peptide transporter and consequences for MHC class I 
expression. Eur J Immunol 33, 264-273.
Garboczi, D. N., Ghosh, P., Utz, U., Fan, Q. R., Biddison, W. E., and Wiley, D. C.
(1996). Structure o f the complex between human T-cell receptor, viral peptide and HLA- 
A2. Nature 384, 134-141.
Germain, R. N. (1994). MHC-dependent antigen processing and peptide presentation: 
providing ligands for T lymphocyte activation. Cell 76, 287-299.
Gething, M. J. (1999). Role and regulation of the ER chaperone BiP. Semin Cell Dev 
Biol 10, 465-472.
Grandea, A. G., 3rd, Golovina, T. N., Hamilton, S. E., Sriram, V., Spies, T., Brutkiewicz, 
R. R., Harty, J. T., Eisenlohr, L. C., and Van Kaer, L. (2000). Impaired assembly yet 
normal trafficking of MHC class I molecules in Tapasin mutant mice. Immunity 13, 213- 
222 .
Greenwood, R., Shimizu, Y., Sekhon, G. S., and DeMars, R. (1994). Novel allele- 
specific, post-translational reduction in HLA class I expression in a mutant human B cell 
line. J Immunol 153, 5525-5536.
Grusby, M. J., and Glimcher, L. H. (1995). Immune responses in MHC class Il-deficient 
mice. Annu Rev Immunol 13, 417-435.
Hammer, G. E., Gonzalez, F., Champsaur, M., Cado, D., and Shastri, N. (2006). The 
aminopeptidase ERAAP shapes the peptide repertoire displayed by major 
histocompatibility complex class I molecules. Nat Immunol 7, 103-112.
Hammond, C., Braakman, I., and Helenius, A. (1994). Role of N-linked oligosaccharide 
recognition, glucose trimming, and calnexin in glycoprotein folding and quality control. 
Proc Natl Acad Sci U S A 91, 913-917.
Hammond, C., and Helenius, A. (1994). Folding of VSV G protein: sequential interaction 
with BiP and calnexin. Science 266, 456-458.
142
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Harris, M. R., Lybarger, L., Yu, Y. Y., Myers, N. B., and Hansen, T. H. (2001). 
Association of ERp57 with mouse MHC class I molecules is tapasin dependent and 
mimics that of calreticulin and not calnexin. J Immunol 166, 6686-6692.
Hebert, D. N., Foellmer, B., and Helenius, A. (1995). Glucose trimming and 
reglucosylation determine glycoprotein association with calnexin in the endoplasmic 
reticulum. Cell 81, 425-433.
Hebert, D. N., Foellmer, B., and Helenius, A. (1996). Calnexin and calreticulin promote 
folding, delay oligomerization and suppress degradation of influenza hemagglutinin in 
microsomes. Embo J 15, 2961-2968.
Helenius, A., and Aebi, M. (2004). Roles o f N-linked glycans in the endoplasmic 
reticulum. Annu Rev Biochem 73, 1019-1049.
Hirano, N., Shibasaki, F., Sakai, R., Tanaka, T., Nishida, J., Yazaki, Y., Talcenawa, T., 
and Hirai, H. (1995). Molecular cloning of the human glucose-regulated protein 
ERp57/GRP58, a thiol-dependent reductase. Identification of its secretory form and 
inducible expression by the oncogenic transformation. Eur J Biochem 234, 336-342.
Howarth, M., Williams, A., Tolstrup, A. B., and Elliott, T. (2004). Tapasin enhances 
MHC class I peptide presentation according to peptide half-life. Proc Natl Acad Sci U S 
A 101, 11737-11742.
Hubbard, S. C., and Robbins, P. W. (1979). Synthesis and processing of protein-linked 
oligosaccharides in vivo. J Biol Chem 254, 4568-4576.
Hughes, E. A., and Cresswell, P. (1998). The thiol oxidoreductase ERp57 is a component 
of the MHC class I peptide-loading complex. Curr Biol 8, 709-712.
Hughes, E. A., Hammond, C., and Cresswell, P. (1997). Misfolded major 
histocompatibility complex class I heavy chains are translocated into the cytoplasm and 
degraded by the proteasome. Proc Natl Acad Sci U S A  94, 1896-1901.
Hughes, E. A., Ortmann, B., Surman, M., and Cresswell, P. (1996). The protease 
inhibitor, N-acetyl-L-leucyl-L-leucyl-leucyl-L-norleucinal, decreases the pool of major 
histocompatibility complex class I-binding peptides and inhibits peptide trimming in the 
endoplasmic reticulum. J Exp Med 183, 1569-1578.
Hwang, C., Sinskey, A. J., and Lodish, H. F. (1992). Oxidized redox state of glutathione 
in the endoplasmic reticulum. Science 257, 1496-1502.
143
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Isenman, D. E., Lancet, D., and Pecht, I. (1979). Folding pathways of immunoglobulin 
domains. The folding kinetics of the Cgamma3 domain of human IgG l. Biochemistry 18, 
3327-3336.
Jackson, M. R., Cohen-Doyle, M. F., Peterson, P. A., and Williams, D. B. (1994). 
Regulation of MFIC class I transport by the molecular chaperone, calnexin (p88, IP90). 
Science 263, 384-387.
Jessop, C. E., and Bulleid, N. J. (2004). Glutathione directly reduces an oxidoreductase in 
the endoplasmic reticulum of mammalian cells. J Biol Chem 279, 55341-55347.
Kadokura, H., Katzen, F., and Beckwith, J. (2003). Protein disulfide bond formation in 
prokaryotes. Annu Rev Biochem 72, 111-135.
Kang, S. J., and Cresswell, P. (2002). Calnexin, calreticulin, and ERp57 cooperate in 
disulfide bond formation in human CD Id heavy chain. J Biol Chem 277, 44838-44844.
Keller, S. H., Lindstrom, J., and Taylor, P. (1998). Inhibition of glucose trimming with 
castanospermine reduces calnexin association and promotes proteasome degradation of 
the alpha-subunit of the nicotinic acetylcholine receptor. J Biol Chem 273, 17064-17072.
Klappa, P., Ruddock, L. W., Darby, N. J., and Freedman, R. B. (1998). The b' domain 
provides the principal peptide-binding site of protein disulfide isomerase but all domains 
contribute to binding of misfolded proteins. Embo J 17, 927-935.
Klein, J., and Sato, A. (2000). The HLA system. First of two parts. N Engl J Med 343, 
702-709.
Kleizen, B., and Braakman, I. (2004). Protein folding and quality control in the 
endoplasmic reticulum. Curr Opin Cell Biol 16, 343-349.
Kowarik, M., Kung, S., Martoglio, B., and Helenius, A. (2002). Protein folding during 
cotranslational translocation in the endoplasmic reticulum. Mol Cell 10, 769-778.
Kozlov, G., Maattanen, P., Schrag, J. D., Pollock, S., Cygler, M., Nagar, B., Thomas, D. 
Y., and Gehring, K. (2006). Crystal structure of the bb' domains of the protein disulfide 
isomerase ERp57. Structure 14, 1331-1339.
Kulig, K., Nandi, D., Bacik, I., Monaco, J. J., and Vukmanovic, S. (1998). Physical and 
functional association of the major histocompatibility complex class I heavy chain alpha3 
domain with the transporter associated with antigen processing. J Exp Med 187, 865-874.
144
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Kulp, M. S., Frickel, E. ML, Ellgaard, L., and Weissman, J. S. (2006). Domain 
architecture of protein-disulfide isomerase facilitates its dual role as an oxidase and an 
isomerase in Erolp-mediated disulfide formation. J Biol Chem 281, 876-884.
Laboissiere, M. C., Sturley, S. L., and Raines, R. T. (1995). The essential function of 
protein-disulfide isomerase is to unscramble non-native disulfide bonds. J Biol Chem 
270, 28006-28009.
Labriola, C., Cazzulo, J. J., and Parodi, A. J. (1995). Retention of glucose units added by 
the UDP-GLC: glycoprotein glucosyltransferase delays exit of glycoproteins from the 
reticulum. J Cell Biol 130, 771-779.
Ladasky, J. J., Boyle, S., Seth, ML, Li, H., Pentcheva, T., Abe, F., Steinberg, S. J., and 
Edidin, M. (2006). Bap31 enhances the endoplasmic reticulum export and quality control 
of human class I MHC molecules. J Immunol 177, 6172-6181.
Leach, M. R., Cohen-Doyle, M. F., Thomas, D. Y., and Williams, D. B. (2002). 
Localization of the lectin, ERp57 binding, and polypeptide binding sites of calnexin and 
calreticulin. J Biol Chem 277, 29686-29697.
Lehner, P. J., Surman, M. J., and Cresswell, P. (1998). Soluble tapasin restores MHC 
class I expression and function in the tapasin-negative cell line .220. Immunity 8, 221- 
231.
Lewis, J. W., and Elliott, T. (1998). Evidence for successive peptide binding and quality 
control stages during MHC class I assembly. Curr Biol 8, 717-720.
Li, S. J., Hong, X. G., Shi, Y. Y., Li, H., and Wang, C. C. (2006). Annular arrangement 
and collaborative actions of four domains of protein-disulfide isomerase: a small angle X- 
ray scattering study in solution. J Biol Chem 281, 6581-6588.
Lindquist, J. A., Jensen, O. N., Mann, M., and Hammerling, G. J. (1998). ER-60, a 
chaperone with thiol-dependent reductase activity involved in MHC class I assembly. 
Embo J 17, 2186-2195.
Lundblad, R. L. (1995). Techniques in Protein Modification (Boca Raton: CRC Press).
Lutz, P. M., and Cresswell, P. (1987). An epitope common to HLA class I and class II 
antigens, Ig light chains, and beta 2-microglobulin. Immunogenetics 25, 228-233.
Ma, Y., and Hendershot, L. M. (2004). ER chaperone functions during normal and stress 
conditions. J Chem Neuroanat 28, 51-65.
145
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Maio, M., Altomonte, M., Tatake, R., Zeff, R. A., and Ferrone, S. (1991). Reduction in 
susceptibility to natural killer cell-mediated lysis of human FO-1 melanoma cells after 
induction of FILA class I antigen expression by transfection with B2m gene. J Clin Invest 
88, 282-289.
Marks, M. S., Blum, J. S., and Cresswell, P. (1990). Invariant chain trimers are 
sequestered in the rough endoplasmic reticulum in the absence of association with HLA 
class II antigens. J Cell Biol 111, 839-855.
Mazzarella, R. A., Marcus, N., Haugejorden, S. M., Balcarek, J. M., Baldassare, J. J.,
Roy, B., Li, L. J., Lee, A. S., and Green, M. (1994). Erp61 is GRP58, a stress-inducible 
luminal endoplasmic reticulum protein, but is devoid of phosphatidylinositide-specific 
phospholipase C activity. Arch Biochem Biophys 308, 454-460.
Meunier, L., Usherwood, Y. K., Chung, K. T., and Hendershot, L. M. (2002). A subset of 
chaperones and folding enzymes form multiprotein complexes in endoplasmic reticulum 
to bind nascent proteins. Mol Biol Cell 13, 4456-4469.
Meyer, T. H., van Endert, P. M., Uebel, S., Ehring, B., and Tampe, R. (1994). Functional 
expression and purification of the ABC transporter complex associated with antigen 
processing (TAP) in insect cells. FEBS Lett 351, 443-447.
Mezghrani, A., Fassio, A., Benham, A., Simmen, T., Braakman, I., and Sitia, R. (2001). 
Manipulation of oxidative protein folding and PDI redox state in mammalian cells. Embo 
J 20, 6288-6296.
Molinari, M., Calanca, V., Galli, C., Lucca, P., and Paganetti, P. (2003). Role of EDEM 
in the release of misfolded glycoproteins from the calnexin cycle. Science 299, 1397- 
1400.
Molinari, M., Eriksson, K. K., Calanca, V., Galli, C., Cresswell, P., Michalak, M., and 
Helenius, A. (2004). Contrasting functions of calreticulin and calnexin in glycoprotein 
folding and ER quality control. Mol Cell 13, 125-135.
Molinari, M., and Helenius, A. (1999). Glycoproteins form mixed disulphides with 
oxidoreductases during folding in living cells. Nature 402, 90-93.
Molinari, M., and Helenius, A. (2000). Chaperone selection during glycoprotein 
translocation into the reticulum. Science 288, 331-333.
Molteni, S. N., Fassio, A., Ciriolo, M. R., Filomeni, G., Pasqualetto, E., Fagioli, C., and 
Sitia, R. (2004). Glutathione limits Erol-dependent oxidation in the endoplasmic 
reticulum. J Biol Chem 279, 32667-32673.
146
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Momburg, F., Roelse, J., Hammerling, G. J., and Neefjes, J. J. (1994). Peptide size 
selection by the major histocompatibility complex-encoded peptide transporter. J Exp 
Med 179, 1613-1623.
Momburg, F., and Tan, P. (2002). Tapasin-the keystone of the loading complex 
optimizing peptide binding by MHC class I molecules in the endoplasmic reticulum. Mol 
Immunol 39, 217-233.
Morrice, N. A., and Powis, S. J. (1998). A role for the thiol-dependent reductase ERp57 
in the assembly of MHC class I molecules. Curr Biol 8, 713-716.
Murthy, M. S., and Pande, S. V. (1994). A stress-regulated protein, GRP58, a member of 
thioredoxin superfamily, is a carnitine palmitoyltransferase isoenzyme. Biochem J 304 ( 
P tl) ,  31-34.
Neefjes, J. J., Momburg, F., and Hammerling, G. J. (1993). Selective and ATP-dependent 
translocation of peptides by the MHC-encoded transporter. Science 261, 769-771.
Neijssen, J., Herberts, C., Drijfhout, J. W., Reits, E., Janssen, L., and Neefjes, J. (2005). 
Cross-presentation by intercellular peptide transfer through gap junctions. Nature 434, 
83-88.
Nossner, E., and Parham, P. (1995). Species-specific differences in chaperone interaction 
of human and mouse major histocompatibility complex class I molecules. J Exp Med 
181, 327-337.
Oda, Y., Hosokawa, N., Wada, I., and Nagata, K. (2003). EDEM as an acceptor of 
terminally misfolded glycoproteins released from calnexin. Science 299, 1394-1397.
Oliver, J. D., Roderick, H. L., Llewellyn, D. H., and High, S. (1999). ERp57 functions as 
a subunit of specific complexes formed with the ER lectins calreticulin and calnexin. Mol 
Biol Cell 10, 2573-2582.
Oliver, J. D., van der Wal, F. J., Bulleid, N. J., and High, S. (1997). Interaction of the 
thiol-dependent reductase ERp57 with nascent glycoproteins. Science 275, 86-88.
Ortmann, B., Copeman, J., Lehner, P. J., Sadasivan, B., Herberg, J. A., Grandea, A. G., 
Riddell, S. R., Tampe, R., Spies, T., Trowsdale, J., and Cresswell, P. (1997). A critical 
role for tapasin in the assembly and function of multimeric MHC class I-TAP complexes. 
Science 277, 1306-1309.
Pagani, M., Fabbri, M., Benedetti, C., Fassio, A., Pilati, S., Bulleid, N. J., Cabibbo, A., 
and Sitia, R. (2000). Endoplasmic reticulum oxidoreductin 1-lbeta (EROl-Lbeta), a
147
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
human gene induced in the course o f the unfolded protein response. J Biol Chem 275, 
23685-23692.
Pamer, E., and Cresswell, P. (1998). Mechanisms of MHC class I—restricted antigen 
processing. Annu Rev Immunol 16, 323-358.
Paquet, M. E., Cohen-Doyle, M., Shore, G. C., and Williams, D. B. (2004). Bap29/31 
influences the intracellular traffic of MHC class I molecules. J Immunol 172, 7548-7555.
Parham, P. (2005). Putting a face to MHC restriction. J Immunol 174, 3-5.
Parham, P., and Brodsky, F. M. (1981). Partial purification and some properties of 
BB7.2. A cytotoxic monoclonal antibody with specificity for HLA-A2 and a variant of 
HLA-A28. Hum Immunol 3, 277-299.
Park, B., Lee, S., Kim, E., and Ahn, K. (2003). A single polymorphic residue within the 
peptide-binding cleft o f MHC class I molecules determines spectrum of tapasin 
dependence. J Immunol 170, 961-968.
Park, B„ Lee, S., Kim, E., Cho, K., Riddell, S. R., Cho, S., and Ahn, K. (2006). Redox 
Regulation Facilitates Optimal Peptide Selection by MHC Class I during Antigen 
Processing. Cell 127, 369-382.
Peace-Brewer, A. L., Tussey, L. G., Matsui, M., Li, G., Quinn, D. G., and Frelinger, J. A. 
(1996). A point mutation in HLA-A*0201 results in failure to bind the TAP complex and 
to present virus-derived peptides to CTL. Immunity 4, 505-514.
Peaper, D. R., Wearsch, P. A., and Cresswell, P. (2005). Tapasin and ERp57 form a 
stable disulfide-linked dimer within the MHC class I peptide-loading complex. Embo J 
24, 3613-3623.
Peh, C. A., Burrows, S. R., Bamden, M., Khanna, R., Cresswell, P., Moss, D. J., and 
McCluskey, J. (1998). HLA-B27-restricted antigen presentation in the absence of tapasin 
reveals polymorphism in mechanisms of HLA class I peptide loading. Immunity 8, 531 - 
542.
Pentcheva, T., Spiliotis, E. T., and Edidin, M. (2002). Cutting edge: Tapasin is retained in 
the endoplasmic reticulum by dynamic clustering and exclusion from endoplasmic 
reticulum exit sites. J Immunol 168, 1538-1541.
Pimeskoski, A., Klappa, P., Lobell, M., Williamson, R. A., Byrne, L., Alanen, H. L, Salo, 
K. E., Kivirikko, K. I., Freedman, R. B., and Ruddock, L. W. (2004). Molecular
148
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
characterization of the principal substrate binding site of the ubiquitous folding catalyst 
protein disulfide isomerase. J Biol Chem 279, 10374-10381.
Pollard, M. G., Travers, K. J., and Weissman, J. S. (1998). Erolp: a novel and ubiquitous 
protein with an essential role in oxidative protein folding in the endoplasmic reticulum. 
Mol Cell 1, 171-182.
Pollock, S., Kozlov, G., Pelletier, M. F., Trempe, J. F., Jansen, G., Sitnikov, D.,
Bergeron, J. J., Gehring, K., Ekiel, I., and Thomas, D. Y. (2004). Specific interaction of 
ERp57 and calnexin determined by NMR spectroscopy and an ER two-hybrid system. 
Embo J 23, 1020-1029.
Purcell, A. W., Gorman, J. J., Garcia-Peydro, M., Paradela, A., Burrows, S. R., Talbo, G. 
H., Laham, N., Peh, C. A., Reynolds, E. C., Lopez De Castro, J. A., and McCluskey, J.
(2001). Quantitative and qualitative influences of tapasin on the class I peptide repertoire. 
J Immunol 166, 1016-1027.
Rammensee, H. G. (1995). Chemistry of peptides associated with MHC class I and class 
II molecules. Curr Opin Immunol 7, 85-96.
Reits, E. A., Vos, J. C., Gromme, M., and Neefjes, J. (2000). The major substrates for 
TAP in vivo are derived from newly synthesized proteins. Nature 404, 774-778.
Rizvi, S. M., Mancino, L., Thammavongsa, V., Cantley, R. L., and Raghavan, M. (2004). 
A polypeptide binding conformation of calreticulin is induced by heat shock, calcium 
depletion, or by deletion of the C-terminal acidic region. Mol Cell 15, 913-923.
Rudd, P. M., Elliott, T., Cresswell, P., Wilson, I. A., and Dwek, R. A. (2001). 
Glycosylation and the immune system. Science 291, 2370-2376.
Russell, S. J., Ruddock, L. W., Salo, K. E., Oliver, J. D., Roebuck, Q. P., Llewellyn, D. 
H., Roderick, H. L., Koivunen, P., Myllyharju, J., and High, S. (2004). The primary 
substrate binding site in the b' domain o f ERp57 is adapted for endoplasmic reticulum 
lectin association. J Biol Chem 279, 18861-18869.
Sadasivan, B., Lehner, P. J., Ortmann, B., Spies, T., and Cresswell, P. (1996). Roles for 
calreticulin and a novel glycoprotein, tapasin, in the interaction of MHC class I molecules 
with TAP. Immunity 5, 103-114.
Sadasivan, B. K., Cariappa, A., Waneclc, G. L., and Cresswell, P. (1995). Assembly, 
peptide loading, and transport of MHC class I molecules in a calnexin-negative cell line. 
Cold Spring Harb Symp Quant Biol 60, 267-275.
149
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Salter, R. D., and Cresswell, P. (1986). Impaired assembly and transport o f HLA-A and - 
B antigens in a mutant TxB cell hybrid. Embo J 5, 943-949.
Saric, T., Chang, S. C., Hattori, A., York, I. A., Markant, S., Rock, K. L., Tsujimoto, M., 
and Goldberg, A. L. (2002). An IFN-gamma-induced aminopeptidase in the ER, ERAP1, 
trims precursors to MF1C class I-presented peptides. Nat Immunol 3, 1169-1176.
Schrag, J. D., Bergeron, J. J., Li, Y., Borisova, S., Hahn, M., Thomas, D. Y., and Cygler, 
M. (2001). The Structure of calnexin, an ER chaperone involved in quality control of 
protein folding. Mol Cell 8, 633-644.
Schroder, M., and Kaufman, R. J. (2005). The mammalian unfolded protein response. 
Annu Rev Biochem 74, 739-789.
Sege, K., Rask, L., and Peterson, P. A. (1981). Role of beta2-microglobulin in the 
intracellular processing of HLA antigens. Biochemistry 20, 4523-4530.
Serwold, T., Gonzalez, F., Kim, J., Jacob, R., and Shastri, N. (2002). ERAAP customizes 
peptides for MHC class I molecules in the endoplasmic reticulum. Nature 419, 480-483.
Sevier, C. S., and Kaiser, C. A. (2002). Formation and transfer of disulphide bonds in 
living cells. Nat Rev Mol Cell Biol 3, 836-847.
Shimizu, Y., Geraghty, D. E., Koller, B. H., Orr, H. T., and DeMars, R. (1988). Transfer 
and expression of three cloned human non-HLA-A,B,C class I major histocompatibility 
complex genes in mutant lymphoblastoid cells. Proc Natl Acad Sci U S A 85, 227-231.
Silvennoinen, L., Myllyharju, J., Ruoppolo, M., Orru, S., Caterino, M., Kivirikko, K. I., 
and Koivunen, P. (2004). Identification and characterization of structural domains of 
human ERp57: association with calreticulin requires several domains. J Biol Chem 279, 
13607-13615.
Solda, T., Garbi, N., Hammerling, G. J., and Molinari, M. (2006). Consequences of 
ERp57 deletion on oxidative folding of obligate and facultative clients of the calnexin 
cycle. J Biol Chem 281, 6219-6226.
Sousa, M., and Parodi, A. J. (1995). The molecular basis for the recognition of misfolded 
glycoproteins by the UDP-Glc:glycoprotein glucosyltransferase. Embo J 14, 4196-4203.
Spies, T., Cerundolo, V., Colonna, M., Cresswell, P., Townsend, A., and DeMars, R. 
(1992). Presentation of viral antigen by MHC class I molecules is dependent on a 
putative peptide transporter heterodimer. Nature 355, 644-646.
150
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Spies, T., and DeMars, R. (1991). Restored expression of major histocompatibility class I 
molecules by gene transfer of a putative peptide transporter. Nature 351, 323-324.
Spiliotis, E. T., Manley, H., Osorio, M., Zuniga, M. C., and Edidin, M. (2000). Selective 
export of MHC class I molecules from the ER after their dissociation from TAP. 
Immunity 13, 841-851.
Stam, N. J., Vroom, T. M., Peters, P. J., Pastoors, E. B., and Ploegh, H. L. (1990). HLA- 
A- and HLA-B-specific monoclonal antibodies reactive with free heavy chains in western 
blots, in formalin-fixed, paraffin-embedded tissue sections and in cryo-immuno-electron 
microscopy. Int Immunol 2, 113-125.
Strehl, B., Seifert, U., Kruger, E., Heink, S., Kuckelkorn, U., and Kloetzel, P. M. (2005). 
Interferon-gamma, the functional plasticity of the ubiquitin-proteasome system, and 
MHC class I antigen processing. Immunol Rev 207, 19-30.
Suh, W. K., Derby, M. A., Cohen-Doyle, M. F., Schoenhals, G. J., Fruh, K., Berzofsky, J.
A., and Williams, D. B. (1999). Interaction of murine MHC class I molecules with 
tapasin and TAP enhances peptide loading and involves the heavy chain alpha3 domain. J 
Immunol 162, 1530-1540.
Suh, W. K., Mitchell, E. K., Yang, Y., Peterson, P. A., Waneck, G. L., and Williams, D.
B. (1996). MHC class I molecules form ternary complexes with calnexin and TAP and 
undergo peptide-regulated interaction with TAP via their extracellular domains. J Exp 
Med 184, 337-348.
Tan, P., Kropshofer, H., Mandelboim, O., Bulbuc, N., Hammerling, G. J., and Momburg, 
F. (2002). Recruitment of MHC class I molecules by tapasin into the transporter 
associated with antigen processing-associated complex is essential for optimal peptide 
loading. J Immunol 168, 1950-1960.
Tector, M., Zhang, Q., and Salter, R. D. (1997). Beta 2-microglobulin and calnexin can 
independently promote disulfide bond formation in class I histocompatibility proteins. 
Mol Immunol 34, 401-408.
Tian, G., Xiang, S., Noiva, R., Lennarz, W. J., and Schindelin, H. (2006). The crystal 
structure of yeast protein disulfide isomerase suggests cooperativity between its active 
sites. Cell 124, 61-73.
Tiwari, R. K., Kusari, J., and Sen, G. C. (1987). Functional equivalents of interferon- 
mediated signals needed for induction of an mRNA can be generated by double-stranded 
RNA and growth factors. EMBO J 6, 3373-3378.
151
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Tjoelker, L. W., Seyfried, C. E., Eddy, R. L., Jr., Byers, M. G., Shows, T. B., Calderon,
J., Schreiber, R. B., and Gray, P. W. (1994). Human, mouse, and rat calnexin cDNA 
cloning: identification o f potential calcium binding motifs and gene localization to human 
chromosome 5. Biochemistry 33, 3229-3236.
Tumquist, H. R., Petersen, J. L., Vargas, S. E., Mcllhaney, M. M., Bedows, E., Mayer,
W. E., Grandea, A. G., 3rd, Van Kaer, L., and Solheim, J. C. (2004). The Ig-like domain 
o f tapasin influences intermolecular interactions. J Immunol 172, 2976-2984.
Tumquist, H. R., Vargas, S. E., Mcllhaney, M. M., Li, S., Wang, P., and Solheim, J. C.
(2002). Calreticulin binds to the alphal domain of MHC class I independently o f tapasin. 
Tissue Antigens 59, 18-24.
Tumquist, H. R., Vargas, S. E., Reber, A. J., Mcllhaney, M. M., Li, S., Wang, P., 
Sanderson, S. D., Gubler, B., van Endert, P., and Solheim, J. C. (2001). A region of 
tapasin that affects L(d) binding and assembly. J Immunol 167, 4443-4449.
Van der Wal, F. J., Oliver, J. D., and High, S. (1998). The transient association o f ERp57 
with N-glycosylated proteins is regulated by glucose trimming. Eur J Biochem 256, 51- 
59.
Van Kaer, L., Ashton-Rickardt, P. G., Eichelberger, M., Gaczynska, M., Nagashima, K., 
Rock, K. L., Goldberg, A. L., Doherty, P. C., and Tonegawa, S. (1994). Altered peptidase 
and viral-specific T cell response in LMP2 mutant mice. Immunity 1, 533-541.
Van Kaer, L., Ashton-Rickardt, P. G., Ploegh, H. L., and Tonegawa, S. (1992). TAPI 
mutant mice are deficient in antigen presentation, surface class I molecules, and CD4-8+ 
T cells. Cell 71, 1205-1214.
van Leeuwen, J. E., and Kearse, K. P. (1996). Deglucosylation of N-linked glycans is an 
important step in the dissociation of calreticulin-class I-TAP complexes. Proc Natl Acad 
Sci U S A  93, 13997-14001.
Van Leeuwen, J. E., and Kearse, K. P. (1997). Reglucosylation o f N-linked glycans is 
critical for calnexin assembly with T cell receptor (TCR) alpha proteins but not TCRbeta 
proteins. J Biol Chem 272, 4179-4186.
Vassilakos, A., Cohen-Doyle, M. F., Peterson, P. A., Jackson, M. R., and Williams, D. B. 
(1996). The molecular chaperone calnexin facilitates folding and assembly of class I 
histocompatibility molecules. Embo J 15, 1495-1506.
Walker, K. W., and Gilbert, H. F. (1997). Scanning and escape during protein-disulfide 
isomerase-assisted folding. J Biol Chem 272, 8845-8848.
152
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Walker, K. W., Lyles, M. M., and Gilbert, H. F. (1996). Catalysis o f oxidative protein 
folding by mutants of protein disulfide isomerase with a single active-site cysteine. 
Biochemistry 35, 1972-1980.
Wang, N., Daniels, R., and Hebert, D. N. (2005). The cotranslational maturation of the 
type I membrane glycoprotein tyrosinase: the heat shock protein 70 system hands off to 
the lectin-based chaperone system. Mol Biol Cell 16, 3740-3752.
Warburton, R. J., Matsui, M., Rowland-Jones, S. L., Gammon, M. C., Katzenstein, G. E., 
Wei, T., Edidin, M., Zweerink, H. J., McMichael, A. J., and Frelinger, J. A. (1994). 
Mutation of the alpha 2 domain disulfide bridge of the class I molecule HLA-A*0201. 
Effect on maturation and peptide presentation. Hum Immunol 39, 261-271.
Ware, F. E., Vassilakos, A., Peterson, P. A., Jackson, M. R., Lehrman, M. A., and 
Williams, D. B. (1995). The molecular chaperone calnexin binds GlclMan9GlcNAc2 
oligosaccharide as an initial step in recognizing unfolded glycoproteins. J Biol Chem 270, 
4697-4704.
Watts, C. (2004). The exogenous pathway for antigen presentation on major 
histocompatibility complex class II and CD1 molecules. Nat Immunol 5, 685-692.
Wearsch, P. A., Jakob, C. A., Vallin, A., Dwek, R. A., Rudd, P. M., and Cresswell, P. 
(2004). Major histocompatibility complex class I molecules expressed with 
monoglucosylated N-linked glycans bind calreticulin independently of their assembly 
status. J Biol Chem 279, 25112-25121. Epub 22004 Mar 25131.
Wei, M. L., and Cresswell, P. (1992). HLA-A2 molecules in an antigen-processing 
mutant cell contain signal sequence-derived peptides. Nature 356, 443-446.
Weissman, J. S., and Kim, P. S. (1993). Efficient catalysis of disulphide bond 
rearrangements by protein disulphide isomerase. Nature 365, 185-188.
Wilkinson, B., and Gilbert, H. F. (2004). Protein disulfide isomerase. Biochim Biophys 
Acta 1699, 35-44.
Williams, A. P., Peh, C. A., Purcell, A. W., McCluskey, J., and Elliott, T. (2002). 
Optimization of the MHC class I peptide cargo is dependent on tapasin. Immunity 16, 
509-520.
Williams, D. B., Barber, B. H., Flavell, R. A., and Allen, H. (1989). Role of beta 2- 
microglobulin in the intracellular transport and surface expression of murine class I 
histocompatibility molecules. J Immunol 142, 2796-2806.
153
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Wilson, C. M., Farmery, M. R., and Bulleid, N. J. (2000). Pivotal role o f calnexin and 
mannose trimming in regulating the endoplasmic reticulum-associated degradation of 
major histocompatibility complex class I heavy chain. J Biol Chem 275, 21224-21232.
Wright, C. A., Kozik, P., Zacharias, M., and Springer, S. (2004). Tapasin and other 
chaperones: models o f the MHC class I loading complex. Biol Chem 385, 763-778.
Yan, J., Parekh, V. V., Mendez-Femandez, Y., Olivares-Villagomez, D., Dragovic, S., 
Hill, T., Roopenian, D. C., Joyce, S., and Van Kaer, L. (2006). In vivo role of ER- 
associated peptidase activity in tailoring peptides for presentation by MHC class la and 
class lb molecules. J Exp Med 203, 647-659.
Yang, S. Y., Morishima, Y., Collins, N. H., Alton, T., Pollack, M. S., Yunis, E. J., and 
Dupont, B. (1984). Comparison of one-dimensional IEF patterns for serologically 
detectable HLA-A and B allotypes. Immunogenetics 19, 217-231.
Yewdell, J. W., and Nicchitta, C. V. (2006). The DRiP hypothesis decennial: support, 
controversy, refinement and extension. Trends Immunol 27, 368-373.
York, I. A., Chang, S. C., Saric, T., Keys, J. A., Favreau, J. M., Goldberg, A. L., and 
Rock, K. L. (2002). The ER aminopeptidase ERAP1 enhances or limits antigen 
presentation by trimming epitopes to 8-9 residues. Nat Immunol 3, 1177-1184.
Zapun, A., Darby, N. J., Tessier, D. C., Michalak, M., Bergeron, J. J., and Thomas, D. Y. 
(1998). Enhanced catalysis of ribonuclease B folding by the interaction of calnexin or 
calreticulin with ERp57. J Biol Chem 273, 6009-6012.
Zarling, A. L., Luckey, C. J., Marto, J. A., White, F. M., Brame, C. J., Evans, A. M., 
Lehner, P. J., Cresswell, P., Shabanowitz, J., Hunt, D. F., and Engelhard, V. H. (2003). 
Tapasin is a facilitator, not an editor, of class I MHC peptide binding. J Immunol 171, 
5287-5295.
Zijlstra, M., Bix, M., Simister, N. E., Loring, J. M., Raulet, D. H., and Jaenisch, R. 
(1990). Beta 2-microglobulin deficient mice lack CD4-8+ cytolytic T cells. Nature 344, 
742-746.
154
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Appendix I: Table of Abbreviations
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Appendix II: Table of Cell Lines
Cell Line Parent cell 
Phenotype Transfected Ref
293T (DuBridge et 
al., 1987)
K41 WT MEF (Gao et al.,
K42 CRT -/- MEF 2002)















(Maio et al., 
1991)
C1R.A2.WT HLA-A*0201,MHC class I WT-FLAG ERp57 (Dick et al., 
2002)reduced HLA-A*0201,C1R.A2.C60A C60A-FLAG
ERp57




























(Peh et al., 
1998)
(Dick et al., 
2002)
C95A Tapasin
B44.N233A-Tpsn HLA-B*4402, N233A Tapasin 
HLA-B*4402, WT
This Study
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148.3 TAPI C-terminal peptide 1:1000 (Meyer et al., 1994)
3B10.7 MHC class I HC Free MHC class I HC 1:10,000
(Lutz and Cresswell, 
1987)
4E HLA-B and -C with |32m
Conformation 
dependent epitope
N/A (Yang et al., 1984)
51.1.3
CD Id/ |32m 
complexes
Conformation 
dependent epitope N/A (Exley et al., 1997)
BB7.2 HLA-A*0201 with Conformation N/A (Parham and|32m dependent epitope Brodsky, 1981)
CD4 APC-coupled N/A eBioscience, L3T4
HC10 Free HLA-B, C HC only 1:1000 (Stam et al., 1990)
M.ERp72 ERp72 Denaturing only 1:100 BD Transduction Labs, 610970
M.GAPDH GAPDH 1:20,000 RDI, 6C5
M.HLA-
ABC-APC
MHC class 1/ p2m 
complexes
Directly coupled BD Biosciences, G46-2.6
M.PDI PDI 1:1000 ABR, MA3-018
M.Tpsn-C Tapasin C-terminal peptide
1:100 This study
M2 FLAG-epitope tag 1:1000 Sigma, M2
MaP.ERp57 FL ERp57 1:1000 (Diedrich et al., 2001)
PaSta 1 Soluble Tpsn Conformation dependent epitope N/A (Dick et al., 2002)
R.DRAB HLA-DR N/A (Marks et al., 1990)
R.ERp57-C ERp57 C-terminal peptide
1:500 (Hughes and Cresswell, 1998)
R.ERp57-FL Full Length ERp57 1:1000 (Diedrich et al., 2001)
R.gp48C Tapasin C-terminal peptide
1:1000 (Bangia et al., 1999)
R.gp48N Tapasin N-terminal peptide
Very redox 
sensitive 1:1000 (Lehner et al., 1998)
R.SinA Soluble Tpsn 1:1000
(Ortmann et al., 
1997)
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RING.4C TAPI C-terminal peptide 1:7,500
(Meyer et al., 1994)
Rt.Grp94 Grp94 1:40,000 Stressgen, SPA-850
W6/32 MHC class I/p2m Conformation N/A (Barnstable et al.,
complexes dependent epitope 1978)
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